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ABSTRACT 
The perinatal period has been recognized as a time of increased vulnerability for women 
to experience mood related symptoms and disorders. Women’s reproductive years, particularly, 
pregnancy and postpartum, are often associated with increased moodiness. These seemingly 
“harmless” mood fluctuations are often regarded as a normal part of a woman’s life. Therefore, 
there is very limited research on perinatal mood instability (MI). The primary goal of this 
dissertation was to systematically review the current existing literature of perinatal MI, its 
relation to perinatal depression, and its effects on children. The second goal was to examine the 
risk factors for perinatal MI, the association between antenatal MI and postpartum depression 
(PPD), and the trajectory of perinatal MI. The third goal was to investigate effects of antenatal 
MI, depression, and anxiety on neonatal outcomes. The fourth goal was to evaluate the construct 
validity of the Affective Lability Scale-18 (ALS-18) in pregnant and postpartum women with 
mood symptoms. 
Manuscript one systematically reviewed existing literature on perinatal MI, its relation to 
perinatal depression, and its effects on children. A significant gap in perinatal MI research was 
identified. 
Manuscript two’s results suggest that depression, history of depression, stress, and 
labour/birth complications were significant risk factors for perinatal MI in a community sample 
of 648 women. Mood instability during early pregnancy was strongly associated with PPD. In 
addition, the trajectory of perinatal MI had an overall decreased trend through perinatal period.   
Manuscript three’s findings indicate no association between antenatal MI or antenatal 
depression and neonatal outcomes in a community sample of 648 women. Antenatal anxiety was 
significantly associated with low 1-minute and 5-minute Apgar scores and LBW.  
iii  
Manuscript four explored the psychometric properties of the ALS-18 in a clinical sample 
of 113 perinatal women with various mood symptoms. The findings suggest that ALS-18 is an 
effective instrument for assessing MI in perinatal women 
Taken together, the findings implicate that more research on perinatal MI is needed. In 
order to optimize the wellbeing of mothers, their babies, and their families, increasing awareness 
of perinatal MI among the general public and health care professionals, and screening and 
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Having a baby is a life-changing event for a woman. For most new mothers, the birth of a 
child arouses joy and a sense of fulfillment (Petch & Halford, 2008). An ideal image of happiness 
and excitement is widely associated with childbirth in our society (Petch & Halford, 2008). 
However, the perinatal period, which spans from conception to the first 12-months postpartum, is a 
period of major transition that can bring about many challenges for the woman and her family 
(Matthey, 2010; Nelson, 2003). For example, changes in relationships, new roles and 
responsibilities, different daily routines and work patterns, and perhaps financial difficulties can 
occur (Nelson, 2003). During this period, expectant and new mothers also undergo many 
psychological and biological changes throughout pregnancy, birth, and breastfeeding. Thus, 
although pregnancy, giving birth, and postpartum are the most natural reproductive phenomena, 
they are associated with significant stress, for example, nausea and vomiting during pregnancy that 
can have an negative impact on the quality of a woman’s life (Chou, Avant, Kuo, & Fetzer, 2008), 
remarkable emotional, behavioural, cognitive adjustments to adapt to the demands of motherhood 
during postpartum and infant care, and the lack of sleep and resulting fatigue that commonly occur 
in postpartum women (Goyal, Gay, & Lee, 2007). 
 In addition, this transition toward motherhood represents a time of greater vulnerability for 
women to develop mood related disorders, such as perinatal depression, anxiety, and other mood 
disturbances including mood instability (MI) (Bowen, A., Bowen, Balbuena, & Muhajarine, 2012; 
Kessler et al., 2003; Steiner, Dunn, & Born, 2003). Depression in women is second only to 
HIV/AIDS regarding global morbidity (O'Hara, 2009). Epidemiologic studies suggest that the 
lifetime prevalence of mood disorders in women is approximately twice that of men (Kessler et al., 
2003; Weissman et al., 1996). Perinatal mood disorders have been investigated extensively; in 
particular, perinatal depression and anxiety have received substantial research attention 






2008; Pope & Pope, 2000).   
1.1 Perinatal depression 
 Perinatal depression encompasses major and minor depressive episodes that occur during 
pregnancy or up to one year following delivery (Matijasevich et al., 2015). Prevalence estimates 
for antenatal depression range from 7.4% in the first trimester, to 12.8% in the second and 12.0% 
in the third (Bennett, Einarson, Taddio, Koren, & Einarson, 2004). The prevalence rate was 
estimated at 19.2%, for minor and major depression in the first 3-months of postpartum (Gavin et 
al., 2005). Based on the data of the Maternity Experiences Survey of the Canadian Perinatal 
Surveillance System, Dennis, C., Heaman, and Vigod (2012) examined 6,421 women between 5 
and 14 months postpartum, and assessed depressive symptoms using the Edinburg Postnatal 
Depression Scale (EPDS), and found that about 8% of Canadian women experienced depression 
(EPDS ≥ 13) in the past 12 weeks during the postpartum period. Another Canadian study, a 
longitudinal cohort of 648 perinatal women utilizing EPDS (≥ 12) to measure depressive 
symptoms, found that 14% of women exhibited depressive symptoms at 17 weeks pregnancy, 
10.4% at 31 weeks pregnancy, and 8.1% at 4 weeks postpartum (Bowen, A., Bowen, Butt, 
Rahman, & Muhajarine, 2012). The authors suggested that antenatal depression seems to be more 
prevalent than postpartum depression (PPD), and perinatal depression appears to have a declined 
trend from pregnancy to postpartum. Similar findings were reported in a longitudinal study with 
239 women using the Clinical Interview Schedule (CIS) to measure depressive symptoms: 15.5% 
of women were depressed during early and mid-pregnancy, 11.1% during in the third trimester, and 
8.7% during 8-10 weeks postpartum (Felice, Saliba, Grech, & Cox, 2004).   
Throughout pregnancy and early postpartum, hormones such as estrogens, and progesterone 
associated with pregnancy and parturition fluctuates substantially (Klier et al., 2007; O'hara, 






rates of a depressive episode (Bennett, Einarson, Taddio, Koren, & Einarson, 2004; Bowen, A., 
Bowen, Butt, Rahman, & Muhajarine, 2012; Matijasevich et al., 2015). The unique timing of 
depressive symptoms observed in perinatal women and the biology of the perinatal period have 
sparked investigations into whether the depressive symptoms experienced by perinatal women are 
unique or different from the depression occurring during non-perinatal periods. A majority of 
evidence has shown that the symptoms of antenatal depression and PPD seem to be remarkably 
similar to the symptoms of depression occurring at other times in the lifespan (Boath & Henshaw, 
2001). The Diagnostic and Statistical Manual of Mental Disorders Fifth Edition (DSM-V) supports 
this point of view, and the description of major depression includes an antenatal or postpartum 
onset up to the first four weeks postpartum (American Psychiatric Association, 2013). Major 
depression symptoms in the DSM-V include nine symptoms: depressed mood, loss of interest or 
pleasure, change in weight or appetite, insomnia or hypersomnia, psychomotor agitation or 
retardation, loss of energy or fatigue, worthlessness or guilt, impaired concentration or 
indecisiveness, and recurrent thoughts of death or suicidal ideation or attempt (American 
Psychiatric Association, 2013). 
To detect and treat perinatal depression early, screening is the key (O'Hara & McCabe, 
2013). The World Health Organization (WHO) does not have a guideline for maternal depression 
screening. Nationally, the Canadian Task Force on Preventive Health Care recommended only 
screening for perinatal depression when symptoms are apparent (Joffres et al., 2013). Universal 
screening for perinatal depression has not been recommended at a national level in Canada. 
Provincially, the British Columbia government developed guidelines entitled “Best Practice 
Guidelines for Mental Health Disorders in the Perinatal Period” which recommended that universal 
screening of perinatal women should occur at periodic intervals (Williams et al., 2014). In 






for both depression and anxiety starting at first prenatal visits, at 28-34 weeks pregnancy, at three 
weeks postpartum, and again at the time when children have their immunizations (Bruce, Béland, 
& Bowen, A. 2012). Internationally, the UK’s National Institute for Health and Care Excellence 
developed “Antenatal and postnatal mental health: clinical management and service guidance”, 
with guidelines covering every stage of a woman’s experience of childbearing from pre-conception 
to postpartum (National Collaborating Centre for Mental Health, 2014). In 2009, the Government 
of Australia developed the National Perinatal Depression Initiative, and updated the Initiative in 
2017, which recommended that women should be universally screened for depression: the first 
time of screening antenatal depression as early as practical in pregnancy and repeat screening at 
least once later in pregnancy; for postpartum women, screening depression 6 – 12 weeks after birth 
and repeat screening at least once within 12 month of postpartum (Austin, Highet, & Expert 
Working Group, 2017). To improve maternal mental health, a national strategy for maternal mental 
health should be prioritized in Canada (Williams et al., 2014).     
1.2 Perinatal anxiety 
The perinatal period from pregnancy to up to one year postpartum is considered to be a time 
of significant risk for experiencing anxiety symptoms (Brockington, Macdonald, & Wainscott, 
2006). The ratio of anxiety disorders between women and men is estimated at 2:1, which is similar 
to depression (Glover, 2014; Martini et al., 2015). According to the DSM-V, anxiety disorders 
include a spectrum of disorders, for example, generalized anxiety disorder, panic disorder, and 
phobias (American Psychiatric Association, 2013). In addition, perinatal-related anxiety is 
characterized by pregnancy-specific and birth-specific fears and worries, which may appear to be a 







The prevalence of perinatal anxiety between 2006 and 2014 was estimated to be 2.6 - 39% 
in pregnancy period and 3.7 - 20% during postpartum according to a systematic review on 98 
articles worldwide (Leach, Poyser, & Fairweather‐Schmidt, 2017). In a UK study of 8,323 women 
recruited between April 1991 and December 1992, 1,105 (13%) women experienced anxiety 
symptoms across the eight-week and eight-month postpartum assessments, and two-thirds of these 
women reported that they experienced anxiety in pregnancy (Heron et al., 2004). A computer-
assisted telephone survey with 1,507 Australian women expecting their first child found that 8.5% 
of women experienced intense anxiety or panic attacks occasionally or often between 6-9 months 
postpartum (Woolhouse, Brown, Krastev, Perlen, & Gunn, 2009). Information on Canadian 
prevalence of perinatal anxiety is lacking. The Public Health Agency of Canada (PHAC) estimated 
the prevalence of perinatal anxiety to be about 16% in 2002 (PHAC, 2002).     
Increasing evidence indicates that women experience anxiety frequently during pregnancy 
and postpartum, and the prevalence rate of anxiety is higher than the rate of depression during the 
perinatal period (Heron et al., 2004; Meades & Ayers, 2011). Despite the scientific evidence of 
anxiety in perinatal women, there are no current guidelines for screening perinatal anxiety globally 
or nationally in Canada. Provincially, the British Columbia government developed guidelines 
entitled “Best Practice Guidelines for Mental Health Disorders in the Perinatal Period” which 
recommended the same screening for anxiety as exists for depression (Williams et al., 2014). In 
Saskatchewan, the “MotherFirst” strategy recommended the same universal screening of perinatal 
women for anxiety (Bruce et al., 2012). Once again, a national strategy for diagnosing perinatal 
anxiety and depression should be in place.  
1.3 The relationship between perinatal anxiety and depression 
Although anxiety and depression are two separate disorders, they occur comorbidly in as 






Abelson, & Cameron, 2004). Pollack (2005) suggests that patients that have depression with 
comorbid anxiety experience more severe depressive symptoms and more prolonged depressive 
episodes in comparison with patients with only depressive symptoms. For perinatal women, studies 
report a strong association between postpartum anxiety and PPD, with the two conditions often 
occurring concurrently (Stuart, Couser, Schilder, O'Hara, & Gorman, 1998; Wenzel, Haugen, 
Jackson, & Brendle, 2005). Women who report experiencing anxiety during pregnancy are also 
significantly more likely to experience postpartum anxiety (Austin, Tully, & Parker, 2007; Heron 
et al., 2004). A French study of 497 perinatal women, who were assessed at their third trimester 
and at six weeks postpartum, found that anxiety during late pregnancy is an independent predictor 
for intensity of PPD symptoms (Sutter-Dallay, Giaconne-Marcesche, Glatigny-Dallay, & Verdoux, 
2004). A population-based study of 4,451 postpartum women in the US reported that of the 18% of 
women who experienced anxiety, 35% also reported postpartum depressive symptoms, indicating 
6.3% of comorbidity (Farr, Dietz, O'Hara, Burley, & Ko, 2014).  
In the literature of comorbidity among psychiatric disorders, studies suggest that 
comorbidity may reflect overlapping diagnostic criteria, and arbitrary subdivision of syndromes 
when one disorder displays an early symptom of another, or one disorder is part of another disorder 
(Brown, Campbell, Lehman, Grisham, & Mancill, 2001; Cerdá, Sagdeo, & Galea, 2008; Kessler, 
Chiu, Demler, & Walters, 2005). In regards to the association between anxiety and depression, the 
comorbidity between them has been conceptualized in a tripartite model (Clark & Watson, 1991). 
The model suggests that depression and anxiety have their distinct symptoms, for example, 
anhedonia for depression and hyperarousal for anxiety, but they share a central common ‘distress’ 
component. The shared general distress factor is manifested both as a transient state and as a more 
stable trait (Clark & Watson, 1991), and is in line with an internalizing factor in depression, 






al., 2001). Emotion regulation appears to play an important role in anxiety and depressive 
disorders, for example, emotion dysregulation may create cognitive and functional difficulties in 
individuals with anxiety and/or depression, such as decreased awareness, poor understanding, 
inhibited or inappropriate expression, and difficulty managing emotions (McLaughlin, 
Hatzenbuehler, Mennin, & Nolen-Hoeksema, 2011; Southam-Gerow & Kendall, 2000).  
1.4 The trajectory of perinatal depression and anxiety 
 A majority of cases of PPD were reported experiencing depressive symptoms during 
pregnancy, suggesting strong predictability of antenatal depression for PPD (Heron et al., 2004). In 
the same study with 8,469 women in the UK, Heron et al. (2004) found that 43.7% of women with 
PPD were preceded by elevated depressive symptoms at early, mid, or late pregnancy. In regards to 
onset timing of antenatal depression, a UK study with 9,028 women found that of the 7,966 women 
who were not depressed at 18 weeks of pregnancy, 673 (8.4%) were new cases of depression at 32 
weeks of pregnancy. Of the 7,806 non-depressed women at 32 weeks of pregnancy, 419 (5.3%) 
became depressed at eight weeks postpartum (Evans, J., Heron, Francomb, Oke, & Golding, 2001). 
In a systematic review, Pope (2000) suggested that 40-50% of all new cases of PPD reported an 
onset within the first three months after giving birth. Smith and Howard (2008) reported that 
maternal depressive symptoms had a declining trend from 6 to 24 months postpartum. Similarly, 
Heron et al. (2004) found a mean decrease in depressive symptoms from pregnancy to postpartum. 
In regards to duration, remission among women with PPD was reported about 25-60% within the 
first three-six months postpartum, and within the first 12 months an additional remission of 15-
25% was found (Pope & Pope, 2000). However, McMahon et al. (2011) suggested that 56% of the 
women who were diagnosed with depression at four months postpartum reported experiencing 






 Research examining the course of anxiety has been less consistent. Studies found relative 
stability in anxiety from pregnancy to postpartum as a majority (64%) of women who experienced 
an elevated level of anxiety during early pregnancy also reported an increased level of anxiety 
during postpartum (Heron et al., 2004). Grant, McMahon, and Austin (2008) also found that 47.6% 
of women who met criteria for an anxiety disorder during pregnancy continued to meet the criteria 
in postpartum, suggesting that antenatal anxiety is the best predictor for postpartum anxiety. 
Similar to depression, Heron et al. (2004) found a mean declining for anxiety level from pregnancy 
to postpartum overall. In contrast, other research showed that the course of anxiety during perinatal 
period had a fluctuating trend. For example, Teixeira et al. (2009) found that anxiety symptoms 
follow a U-shaped pattern during pregnancy: elevated during the first trimester, declined during the 
second trimester, and elevated again in the third trimester. 
1.5 Risk factors for perinatal depression and anxiety 
 The etiology of perinatal depression and anxiety remains unclear; however, it is known that 
there is no one single cause (O'Hara & McCabe, 2013). Although neurobiological and genetic 
studies of depression and anxiety demonstrated that some individuals have a genetic vulnerability 
or predisposition to developing mood disorders, other psychosocial and non-psychosocial factors 
also play a role in causing the disorders (Dubovsky, Davies, & Dubovsky, 2003).  
 Studies on the risk factors for antenatal depression concluded that significant predictors for 
antenatal depression and anxiety include multiparity, unintended pregnancy, low self-esteem, 
antenatal anxiety, low social support, negative cognitive style, major life events, low income, and 
history of abuse (Fellenzer & Cibula, 2014; Halbreich, 2004; Lee et al., 2007; Leigh & Milgrom, 
2008). Antenatal depression is also identified as a mediator between PPD and other risk factors 
(low self-esteem, antenatal anxiety, low social support, negative cognitive style, major life events, 






Ample studies have been conducted to investigate risk factors for PPD, including cross-
sectional and longitudinal studies. The best-estimated risk factors are proposed to be a history of 
depression, antenatal depression, antenatal anxiety, and adverse life event  ( Guintivano, Manuck, 
Meltzer-Brody, 2018; Pope, S. & Pope, 2000; Robertson, Grace, Wallington, & Stewart, 2004). 
Stowe, Hostetter, and Newport (2005) suggest that nearly 90% of women with antenatal depression 
had a history of depression, while over 50% of women reported a history of PPD. A longitudinal 
study investigates the relationship between perinatal depression and a history of mental health 
problems before conception in adolescence and young adults, and found that a history of mental 
health problems predicts perinatal depression (Patton et al., 2015). The study indicates that 34% of 
women with a history of mental health problems experienced symptoms of perinatal depression, 
compared to 8% of those without a history of mental health problems.  
A synthesis of two major meta-analyses conducted on over 14,000 women, and subsequent 
large-scale clinical studies identified strong, moderate, and weak risk factors for PDD (Roberts, A. 
et al., 2004). Strong risk factors for PPD include antenatal depression, a history of depression, and 
a history of mental health disorders, life events, and lack of social support; moderate risk factors 
are recognized as neuroticism and marital relationship; weak risk factors are known as obstetric 
factors and socioeconomic status; maternal age, level of education, and parity were not associated 
with PPD (Robertson et al., 2004). Other studies produce mixed results of risk factors for PPD: 
maternal age and parity, terminating breastfeeding, and childhood abuse (Reck et al., 2008; 
Wilkinson & Scherl, 2006; Ystrom, 2012). The mixed results may be due to different measures, or 
assessment at various time points of perinatal period.  
Risk factors for anxiety during the postpartum period have been identified, for example, 
low self-esteem, poor social support, cesarean birth, stress, and child sleep problems (Clout & 






factors increase the likelihood of postpartum anxiety: multiparous parity, history of psychiatric 
problems, perceived stress, and childcare stress (Dennis, C, Falah‐Hassani, Brown, & Vigod, 
2016). Relatively limited research is available on risk factors for perinatal anxiety, especially the 
longitudinal relationship between perinatal anxiety and its risk factors at different timing of 
perinatal period.  
1.6 Effects of perinatal depression and anxiety on mothers, neonatal, and child health 
outcomes 
Perinatal depression and anxiety have a profound impact on women’s lives; ranging from 
physical, psychological, and mental suffering to diminishing their ability to function effectively 
(O'Hara & McCabe, 2013). Thus, the consequences of perinatal depression and anxiety can be far-
reaching and extended to the long-term effects on women, their children, and their family.  
1.6.1 Effects of perinatal depression and anxiety on mothers 
During the perinatal period, mothers with depression and anxiety are more likely to 
experience somatic symptoms, anxiety, irritability, withdrawal, sadness, worthlessness, or guilt 
(O'Hara, 2009). Mothers with antenatal depression have been found to be less interested in 
attending perinatal classes and routine check-ups, and are less likely to adhere to a nutritious diet 
(Lee et al., 2007; Leigh & Milgrom, 2008). Studies showed that mothers with perinatal depression 
are significantly associated with the risk for suicidality (Lindahl, Pearson, & Colpe, 2005; Sit et al., 
2015). Depressed and anxious mothers are at a higher risk of using tobacco, alcohol, and drugs 
(Bonari, Bennett, Einarson, & Koren, 2004; Chan, Natekar, Einarson, & Koren, 2014). Studies 
showed that women with depression and anxiety are more likely to experience labour/birth 
complications such as caesarean section, induced labour, or pre-term birth (Andersson, Sundström-
Poromaa, Wulff, Åström, & Bixo, 2004; Wilkie & Deligiannidis, 2014). In regards to infant care, 






breastfeeding (Dennis, C. & McQueen, 2009; Hahn-Holbrook, Haselton, Schetter, & Glynn, 2013). 
Less optimal infant sleep practices have been observed in mothers who experience depressive 
symptoms, such as sharing a bed with parents, prone position, and disturbed sleep patterns (Dennis, 
C. & Ross, 2005; Sadeh, Tikotzky, & Scher, 2010).  
 Parenting styles among mothers with PPD have been documented. Mother-infant 
interaction has been viewed as a very important aspect of late cognitive, social, emotional and 
physical development (Field, T., Diego, & Hernandez-Reif, 2006). Depressed mothers have been 
observed using less vocal and visual communication, being withdrawn and passive, and displaying 
less affection and smiling during interactions with their infants (Ferber, Feldman, & Makhoul, 
2008; Field, 2010). Mothers with PPD were found less likely to read, sing, and play games with 
their babies (Paulson, Dauber, & Leiferman, 2006). Depressed mothers were found to be more 
likely to use physical punishment in parenting, such as slapping or spanking the child with an 
object (McLearn, Minkovitz, Strobino, Marks, & Hou, 2006). 
Perinatal depression and anxiety may put a strain on women’s relationships with their 
partners. Postpartum depression has been associated with marital dysfunction such as 
disagreements, hostility, withdrawal, separation, and divorce (Davies & Windle, 1997; Meadows, 
McLanahan, & Brooks‐Gunn, 2007). Furthermore, marital problems persist beyond women’s 
remission from the depression (Goodman, 2005). Studies found that men whose partners 
experience PPD are at an increased risk of developing a depressive disorder, having non-specific 
psychological issues, experiencing fatigue, and more likely to seek a marital separation or divorce  
(McCue-Horwitz, Briggs-Gowan, Storfer-Isser, & Carter, 2007; Roberts, S., Bushnell, Collings, & 








1.6.2. Effects of perinatal depression and anxiety on neonatal and child outcomes 
The work of Barker’s fetal origins of adult disease hypothesis states that adverse influences 
early in development, and particularly during intrauterine life, can result in permanent changes in 
physiology and metabolism, which result in increased disease risk in adulthood (Godfrey & Barker, 
2001). The key observation was based on birth weight (BW) that was a strong risk factor for 
coronary heart disease, diabetes mellitus, and obesity later in life (Barker, 2002; Das, 2003).  
 Perinatal depression and/or anxiety have been associated with adverse neonatal outcomes 
such as low BW, small for gestational age (SGA), preterm birth, and low Apgar score (Berle et al., 
2005; Glover, O’Connor, & O’Donnell, 2010; Li, Liu, & Odouli, 2008; Patel, V. & Prince, 2006). 
Several potential causal pathways through which prenatal depression and anxiety may lead to 
adverse birth outcomes have been proposed. One potential mechanism was identified as changes in 
maternal hypothalamic–pituitary–adrenal (HPA) axis activity. Increased maternal HPA axis 
activity has been observed during the perinatal period (Smith, A. et al., 2011). However, 
experiencing elevated levels of depression and anxiety during pregnancy may contribute to an 
increase in stress hormones, such as cortisol and catecholamine (Evans, L., Myers, & Monk, 2008). 
The release of stress hormones have also been found to cause changes in immunologic functioning 
and uterine blood flow during human pregnancy, thus increasing vulnerability to preterm birth, 
SGA, and low BW (Challis, 2000; Chen, K., Chen, L., & Lee, 2012; Goldenberg, Culhane, Iams, & 
Romero, 2008; Harrington, Cooper, Lees, Hecher, & Campbell, 1996; Misra, Hobel, & Sing, 2009; 
Mulder et al., 2002). In addition, placental 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2) 
as another potential mechanism contributing to adverse birth outcomes has been investigated. 11β-
HSD2, which catalyzed rapid inactivation of maternal corticosterone to inert 11-
dehydrocorticosterone, served as a physiological ‘barrier’ to maternal glucocorticoids. Maternal 






activity depressed placental barrier function (O’Donnell et al., 2012). Evidence indicated that 
overexposure to maternal glucocorticoids induced by downregulation of 11β-HSD2 mRNA 
expression and activity predicted subsequent preterm birth (PTB) and low BW (Dy, Guan, 
Sampath-Kumar, Richardson, & Yang, 2008; Kajantie et al., 2003).  
Extensive research has suggested that maternal depression and anxiety can have a negative 
impact on the infant and the mother-infant relationship, and also has a long-lasting effect on 
childhood and beyond (O'Hara & McCabe, 2013). For example, Field (1984) investigated the early 
interaction between infants and depressed mothers at three months postpartum, and found the 
depressed mothers’ infants show fewer positive facial expressions and more negative expressions 
compared to infants with non-depressed mothers. Infants of mothers with PPD were observed 
having regulation difficulties as early as one month after delivery, for instance, infants displayed 
poorer self-regulation, more stress signs, and heightened arousal compared with infants of mothers 
without PPD (Salisbury et al., 2007). Studies on mother-infant interactions found that women with 
PPD are linked to maternal withdrawal, disengagement, intrusion, and hostility (Lovejoy, Graczyk, 
O'Hare, & Neuman, 2000; Martins & Gaffan, 2000). An association between PPD and insecure 
infant attachment with predominantly avoidance was suggested at 12 months and 18 months  
(McCabe, 2014; Stacks et al., 2014). Regarding the longer term outcome, maternal depression has 
been associated with behavioural, cognitive, and health-related problems in children’s development 
(O'Hara & McCabe, 2013). Brennan et al. (2000) examined the relationship between PPD and child 
behaviour, and found that both severity and chronicity of maternal depressive symptoms predicted 
future child behavioural problems, which was confirmed in another prospective longitudinal study 
of children with depressed mothers ( Bell, Bayliss, Glauert, Harrison, & Ohan, 2018). The 
literature investigating the impact of PPD on child cognitive development has been well 






children, and that the effect may last into adolescence (Brand & Brennan, 2009; Grace, Evindar, & 
Stewart, 2003; Sohr-Preston & Scaramella, 2006). Finally, negative impacts on physical 
development have been related to PPD, such as poor child physical growth (Ertel, Koenen, Rich‐
Edwards, & Gillman, 2010).  
1.7 Mood Regulation  
Mood can vary from moment to moment, and one’s transient moods can have profound 
impacts on judgment, behaviour, and a variety of cognitive process (Clore et al., 2001). Mood 
regulation is conceptualized as consisting of a series of modifying or maintaining of the 
occurrence, duration, and intensity of both negative and positive moods (Cole, Martin, & Dennis, 
2004; Eisenberg & Spinrad, 2004; Larsen, 2000). One assumption is that people want to feel good, 
therefore are motivated do things by creating and retaining the pleasure they feel (Larsen, 2000). 
Larsen (2000) analogues mood regulation as a home thermostat in the winter or air-conditioner in 
the summer. The “feeling good” mood is the temperature people set on the thermostat/air-
conditioner. When the temperature in the home is altered by opening the door or outside 
temperature, the thermostat/air-conditioner starts to work or regulate until the indoor temperature 
returns to the “feeling good” point. Individuals either consciously or automatically use various 
strategies to regulate their mood (Larsen, 2000). Some of the strategies focus on modifying 
emotions, for example by distracting the attention away from the negative situations, reappraising 
the situation, and labeling the emotions (Schmidt, Tinti, Levine, & Testa, 2010). Individual 
differences of mood regulation or ability to regulate mood have many important consequences, for 
example, mood dysregulation or mood instability (MI) have been associated with many 
psychopathologies (depression, borderline personality disorder (BPD), anxiety disorder) (Bowen, 
R., Baetz, Hawkes, & Bowen, 2006; Thompson, R. J., Berenbaum, & Bredemeier, 2011; Trull et 






1.8 Mood Instability 
Mood instability is widely described in psychiatric literature. The term is used 
interchangeably with mood dysregulation, affective instability, affective lability, affective and 
emotional dysregulation, and mood swings (Marwaha, Broome, Bebbington, Kuipers, & Freeman, 
2014; Teicher, Ohashi, Lowen, Polcari, & Fitzmaurice, 2015). Mood instability is defined as 
“extreme and frequent fluctuations of mood over time” (Trull et al., 2008). Mood instability as a trait 
is defined as “a marked reactivity of mood” in the DSM-V as a borderline personality disorder 
(BPD) criterion (American Psychiatric Association, 2013). Mood instability is a 
psychophysiological symptom reported not only in psychopathologies, such as BPD and bipolar 
disorders (BD), but it is also seen in other psychiatric disorders (e.g., depressive, anxiety, eating 
disorders, substance abuse, seizures, and brain lesions) (Anestis et al., 2009; Benazzi, 2008; 
Bowen, R., Balbuena, Peters, Leuschen-Mewis, & Baetz, 2015; Bowen, R., Clark, & Baetz, 2004; 
Kober & Bolling, 2014; Koenigsberg, 2010; Sobanski et al., 2010; Thompson, R. J. et al., 2011). 
Patients often describe MI as an “emotional roller coaster” that related to a subjective sense of 
strong affects and emotions that are experienced in an uncomfortable and rapid sequence. Based on 
a study of the Adult Psychiatric Morbidity Survey 2007 in England, the prevalence of MI was 
estimated as 13.9% of the population over 16 years of age (Marwaha, Parsons, Flanagan, & 
Broome, 2013). 
1.8.1 The association between mood instability and psychiatric disorders 
According to DSM-V, MI is not a diagnosable psychiatric disorder, however, evidence has 
gradually emerged that MI as a stable personality trait increases vulnerability to a variety of mental 
disorders (Berenbaum, Bredemeier, Boden, Thompson, & Milanak, 2011). Mood instability 
constitutes a primary feature of various types of psychopathology including depression (Bowen, R., 






al., 2004; Campbell-Sills, Barlow, Brown, & Hofmann, 2006), BD (Hofmann & Meyer, 2006; 
Stange et al., 2016), eating disorders (Anestis et al., 2009; Santangelo et al., 2014), suicidality 
(Arria et al., 2009; Baetz & Bowen, 2011), attention deficit hyperactivity disorder (ADHD) 
(Gudjonsson, Sigurdsson, Adalsteinsson, & Young, 2013; Skirrow & Asherson, 2013), post-
traumatic stress disorder (PTSD) (Kashdan, Uswatte, Steger, & Julian, 2006; Marwaha, Parsons, & 
Broome, 2013), and BPD (Conklin, Bradley, & Westen, 2006; Leichsenring, Leibing, Kruse, New, 
& Leweke, 2011). Some researchers suggested that MI is important and distinct enough to be 
considered as a separate construct (Angst, Gamma, & Endrass, 2003; Bowen, R., Baetz, Leuschen, 
& Kalynchuk, 2011; Marwaha, Parsons, & Broome, 2013).  
1.8.2 Neurobiological risk factors for mood instability 
Most of neurobiological studies in the relationship between MI and neurobiological factors 
have been focused on borderline personality disorder (BPD) and bipolar disorder (BD). Mainly 
because MI is a core feature of BPD and BD, and has assumed importance in the psychiatric 
literature (Aas et al., 2015; American Psychiatric Association, 2013). Neuroimaging has been 
commonly used to investigate structure-function and brain-behaviour relationships.       
Ample hypotheses have suggested the relationships between MI and neural substrates, 
between MI and neural networks, and between MI and neurochemical modulatory mechanisms 
(Kober & Bolling, 2014). For example, the wealth of the studies suggested that anomalies in 
amygdala activity and connectivity underlie the emotional instability in BPD (Broome, He, 
Iftikhar, Eyden, & Marwaha, 2015; Koenigsberg et al., 2014; Schulze, Schmahl, & Niedtfeld, 
2016). Whalley et al. (2015) report that there are deficits within fronto-limbic connections in 
individuals with BPD. Three networks (salience network, default mode network, and central 
executive network) have been known for their involvement in emotion and behaviour regulation in 






cognitive control and the salience network in emotion regulation, studies examined intrinsic 
functional connectivity within the three networks, and provide evidence for an aberrant three 
network in BPD (Doll et al., 2013; Wolf et al., 2011). Jukic et al. (2015) suggested that aberrant 
development of monoaminergic neurons leads to mood fluctuations, and may be associated with 
BD. Studies suggest that a reduced connectivity between dorsolateral prefrontal cortex and 
amygdala may reflect abnormal modulation of mood in bipolar patients (Radaelli et al., 2015), and 
impairment of the ventromedial system is responsible for involuntary regulation of the behavioral 
response to emotional stimuli, and the appraisal and encoding of emotional stimuli in patients with 
BD (Almeida et al., 2009).  
Dysregulations of homeostatic mechanisms may play an important role of affective 
instability in depression and PTSD, specifically, dysregulations of the feedback loops (Siever & 
Davis, 1985; Yehuda, Teicher, Trestman, Levengood, & Siever, 1996). Under-responsive feedback 
signals of homeostatic mechanisms may be associated with affective instability in patients with 
depression (Siever & Davis, 1985), and over-responsivity of the feedback signals are proposed to 
be the link between affective instability and PTSD (Yehuda et al., 1996). Dysregulation of 
amygdala neural circuitry has been documented to be central to development and maintenance of 
symptoms with PTSD (Aghajani et al., 2016; Etkin & Wager, 2007; Lanius et al., 2010). The 
structural/functional findings on brain scans of people with OCD indicated that white matter 
pathway abnormalities allow for unstable connectivity which might be related to MI (Bora et al., 
2011), as well as abnormalities in the amygdala and its connections with the pre-frontal cortex 
(Broome et al., 2015).  
A large body of studies suggest that prenatal adversity (e.g., prenatal stress, drugs, tobacco 
smoking or medical complications) may lead to intrauterine growth restriction and to impaired fetal 






associated with BPD, and is an important risk factor for the psychopathology of BPD (Schwarze et 
al., 2013; Swanson & Wadhwa, 2008). Affective instability was associated with elevated rates of 
family history of mood disorders (Berenbaum et al., 2011). Studies reported that offspring of 
parents with BD have higher levels of mood lability, negative affect, anxiety, and aggressive 
behaviours when compared with healthy controls (Chang, K., Steiner, & Ketter, 2000; Diler et al., 
2011; Jones, Tai, Evershed, Knowles, & Bentall, 2006). There is substantial evidence of familial 
aggregation of BPD (White, Gunderson, Zanarini, & Hudson, 2003), and an even stronger familial 
aggregation of core features of BPD, specifically affective instability and impulsivity, compared to 
the fully diagnosed disorder (Barnow, Spitzer, Grabe, Kessler, & Freyberger, 2006; Davidson & 
Siever, 1991; Zanarini, Gunderson, Marino, Schwartz, & Frankenburg, 1988). These features have 
been found to aggregate separately, suggesting that they may be inherited independently (Davidson 
& Siever, 1991).  
1.8.3 Psychosocial risk factors for mood instability 
Affective instability has been linked to the impairment of interpersonal relationships 
(Koenigsberg, 2010). Studies both in a clinical sample and in a large adult population found that 
individuals with MI are more likely to be young, female, unemployed, single status, and have a low 
income (Marwaha et al., 2013; Patel, R. et al., 2015). Extensive studies on the relationship between 
MI and psychosocial factors have emphasized on the period of child development. Both theory and 
empirical studies suggest that relationship or attachment between infant and primary caregiver 
plays an essential role in infant’s emotional regulatory abilities (Cassidy, 1994). The ability to 
regulate emotions in socially appropriate ways is an important objective for a child’s development 
(Bridges & Grolnick, 1995; Calkins, 1994; Calkins & Leerkes, 2004; Tronick, 1989). During a 
child’s development, emotional and adaptive regulatory strategies are learned through the 






Spinrad & Stifter, 2002), and learned using social interaction to regulate emotions (Koenigsberg, 
2010). The ability to modify one’s emotional reactions by utilizing emotional and adaptive 
regulatory strategies has a significant impact on the development of psychological and 
psychosocial capacities (e.g., coping with stressful events, controlling impulsive behaviour, 
flexibly using appropriate emotion regulation strategies to meet situation requirements) 
(Thompson, R. A., 2001). Attachment difficulties increase vulnerability to dysregulating emotions 
that may subject one to intense, unpredictable, or over-reactive shifts in affect that will result in 
impaired social interactions, low self-esteem, poor sense of identity, and lack of motivation 
(Koenigsberg, 2010). 
 Exposure to adverse childhood experiences (ACES) (e.g., abuse (emotional, physical, and 
sexual), neglect, maltreatment) has been associated with physical diseases, social malfunction, and 
mental illness through the life span (Dube et al., 2003; Read, Fosse, Moskowitz, & Perry, 2014; 
Van Niel, Pachter, Wade Jr, Felitti, & Stein, 2014). In addition, ACES can influence subsequent 
capacity for affect regulation. When the infant is maltreated or abused, the interaction between the 
infant and the caregiver most often fails to facilitate effective emotion regulation, and the caregiver 
most likely dismisses or punishes their child’s emotional responses instead of validating them 
(Morris, Silk, Steinberg, Myers, & Robinson, 2007). The lack of sensitive interactions between the 
maltreating caregiver and the child can lead to emotion regulation difficulties (Kim & Cicchetti, 
2010). Several studies confirm medium to high correlations between child maltreatment and 
emotion dysregulation in adulthood (Moulton, Newman, Power, Swanson, & Day, 2015; Rellini, 
Vujanovic, Gilbert, & Zvolensky, 2012; Zanarini, Williams, Lewis, & Reich, 1997). Teicher et al. 
(2015) investigated the association between child maltreatment and disturbances in positive or 
negative mood regulation, and suggests that positive mood ratings were more variable and negative 






Maternal psychopathology may menace the development of mood regulation abilities. 
Cione (2015) investigated the relationship between maternal depression, parenting practices and 
children’s emotional and behavioural expression, and found that emotion dysregulation in children 
was significantly associated with behavioural problems. Cione (2015) also found that emotional 
regulation capacities in children play a mediating role between parental psychological aggression 
and the occurrence of child internalizing and externalizing behavioural problems. Maternal PTSD 
symptoms were associated with infant emotion regulation difficulties and with infant being less 
able to recover from distress (Enlow et al., 2011).  
Exposure to adverse experiences and maternal mental illness during early child 
development can predispose children to poor emotion regulation that may lead to developing 
psychiatric disorders. Studies based on the US national comorbidity survey in 2001 and 2003 
suggested that family violence, physical and sexual abuse, neglect, parental mental illness, 
substance misuse, and criminality may explain 32.4% of all disorders, 41.2% of disruptive 
behavior disorders, 32.4% of anxiety disorder, 26.2% of mood disorders, and 21.0% of substance 
use disorders in youth (Green et al., 2010; McLaughlin et al., 2010).  
Neurobiological and psychological factors both contribute to affective regulation. Failure of 
regulating emotions has been proven to have significant consequences, from unstable interpersonal 
relationships to strong correlations with an array of psychiatric disorders.  
1.8.4 Effects of mood instability 
There is limited information on the impacts of MI in general and clinical population. One 
study found that inability or decreased ability to regulate mood has been linked to greater 
functional impairments (including interpersonal impairment), and decreased quality of life in the 
general population (Miller & Pilkonis, 2006). Myin-Germeys et al. (2009) investigated the 






interpersonal communication skills may contribute to stressful events (e.g., relationship break-up, 
getting fired from a job), which lead to decreased quality of life. In a clinical sample of 27,704 
British adults with psychotic, affective or personality disorder (data was collected from 2006 to 
2013), MI has been linked to poorer clinical outcomes, and correlated with increased health care 
utilization (Patel, R. et al., 2015). As described above, MI as a primary feature plays an essential 
role in many psychiatric disorders. Thus MI has a substantial negative impact on individuals who 
suffer from mental health disorders.   
1.8.5 Measures 
Different measures have been developed and used to assess constructs of MI in non-
perinatal women population. A systematic review screened over 10,000 abstracts, analyzed 37 
studies, and identified 24 distinct measures of MI (Marwaha et al., 2014). The measurements 
include self-reported scales such as the Affective Lability Scale (ALS) (Harvey, Greenberg, & 
Serper, 1989) and ALS short form (ALS-SF) (Oliver & Simons, 2004). While some of the 
measurements are according to DSM definitions, others are comprised of a few questions or items 
related to MI (Marwaha et al., 2014). However, perinatal-specific measures of MI have not yet 
been developed, and items unique to pregnancy and giving birth may need to be included in the 
development of MI measures for perinatal women. 
The Affective Lability Scales 54 (ALS-54) has been widely used in measuring individual 
mood variation involving rapid shifts from different emotional states of anxiety, depression, anger 
and elation, and also between anxiety and depression, and elation and depression (Harvey et al., 
1989). The ALS includes 54 items, structured into six subscales, evaluating lability shifts between 
normal mood and depression, elation, anxiety and anger, and variations between anxiety/depression 
and depression/elation (Harvey et al., 1989). The scales have high internal consistency (Cronbach’s 






Recognizing the lengthiness of the original ALS-54, Oliver and Simons (2004) developed a 
short form of ALS (ALS-18), which was derived from the ALS-54 and includes fewer questions 
(18 items), and consequently is less time-consuming. ALS-18 measures three correlated conceptual 
scales based on the original scales: depression/anxiety, anger, and biphasic affect 
(depression/elation). Each item is scored on a 4-point scale (0-3), ranging from “very 
uncharacteristic of me” to “very characteristic of me.” The internal consistencies of the ALS-18 
were determined to be favorable (Cronbach’s alpha = 0.90), and the scale was highly correlated 
with the ALS-54 version (r = 0.94) (Look, Flory, Harvey, & Siever, 2010). The measurement has 
been validated in clinical samples, for example, personality disorders (Look et al., 2010), bipolar 
disorder (Aas et al., 2015), and ADHD (Weibel et al., 2017).  
1.9 Perinatal mood instability 
Mood instability has always been associated with women during their reproductive years in 
puberty, pre-menstruum, pregnancy, postpartum, and menopause.  
Studies have found that perinatal women often experience the highest irritable, euphoric, 
and depressed moods in early pregnancy and again around the time of giving birth (Cunningham et 
al., 2010; Steiner et al., 2003). This phenomenon is thought to be triggered by the large hormonal 
changes that occur at these times (Buttner, O’Hara, & Watson, 2012; Cunningham et al., 2010; 
Fooladi, 2006). Bowen, A. et al. (2012) investigated MI in perinatal women in a longitudinal study, 
and found that perinatal women significantly experienced a higher level of depressed, irritable, 
anxious, and euphoric mood fluctuation compared to non-perinatal women with normal menstrual 
cycles.   
This seemly ‘harmless’ phenomenon has been seen as a normal part of women’s life. 
Therefore, little attention has been paid to it. However, MI is correlated with many psychiatric 






interest in research on MI in the general population and clinical samples, however, little study has 
been focused on MI in women during pregnancy and postpartum.  
1.10 Effects of perinatal mood instability on mothers, and neonatal and child outcomes 
Hapgood, Elkind, and Wright (1988) investigated the longitudinal relationship between 
postpartum blues (PPB) and later psychopathology during the perinatal period in 66 postpartum 
women. The study found that emotional lability during the early postpartum was the most 
important predictor of later psychiatric symptoms up to 14 months postpartum.  
Jaffe et al. (2001) investigated the longitudinal relationship between facial affect synchrony 
in infant-mother interaction and infant development with a sample of 88 4-month-old infants and 
mothers. The study found that facial affect synchrony in infant-mother interaction at age 4 months 
predicts attachment and cognition at age 12 months, and suggested that facial affect synchrony in 
infant-mother interaction at a moderate level prompts a natural and appropriate interaction between 
mother and infant, whereas a heightened and lowered level of facial affect synchrony create 
impediment in infant development. Studies found that maternal psychiatric disorders obstruct the 
interaction between mother and infant (Field, T., 2010; Martinez-Torteya et al., 2014). For 
example, mothers with higher maternal depressive symptoms showed a heightened level of facial 
affect synchrony when interacting with their infants in comparison to mothers with lower 
depressive symptoms (Beebe et al., 2008).  
Very limited studies in the area of perinatal MI have been found, especially the effects of 
perinatal MI. More research is required to understand perinatal MI.  
1.11 Study rationale  
Mood instability is common in women during pregnancy and postpartum, and has been 
associated with a wide array of psychiatric disorders. However, perinatal MI has not received 






adverse impacts on mothers, their babies, and their families. The limited information of perinatal 
MI further indicates the necessity and importance of better understanding of MI in perinatal 
women.  
1.12 Goals and objectives of the study 
 The overall goals of this dissertation were to review perinatal MI systematically, and to 
understand perinatal MI by assessing its risk factors, and its effects on neonatal outcomes across 
the perinatal period: early pregnancy, late pregnancy, and postpartum, as well as to determine 
whether the psychometric properties of ALS-18 was a useful instrument for measuring MI in 
perinatal women.  
This dissertation includes four manuscripts that are related to perinatal MI. The objectives 
of each study were formulated based on an extensive literature search and the expertise of the 
Ph.D. student’s supervisor, and advisory committee members. The objectives were presented in the 
studies as research question, or research hypothesis.  
Chapter 2 is manuscript one. The research question was “What is the state of the literature 
related to perinatal MI, its relation to perinatal depression, and its effects on children?” 
Manuscript one systematically reviews the currently available publications on perinatal MI. The 
review used the PRISMA guidelines for reporting systematic reviews (Moher, Liberati, Tetzlaff, 
Altman, & PRISMA Group, 2009) and the Critical Appraisal Skills Program (CASP) tools were 
used for assessing the quality of articles (CASP, 2017). 
Chapter 3 is manuscript two. The research hypothesis was “Perinatal MI would be 
associated with its risk factors at early pregnancy, late pregnancy, and postpartum, antenatal MI 
would be correlated with PPD, and perinatal MI would have its distinct trajectory.” Manuscript two 
examines risk factors for MI at early and late pregnancy, and postpartum cross-sectionally, the 






MI across the perinatal continuum. A total of 648 women participated in this longitudinal study of 
maternal depression at three points: early pregnancy (T1, 17.4 ± 4.9 weeks), late pregnancy (T2, 
30.6 ± 2.7 weeks), and postpartum (T3, 4.2 ± 2.1 weeks). Mood instability, depression, stress, and 
social support were measured at T1, T2, and T3, other sociodemographic data were collected at T1, 
and obstetrical information was obtained at appropriate times. Multi-linear regression was used to 
examine MI and its risk factors cross-sectionally, hierarchical multiple regression was used to 
investigate longitudinal relationship between antenatal MI and PPD, and a linear mixed effect 
model was employed to examine the trajectory of perinatal MI over three periods (T1-T3). 
Chapter 4 is manuscript three. The research hypothesis was “Antenatal MI, depression, and 
anxiety would be associated with neonatal outcomes (low BW, SGA, preterm birth, low 1-minute 
and 5-minute Apgar score) at 17 weeks and 31 weeks pregnancy”. Manuscript three investigates 
whether antenatal MI, depression, and anxiety are risk factors for adverse neonatal outcomes. A 
total of 555 women participated in a longitudinal study of maternal depression at two points: early 
pregnancy (T1, 17.4 ± 4.9 weeks), and late pregnancy (T2, 30.6 ± 2.7 weeks). MI, depression, 
anxiety, psychosocial, and behaviour variables were measured at T1 and T2, other social 
demographic data were collected at T1, and obstetrical and neonatal information was obtained at 
appropriate times. Binary logistic regression was utilized in this study. 
Chapter 5 is manuscript four. The hypothesis of this study was “The ALS-18 would be a 
valid instrument in measuring affective lability in pregnant and postpartum women with mood 
symptoms”. A confirmatory factor analysis was conducted on three models in the total sample to 
evaluate model fit. Manuscript four evaluated the psychometric properties of ALS-18 in perinatal 
women with various mood symptoms. A total of 113 pregnant and postpartum women participated 







Finally, Chapter 6 includes the overview of dissertation objectives, implications, 
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Background: Perinatal mood instability (MI) is a common clinical observation in perinatal women 
and existing research indicates that MI is strongly associated with a variety of mental disorders. 
Objective: To review the evidence of perinatal MI systematically, with a focus on perinatal MI, its 
relation to perinatal depression, and its effects on children. Methods: A systematic search of the 
literature was conducted on seven academic health databases to identify any peer-reviewed articles 
published in English from 1985 to July 2017. Studies were screened, data were extracted, and 
quality was appraised. Results: A total of 1,927 abstracts were returned from the search, with 1,063 
remaining for abstract screening after duplicate removal, and seven studies were selected for final 
analysis. The selected articles included quantitative (n = 5) and qualitative (n = 2) studies. No 
reviews were retrieved. The articles addressed perinatal MI (n = 2), the relation of perinatal MI to 
perinatal depression (n = 4), and the effects of perinatal MI on children (n = 1). Studies identified 
that perinatal women are moodier than non-perinatal women, MI is a prominent feature in perinatal 
women with and without depression, mood lability during the early postpartum predicts 
psychopathology up to 14 months postpartum, and maternal emotion dysregulation, rather than 
maternal psychopathology, increases the risk of heightened facial affect synchrony in mother-infant 
interaction. Conclusion: The study reveals a significant gap in the literature of perinatal MI.  













Being pregnant and giving birth to a baby can be joyous and exciting times for a woman, 
however, the transition to motherhood can also bring many challenges both physical and emotional 
that can impact maternal and child health outcomes (Dayan et al., 2002; Li, Liu, & Odouli, 2008; 
Nelson, 2003). Some women may experience mood disturbances, depression, or anxiety during the 
perinatal period, but mood instability (MI) can also be distressing for pregnant and postpartum 
women (Bowen, A., Bowen, Balbuena, & Muhajarine, 2012; Kessler et al., 2003; O'Hara & 
Wisner, 2014).  
Mood instability is defined as extreme shifts in mood that last from a few hours to a few 
days (Koenigsberg et al., 2002). The term MI is sometimes used interchangeably with mood 
swings, affect instability, or emotional dysregulation (Marwaha et al., 2014). MI has been 
associated with women during various stages of their reproductive years, such as menstruum, 
pregnancy, and postpartum (Bowen, A. et al., 2012; Bowen, R, Bowen, Baetz, Wagner, & Pierson, 
2011; Mitchell, 2017). The mood changes often seen in perinatal women have been attributed to 
the high hormonal fluctuations that occur during this time (Cunningham et al., 2010). Mood lability 
in the early postpartum has been discussed under the concept of postpartum blues (PPB) or 
maternity blues (Kennerley, Helen & Gath, 1989; O'Hara, Schlechte, Lewis, & Wright, 1991). 
Postpartum blues has been described as a transient disturbance in mood occurring in 40-80% of 
new mothers (Kennerley, H. & Gath, 1985; O'Hara et al., 1991; Steiner, 1998). Symptoms typically 
begin within the first few days after delivery and resolve without requiring medical or 
psychological treatment by day 10 or longer. The PPB are most commonly characterized by 
dysphoric mood, irritability, emotional lability, tearfulness, anxiety, sleep disturbance, and lack of 






changing moods is often viewed as a harmless or normal part of a woman’s life (Steiner, Dunn, & 
Born, 2003).  
Studies of MI in general populations and clinical samples have shown a strong association 
of MI with a variety of psychiatric disorders including depression, anxiety, and personality 
disorders (Bowen, R., Baetz, Hawkes, & Bowen, 2006; Marwaha, Balbuena, Winsper, & Bowen, 
2015; Thompson, Berenbaum, & Bredemeier, 2011). Marwaha et al. (2015) investigated whether 
MI at intake was associated with the new inception of depression at follow-up by removing 
participants with depression at baseline, and found MI to be a precursor to depression. Literature 
examining the relationship between MI and psychological distress speculates that having an 
inability to manage intense physiological arousal, difficulties identifying emotions, and 
experiencing conflictive emotions are related to psychological distress (Ebner-Priemer et al., 2008; 
Stiglmayr, C. et al., 2005; Stiglmayr, C., Shapiro, Stieglitz, Limberger, & Bohus, 2001), which 
may lead to interpersonal difficulties that cause stressful life events (e.g., the break-up of a 
relationship, loss of a job) (Koenigsberg et al., 2002). 
Studies suggest that maternal psychiatric disorders obstruct the interaction between mother 
and infant (Field, 2010; Martinez-Torteya et al., 2014). In regards to the relationship between 
maternal emotional dysregulation and child outcomes, studies suggest that mother-infant 
interaction is a dynamic process that is mutually regulated by their behaviours (Schmidt & 
Richardson, 2008; Sroufe, 2013). One essential attribute of the process is synchrony, which reflects 
the temporal coordination of behaviour between mother and infant (Bernieri & Rosenthal, 1991). 
Jaffe et al. (2001) indicate that facial affect synchrony in infant-mother interaction at a moderate 
level prompts a natural and appropriate interaction between mother and infant, whereas a 
heightened and lowered level of facial affect synchrony create an impediment in infant 






showed a heightened level of facial affect synchrony when interacting with their infants in 
comparison with mothers with lower depressive symptoms.  
The present lack of research of perinatal MI may be partly due to the normalization of 
perinatal MI and the tendency for investigators to examine diagnosable entities, such as depression 
and anxiety.  
2.2 Research question 
What is the state of the literature related to perinatal MI, its relation to perinatal depression, 
and its effects on children?  
2.3 Methods 
Since there is limited research on perinatal MI, this study conducted a systematic review of 
existing literature published between January 1985 and July 2017 (a period of over 30 years). The 
review used the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 
guidelines for reporting systematic reviews (Moher, Liberati, Tetzlaff, Altman, & PRISMA Group, 
2009) and the Critical Appraisal Skills Program (CASP) tools were used for assessing the quality 
of articles (CASP, 2017).  
2.3.1 Search strategy and inclusion and exclusion criteria 
Seven academic health databases were searched by a health sciences librarian and a Ph.D. 
student (HL) including PUBMED, MEDLINE, PsycINFO, CINAHL, EMBASE, Scopus, and 
Cochrane Library (Cochrane Database of Systematic Reviews). Search terms were developed in 
consultation with the health sciences librarian, a co-researcher, and a psychiatrist who specializes 
in mood disorders, and covered the relevant domains: perinatal women, and MI. The search 
strategy included MEDLINE MeSH headings and keywords that were relevant to pregnancy 
(pregnan*, OR pregnant women, OR pregnancy outcome*, OR pregnancy trimester*, OR prenatal, 






parturition, OR childbirth, OR birth, OR deliver*, OR postpartum, OR postnatal, OR puerperium, 
OR puerperal), OR perinatal (matern*, OR perinatal, OR childbearing, OR mother*), AND mood 
instability (mood instability, OR mood dysregulat*, OR mood lability, OR mood swings, OR 
affect* instability, OR affect* dysregulat*, OR affect* lability, OR emotion* instability, OR 
emotion* dysregulat*, OR emotion* lability). The three search strings were combined using the 
Boolean operators OR and AND. Two additional articles were also identified by a reviewer before 
the manuscript peer-review process. The search strategy and search terms used in the search can be 
found in Appendix 2-A.     
The inclusion criteria were any studies using quantitative or qualitative or mixed methods, 
including literature review, systematic reviews, or meta-analysis, or meta-syntheses that were 
published between January 1985 and July 2017 (search was conducted between July 15 and August 
1, 2017). Articles were not included if they were not published in English or if they were not peer-
reviewed publication (e.g., grey literature). 
2.3.2 Screening and selection 
HL and a trained research assistant (RA) independently screened titles and abstracts of 
articles for the search terms to identify relevant articles. There was a high level of agreement (82%) 
between HL and RA. Any disagreements were resolved by discussion. If an article’s abstract was 
not available, but the title appeared relevant, the full article was retrieved. The review of full-text 
articles, which were retained at the stage of screening title and abstract, was carried out to 
determine the relevance by HL and the RA. Any discrepancies between HL’s and RA’s results at 
this stage were discussed to reach an agreement. After the review process, the studies that passed 








2.3.3 Quality appraisal and data extraction 
 The Critical Appraisal Skills Program (CASP) tools were used for assessing study quality 
(CASP, 2017). The quality appraisal of each study was evaluated independently by two of the 
authors. The CASP checklist contains 10 questions for both quantitative and qualitative studies, 
which can be scored “yes,” “no” or “cannot tell.” A “yes” score indicates that the study meets the 
criteria, a “no” means that the study did not meet the criteria, and “cannot tell” indicates that 
insufficient information was provided. The potential maximum score on the list is 10. The total 
score is the sum of all the criteria which are scored “yes,” “no” or “cannot tell” scores are not 
subtracted. We chose to consider a study of “high quality” when it scores more than 80.0%, 
“moderate” (60.0 to 80.0%), and “weak” (<60.0%) (Kuijpers, van der Windt, van der Heijden, & 
Bouter, 2004; Legere et al., 2017). 
 Data extraction was performed using a table for each study and included information on the 
study’s quality score, author, year, objective, design, methods, sample, setting, analysis, outcome 
measures, results, strengths, limitations, implications, and conclusion (Marwaha et al., 2014). Data 
extraction was carried out by reviewing the full-text article.  
2.3.4 Data synthesis 
 Given the heterogeneity of the included qualitative studies, we used a narrative approach to 
data synthesis. We categorized articles into groups based on the focus of perinatal MI, or perinatal 
MI in relation to perinatal mood disturbances, or effect of perinatal MI on children. The narrative 











2.4.1 Study selection 
 A total of 1,925 articles were identified from a search of seven selected databases based on 
the pre-specified limits. Two additional articles were submitted by members of the research team 
after the search was completed (n = 1,927). After removing duplicates, 1,063 articles were screened 
for title and abstract. Of 1,063 articles, 18 articles were perinatal mood-related, and were assessed 
further for eligibility. After reviewing the full articles for eligibility, seven articles were included in 
the quality appraisal, data extraction, and categorization process. The seven selected articles had a 
central theme of perinatal MI, perinatal MI in relation to perinatal mood disturbance, or effect of 
perinatal MI on children. A PRISMA flow diagram presents all phases of the review (Figure.2.1) 






























2.4.2 Summary of study characteristics 
 All seven studies were published between 1988 and 2016. The studies were located in 
Canada (Bowen, A. et al., 2012), the US (Beck & Indman, 2005), Germany (Lotzin, Schiborr, 
Barkmann, Romer, & Ramsauer, 2016), Australia (Wilkinson, 1999), New Zealand (Hapgood, 
Elkind, & Wright, 1988), Taiwan (Tseng, Hsu, Liu, & Chen, 2008), and Singapore (Ong et al., 
2014). All of the studies were conducted in, or involved hospital or community settings (primary 
care sites or participants’ homes). The research designs were varied in the seven studies, with the 
majority of the studies being quantitative (n = 5) and two qualitative studies. The study designs 
included cross-sectional (Beck & Indman, 2005; Lotzin et al., 2016), longitudinal prospective 
(Bowen, A. et al., 2012; Hapgood et al., 1988; Wilkinson, 1999), and two qualitative studies (Ong 
et al., 2014; Tseng et al., 2008). No reviews, randomized controlled trials, or mixed methods 
studies were retrieved.  
A total of 452 women, 86 partners, and 68 children were involved in the seven studies, with 
sample sizes ranging from 12 to 172. Various measures for MI were used including the Visual 
Analogue Scale (VAS) (Bowen, A. et al., 2012; Hapgood et al., 1988), the Emotion Regulation 
Scale (Lotzin et al., 2016), the Positive and Negative Scale (Wilkinson, 1999), the Postpartum 
Depression Screening Scale (PDSS) (Beck & Indman, 2005), and semi-structured interviews (Ong 
et al., 2014; Tseng et al., 2008). The VAS used in Bowen, A. et al. study (Bowen, A. et al., 2012) 
included a five items: 1 “mood frequent ups and downs”, 2 “mood swings occur for no reason”, 3 
“other people complain about your mood swings”, 4 “having trouble following through with plans 
because of mood swings”, and 5 “not making commitments because moods might change”. 
Women were asked to mark an “X” on with a 10cm line. The X was then measured on a metric 
ruler by a research assistant. This self-reported measure has a total possible score of 50. Hapgood 






confident”, 2 “I am feeling miserable and depressed”, 3 “I have been in tears”, 4 “I am very 
worried and anxious”, 5 “I am very irritable and quick tempered”, and 6 “my spirits are going up 
and down like a yoyo”.  The VAS used by Hapgood et al. (1988) had a similar measure as Bowen, 
A. et al. study, and has a total possible score of 60. 
Four studies included postpartum women (Beck & Indman, 2005; Hapgood et al., 1988; 
Lotzin et al., 2016; Ong et al., 2014), one study included only pregnant women (Tseng et al., 2008), 
and two studies followed women through their pregnancy to postpartum (Bowen, A. et al., 2012; 
Wilkinson, 1999) (Appendix 2-B Table 2-B.1). 
 Based on the score of the quality appraisal, one quantitative study was rated as weak (Beck 
& Indman, 2005), three quantitative studies were rated as moderate (Bowen, A. et al., 2012; 
Hapgood et al., 1988; Wilkinson, 1999), and one quantitative study (Lotzin et al., 2016) and two 
qualitative studies (Ong et al., 2014; Tseng et al., 2008) were rated as strong. The weak rating was 
mostly attributed to insufficient descriptions of data analysis and methods of data collection. The 
quality appraisal ratings can be found in Appendix 2-B, Table 2-B.1.  
2.4.2.1 Quantitative studies 
  In a longitudinal study, Bowen, A et al. (2012) examined whether perinatal women are 
moodier than non-perinatal women. A subgroup of 45 perinatal women participated in this study 
from the Feelings in Pregnancy and Motherhood Study (Bowen, A., Bowen, Butt, Rahman, & 
Muhajarine, 2012). Co-currently, a control group comprised of normally menstruating non-
perinatal women without depressive symptoms (n = 31) from a separate study of moods was also 
recruited (Bowen, R, Mahmood, Milani, & Baetz, 2011). The perinatal women were interviewed at 
early pregnancy (mean gestation 16.4 weeks, SD 4.4), late pregnancy (mean gestation 30.4 weeks, 
SD 2.3), and postpartum (mean 4.3 weeks postpartum, SD 1.5). Mood instability was measured by 






euphoric moods for both groups in the morning and evening. Depression symptoms were assessed 
by using the Edinburgh Postnatal Depression Scale (EPDS) (Cox, Holden, & Sagovsky, 1987). The 
perinatal women completed three separate mood diaries (each for seven days) after three 
interviews, while the control group completed the mood diaries for two consecutive menstrual 
cycles (eight weeks). Mood instability for both groups was assessed with the mean square 
successive difference (MSSD) statistic derived from the serial VAS ratings, and the linear mixed 
modeling procedure was used to examine the trajectory for MI over three periods. The study found 
that moods of perinatal women were more widely fluctuated than moods of non-perinatal women 
regarding depressed, irritable, anxious, and euphoric mood fluctuation, indicating that perinatal 
women are moodier, while the findings held when depressed perinatal women were removed from 
the comparison except for depressed mood of the VAS, suggesting that perinatal women without 
depressive symptoms still experienced a higher level of MI than the control group. In addition, 
contrary to the view of dysphoric mood in pregnancy and postpartum women, the study found that 
MI is a prominent feature in women during the perinatal period. There are several strengths of this 
study. First, it is the first study of perinatal MI. Second, it has a control group which serves as a 
baseline to evaluate what effects perinatal period has on women’s mood. Third, the study utilized 
the MSSD that determine point-to-point variability of mood and also takes into account the 
temporal order of ratings (Jahng, Wood, & Trull, 2008). The small sample size of the study limits 
the generalization of the findings. 
     In the article entitled “The many faces of postpartum depression,” Beck and Indman (2005) 
aimed to provide a profile of women with postpartum depression (PPD) by using the Postpartum 
Depression Screening Scale PDSS (Beck & Gable, 2002). PDSS includes seven dimensions: 
sleeping/eating disturbances, anxiety/insecurity, emotional lability, mental confusion, loss of self, 






practice in the San Francisco Bay Area of the US, and 133 women with PPD participated the study. 
The women completed the PDSS and a Diagnostic and Statistical Manual of Mental Disorders-IV 
(DSM-IV) diagnostic interview at 16 mean weeks of postpartum. Anxiety and irritability were 
found to be prominent elements of PPD, but emotional lability was the dimension that obtained the 
highest mean total score, and irritability is a component of emotional lability. The authors indicated 
that “depression is not necessarily the first or most important symptom of mothers suffering from 
postpartum depression,” (p. 570) suggesting that depression in women with PPD does not display 
as a uni-dimensional mood symptom, rather it is a multi-dimensional mood manifestation that 
includes emotional lability, anxiety, and irritability. The study conducted descriptive data analysis 
only, used means of all seven dimensions to make conclusions, and did not take confounders into 
consideration, and was therefore rated as weak in the quality appraisal.    
In another longitudinal study, Hapgood et al. (1988) investigated the relationship between 
PPB in the early postpartum and later psychopathology. Sixty-six women from six antenatal clinics 
at the National Women’s Hospital in New Zealand participated in the study. Mental health status 
was assessed using the Goldberg semi-structured psychiatric interview at 36 weeks pregnant and at 
3 weeks, 3 months, 6 months, and 14 months postpartum (Goldberg, Cooper, Eastwood, Kedward, 
& Shepherd, 1970), and mood fluctuations were assessed using a VAS which included six mood 
scales (happiness, depression, tears, anxiety, irritability, and lability). Women rated their moods 
over the past 24 hours on each scale at the same time each day (early evening) from the first one of 
giving birth to the 14th day of postpartum. The study found that emotional lability during the early 
postpartum was an essential component of the PPB. The factor analysis of the VAS data suggests 
that emotional lability is a separate factor that indicates “mood going up and down” as an 
independent phenomenon. Longitudinally, emotional lability during the early postpartum was the 






women who experience elevated lability of mood during first two weeks of postpartum may be at 
risk of later depression.  Generalization of the findings may be limited due to relatively small 
sample size.  
Wilkinson (1999) examined mood changes in 86 perinatal women (44 multiparous and 42 
primiparous) and their partners recruited from a public hospital in Australia. To assess mood 
lability at the second and third trimesters, and at ten days and three months postpartum, women 
were asked to rate to what extent their mood had fluctuated during the past week using a five-point 
scale (1 = very stable; 5 = very changeable). The Positive and Negative Affect Scale (PANAS) 
(Watson, Clark, & Tellegen, 1988) was used for measuring mood states. Positive affect was found 
to be significantly higher at ten days and three months postpartum than the second trimester. When 
compared to the second trimester, negative affect was higher in the third trimester, and ten days 
and three months postpartum. In regards to parity, multiparous reported significantly higher levels 
of negative affect in the third trimester than primiparous. However, at day ten of postpartum there 
was no significant difference between multiparous and primiparous. Mood lability did not vary 
much over the study period except women having their first child. Primiparous showed 
significantly increased mood lability from the third trimester to the ten-day postpartum. Overall, 
the study suggests that mood in perinatal women cannot simply be characterized as a negative 
state, rather a modest overall increase in positive affect from the second trimester to postpartum, 
suggesting that mood experience can be characterized as a mixed mood state for perinatal women. 
The mood lability data from this study also support that the impact of childbearing on women’s 
moods is more pronounced for first-time mothers. Several strengths of the study were indicated. 
The study included both first-time mothers and mothers with one or more children, and found that 
the mood experienced by first-time mothers may be different from experienced mothers. Second, it 






self-report mood studies (Diener, Kanazawa, Suh, & Oishi, 2015; Diener et al., 2010). By utilizing 
both measures (PANAS and MI questionnaires) to assess women’s mood, the importance of 
understanding the etiology and characteristics of mood symptoms during perinatal period is 
underscored (Buttner, O’Hara, & Watson, 2012). The study did not specify the mood lability scale 
used; it is unknown what mood symptoms were assessed and how many questions were asked. A 
relatively small sample size restricted the generalization of the findings. 
Studies found that maternal psychiatric disorders obstruct the interaction between mother 
and infant (Field, T., 2010; Martinez-Torteya et al., 2014). For example, mothers with higher 
maternal depressive symptoms showed a heightened level of facial affect synchrony when 
interacting with their infants in comparison to mothers with lower depressive symptoms (Beebe et 
al., 2008). Lotzin et al. (2016) examined whether maternal emotion dysregulation was associated 
with mother-infant facial affect synchrony. The cross-sectional study included 68 mothers and their 
infants aged 4-9 months from a psychiatric mother-infant outpatient unit in Germany; all mothers 
were diagnosed with a variety of mood disorders according to the DSM-IV (88.2% major 
depression, 4.4% of bipolar, 4.4% of dysthymia, 2.9% adjustment disorder with depressed mood). 
Measuring mother-infant interaction was through observation using the Still-Face paradigm during 
two play interactions (Tronick, Als, Adamson, Wise, & Brazelton, 1978), and facial affect of 
mother and infant was rated from high negative to high positive, and a time-series analysis was 
computed to assess the degree of synchrony between the mother’s and infant’s facial affect. It also 
used a comparison group of babies who were not related to mothers as a baseline level of facial 
affect synchronization. The Difficulties in Emotion Regulation Scale was used to assess maternal 
emotion dysregulation (Gratz & Roemer, 2004), and maternal mood disorders were evaluated by 
the Symptom Checklist-90-Revised (Franke, 2002). The study found that emotion dysregulation in 






synchrony after controlling for maternal psychopathology, infant gender, and age. The authors 
suggested that a heightened mother-infant facial affect synchrony was most likely induced by the 
mother’s overreactivity, which indicates distress and hypervigilance (Beebe et al., 2008) that 
probably hinders the infant’s developing abilities to self-regulate and to explore (Bornstein & 
Manian, 2013). Strengths of the research include utilizing a comparison group as a baseline in the 
study design, and a time-series analysis was used to analyze the level of facial affect 
synchronization in mother-infant interaction. The study suggests that mothers with psychiatric 
disorders would benefit from emotion regulation training including the importance of mother-infant 
facial synchrony, indicating that interaction between mother-infant could be improved through 
education.  
2.4.2.2 Qualitative studies  
In a qualitative study exploring first-time mother’s postnatal experience and support needs 
after hospital discharge in Singapore, a purposive sample of 13 mothers was recruited, and a semi-
structured interview was conducted at 10-14 days of postpartum (Ong et al., 2014). Participants’ 
age ranged from 21 to 39 years old, and there were six Chinese, two Malay, two Indian, two 
Caucasian, and one Burmese woman. There was one single mother, and only two mothers attended 
prenatal classes. Different financial backgrounds were reported as monthly family income ranged 
from $800 US to more than $4,000 US. Upon analysis, five themes emerged: negative emotions 
(anxiety, labile emotion, and stress), breastfeeding concerns (low breast milk supply and physical 
discomfort), social support, postnatal cultural practice, and professional support needs. The study 
found that emotional issues were prevalent in mothers, and while some mothers expressed 
happiness, negative feelings were common across all interviews. In addition, mothers experienced 
episodic crying spells and labile emotions during this period, and in the severe cases, emotional 






others because the women did not perceive that it was serious enough or their relatives lacked 
knowledge of postpartum emotional issues. However, in this study participants’ mental health 
assessment was not conducted before the interviews, which may not provide a more comprehensive 
view of women’s experiences in regards to understand women’s emotional issues, and the 
relationship between mental health and emotional issues or distress. 
Tseng et al. (2008) explored the experience of prenatal depression in an in-depth interview 
of 12 depressed pregnant women at their 2nd or 3rd trimester of pregnancy (EPDS ≥ 15) in Taiwan. 
Women were recruited from prenatal clinics at two teaching hospitals, were aged from 19 to 33 
years old. Seven women had a college or higher level of education and the rest of the women 
graduated from high school. All women were married, four were first-time mothers, and five had 
planned pregnancies, while seven were unplanned pregnancies. Five were employed, and eight 
were of middle socioeconomic status (SES), while two were low SES and two were high SES. Two 
women reported having a history of depression. From the interviews, five themes were identified: 
emotional instability, uncertainty of future, lack of social support, multiple conflicting roles, and 
dissatisfaction with body image. The findings indicate that pregnant women often experience 
emotional ups-and-downs by expressing feelings of being emotionally fragile, sensitive, impatient, 
and easily angered. Furthermore, women also overreacted to small things while also feeling 
depressed and tended to cry spontaneously for unknown reasons. In addition, the study suggests 
that emotional instability is connected with feelings of burdened by the increased work load, 
constant fatigue and reduced energy level during pregnancy. First time mothers described that they 
lose their temper easily due to discomfort caused by pregnancy, and multiparous mothers were 
particularly anxious to avoid repeating previous negative experiences. The study could conduct a 
follow-up interview to provide women the chance to add on information, and also give researchers 








The purpose of this systematic review was to synthesize the evidence of MI in pregnant and 
postpartum women, its relation to perinatal depression, and its effects on children. Our review 
found seven articles of weak, moderate, and strong quality according to CASP, and none of these 
articles were reviews. Only two studies investigated perinatal MI, one examined the relationship 
between maternal emotion dysregulation and facial affect synchrony in mother-infant interaction, 
and rest of studies found MI as a component of PPB, PPD, or experience of pregnant women. 
Nevertheless, the findings suggest that MI is a prominent feature in perinatal women, MI in the 
early postpartum is an important predictor for late psychopathology up to 14 months postpartum, 
and maternal emotion dysregulation impedes child development. Although selected studies 
confirmed that women experience elevated MI in pregnancy and postpartum, its etiology and risk 
factors, the relationship between perinatal MI and other mood disorders, and between perinatal MI 
and neonatal and child outcomes are still unknown. 
2.5.1 Suggestions for future work 
To better understand MI in pregnant and postpartum women, future quantitative research 
could include examining the risk factors for perinatal MI, and the predictability of antenatal MI for 
postpartum MI. Although mood lability during the early postpartum was found to be associated 
with late psychopathology up to 14 months postpartum, based on the evidence that women 
experience MI through the entire perinatal period, the investigation of the relationship should be 
expanded from early pregnancy to late postpartum. The relationship between antenatal MI and 
postpartum psychopathology including depression, anxiety, and bipolar disorders, and between 
antenatal MI and maternal birth outcomes should be examined. To further unravel perinatal MI, 






identify the risk factors before pregnancy associated with perinatal MI. In regards to the 
relationship between perinatal MI and neonatal and child outcomes, future studies could investigate 
whether perinatal MI is associated with adverse neonatal and child outcomes.  
In qualitative studies, perinatal MI was described as one element of women’s perinatal 
experience. Future research in qualitative studies could explore women’s lived experiences of 
perinatal MI to understand MI further, its risk factors, and women’s perception of how to alleviate 
MI symptoms such as social support, coping skills, and what kind of health care services would 
help them. The rich and comprehensive content from qualitative research would provide valuable 
information in terms of understanding women’s perspective, lived experience of MI, and ultimately 
improve women’s quality of life. 
2.5.2 Implications 
This current review has several implications. Increased education and awareness of 
perinatal MI are necessary for both the general population and for health care professionals. 
Clinicians need to be alert to the range of symptoms of perinatal MI to identify women suffering in 
silence from mood fluctuation assumed as normal part of women’s life. Not every mother will 
present with the same constellation of symptoms (Bowen, A.et al., 2012; Ong et al., 2014; Tseng et 
al., 2008). It is important to screen all pregnant and postpartum women, because many women with 
MI may outwardly appear to be doing well or women may believe that MI is normal for them. 
Routine screening for perinatal MI should be included in the routine perinatal care. Although 
instruments of assessing MI have been developed and validated in general and clinical population, 
measurements of evaluating MI for pregnant and postpartum women have not been developed or 
validated, which indicates that a valid instrument for assessing perinatal MI should be in place for 
the routine screening. Once an accurate assessment has been made, therapeutic interventions can be 






In addition, it is essential for health care professionals to recognize the potential risk factors 
that may be linked to emotional lability. For example, Tseng et al. (2008) suggest that culturally-
influenced distress plays a role in emotional lability. For example, in Chinese culture, the women’s 
in-laws expect the couple to have a baby soon after marriage, and also prefer that the child is a boy 
to extend the family line, which puts considerable pressure on women (Tseng et al., 2008). 
However, Ong et al. (2014) studied a diverse group of first time mothers from different ethnic 
backgrounds, and found that all first time mothers are vulnerable to emotional distress cross-
culturally.  
In regards to inability to cope with the emotional issues, education on coping strategies with 
infant care, and coping skills incorporated with interpersonal psychotherapy among perinatal 
women should also be included as a component in perinatal classes (Ong et al., 2014). Social 
support has been recognized as a risk factor for emotional issues in both qualitative studies, 
suggesting more support from women’s social network and professionals, and fostering coping 
resources are required to alleviate emotional lability (Tseng et al., 2008).  
2.6 Limitations 
The main limitation of this review is the relatively sparse amount of studies and literature 
about MI, particularly in perinatal women. Only seven of the retrieved research studies were 
relevant to our research question, and several were not current (within ten years). Different 
instruments were used for measuring MI in the studies, most of which were not validated in 
perinatal women. The timing of assessment of MI ranged widely across the perinatal period. 
Reviewed studies all relied on the mothers’ retrospective self-reports, which may cause recall bias 
(Schwartz & Rapkin, 2004). Overall, these factors limit the generalizability of our findings. 








As the first known systematic review of MI in pregnant and postpartum women, this review 
adds to the scientific evidence of perinatal MI, its relation to perinatal depression, and its effect on 
child outcomes. A significant gap of research in perinatal MI has been uncovered. The reviewed 
literature reveals that perinatal women are moodier, mood lability during early postpartum predicts 
psychopathology up to 14 months of postpartum, the mood experienced by first-time mothers may 
be different from experienced mothers, and higher maternal emotional dysregulation is associated 
with heightened mother-infant facial affect synchrony. The association between MI in the early 
postpartum and subsequent psychopathology indicates that it is essential to screen MI during early 
postpartum. However, perinatal MI is clearly understudied. Future research should investigate the 
relationship between MI and other mood disorders throughout perinatal period, not just during the 
early postpartum, explore risk factors for perinatal MI, and the relationship between perinatal MI 
and neonatal outcomes. To ensure optimal quality of perinatal mental health, education and 
promotion of perinatal MI in the general population and health care professionals are necessary, 
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Appendix 2-A: Search strategy and search terms 
Search strategy  
Database Search 
A systematic search for recent literature relevant to perinatal mood instability (MI) was 
conducted by a health sciences librarian and a PhD student. 
 
List of Databases Searched: Seven databases were searched: Cumulative Index to Nursing and 
Allied Health (CINAHL), Cochrane Library (Cochrane Database of Systematic Reviews and 
Cochrane Central Register of Controlled Trials), Embase,  PUBMED, MEDLINE, PsychINFO, 
and Scopus. 
 
Research Question: What is the state of the literature related to perinatal MI, its relation to 
perinatal depression, and its effects on children? 
 
Inclusion Criteria 
The following criteria were used to guide the search: 
 A primary focus of the article is on the topic area: MI in pregnant women or women with a 
newborn or infant less than 24 months, MI in relation to perinatal mood disturbances, and effects 
of perinatal MI on children  
 Study methodology limited to all types of primary studies: quantitative, qualitative, mixed 
methods, and reviews 
 Published between January 1985 and July 2017 
 Published in English 
 Accessible for retrieval 
 
Exclusion Criteria 
The following criteria were used to exclude literature from the search: 
 Topic not related to perinatal MI or in relation to perinatal MI (e.g., antennal and postpartum 
depression, and antenatal and postpartum anxiety only, etc.). 
 Dissertations, commentaries, narrative, anecdotal articles, letters to the editor, editorials, 
expert reports, consensus documents, discussion papers 
 Non-English studies 
 Unpublished (e.g., grey literature) 
 Studies involving animals 















Below are condensed search terms used in MEDLINE. Comparable terms were used in the 
additional databases searched 





















1-Birthing [mesh:noexp]/ maternity [embase] 
2-Delivery, Obstetric[mesh:noexp] 
3-Maternal Health Services[mesh:noexp] 














18-Pregnancy in Adolescence[mesh:noexp] 






























47-(mood adj2 (instab* or dysregulat* or 
lability)).tw. 
48-(affect* adj2 (instab* or dysregulat* or 
lability)).tw. 
49-(emotion adj2 (instab* or dysregulat* 
or lability)).tw. 
50-(blues adj2 (matern* or baby or 
postpartum or postnatal)).tw. 
51-or/47-50 
52-46 and 51 
 
 
53-limit 52 to 
human and English 
language 










      
































































Scores on all seven 
dimensions of the PDSS were 
elevated. Dimension of 
emotional lability had the 




        









VAS, EPDS 16 and 30 
weeks  
4 weeks Perinatal women showed 
higher mean levels of 
irritable, anxious, and high 
MI than the non-perinatal 
women. The findings still 
held when pregnant women 
with depressive symptom 
were excluded from the 
study.  
M 





















    *Quality rating scores are abbreviated. “S” reflects a strong rating, “M” reflects a moderate rating and “W” reflects a weak rating. 
 
 


























        
        
Hapgood, Elkind, 













 0-2, 6, 13, 26,  
and 60 weeks 
Emotional lability was the 
important affective 
component of the early 
postpartum. Lability of mood 
in the early postpartum was 
related to psychiatric 
symptoms up to 14 months 
postpartum and was the 







        
















 24 weeks Higher maternal emotion 
dysregulation was 
significantly associated with 
higher facial affect 
synchrony; the relationship 
between the effect of 
maternal psychopathology 
and facial affect synchrony 

















































Five themes were identified:  
1) negative emotion including labile 
emotions, 2) breastfeeding concerns, 
3) social support, 4) cultural 
postnatal practice, and 5) 
professional support needs. 
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2nd or 3rd 
trimester 
 Five themes emerged: 1) multiple 
conflicting roles, 2) lack of social 
support, 3) dissatisfaction with body 
image, 4) future uncertainty, and 5) 
emotional instability. 
S 





















The immediate postpartum was the 
peak period of positive affect for 
both primiparous and multiparous 
mothers and their male partners and 
was also the peak period of negative 
affect and mood lability for 
primiparous women. There was 
relatively little change in mood from 
the second to the third trimester, and 
in the early postpartum. However, 
primiparous women showed 
increased mood lability while 
multiparous women did not 
experience the increase.  
M 







Transition Note 1 
In Chapter 2, the systematic review identified a significant gap in perinatal MI research. 
The focus of the study was to review existing peer-reviewed publications in English that were 
related to perinatal MI, its relation to PPD, and its effects on child outcomes. The literature 
search was conducted on seven academic health databases from 1985 to July 2017, and seven 
articles met the inclusion criteria. Two of the selected articles discussed perinatal MI 
longitudinally, one article examined the effects maternal emotion dysregulation on mother-infant 
interaction, and the rest of the articles investigated PPD, PPB, and the experience of being 
pregnant, while perinatal MI was a component of the studies. In addition, of the seven selected 
articles, only three articles were published within ten years. The remarkable gap of perinatal MI 
research was not just presented in limited quantity, but also in limited types of studies. The 
findings indicated that in order to further understand perinatal MI, more research in perinatal MI 
is needed, for example, determining the etiology of perinatal MI, genetic influences, risk factors 
for perinatal women, longitudinal association between antenatal MI and postpartum 
psychopathologies, and the effects of perinatal MI on mothers, neonatal, and child outcomes. 
Therefore, in Chapter 3, a second manuscript is presented to explore the risk factors for perinatal 
MI at early and late pregnancy, and postpartum, the association between antenatal MI and PPD, 


















Chapter 3: Manuscript Two 

















Objective: The purpose of this study was to understand the relationship between perinatal MI 
and its risk factors at distinct points, between antenatal MI and postpartum depression (PPD), 
and the trajectory of MI in perinatal women across the perinatal continuum. Method: a total of 
648 women participated in a longitudinal study of maternal depression at three points: early 
pregnancy (T1, 17.4 ± 4.9 weeks), late pregnancy (T2, 30.6 ± 2.7 weeks), and postpartum (T3, 
4.2 ± 2.1 weeks). Mood instability, depression, stress, and social support were measured at T1, 
T2, and T3, other sociodemographic data were collected at T1, and obstetrical information was 
obtained at appropriate times. Multi-linear regression was used to examine MI and its risk factors 
cross-sectionally, hierarchical multiple regression was utilized to investigate longitudinal 
relationship between antenatal MI and postpartum depression, and a linear mixed model (LMM) 
was employed to examine the trajectory of perinatal MI over three periods (T1-T3). Results: In 
the cross-sectional study, MI was significantly associated with perinatal depression, history of 
depression, and stress at T1, T2, and T3, and with labour/birth complications at T3. Perinatal 
depression exerts the most effect on MI among the risk factors. Mood instability at T1 was 
significantly associated with PPD after controlling depression at T1. The trajectory of perinatal 
MI had a decreased trend overall with a significant declining from T2 to T3. Conclusion: The 
study expands our understanding of MI in perinatal women, which can impact the mental and 
physical health of their children.  











Mood instability is sometimes used interchangeably with mood dysregulation, affective 
instability, affective lability, affective and emotional dysregulation, and mood swings (Marwaha, 
Broome, Bebbington, Kuipers, & Freeman, 2014; Teicher, Ohashi, Lowen, Polcari, & Fitzmaurice, 
2015). A useful definition is “extreme and frequent fluctuations of mood over time” (Trull et al., 
2008), but time is not well defined and neither are the terms “extreme” or “frequent”. 
Women’s reproductive years, spanning pubescence, pregnancy, postpartum, and 
menopause, are often associated with increased moodiness (Bowen, A., Bowen, Balbuena, & 
Muhajarine, 2012; Mitchell, 2017; Toffol, Heikinheimo, & Partonen, 2015). These seemly 
“harmless” mood switches are often regarded as a normal part of a woman’s life by hormonal 
changes (Buttner, O’Hara, & Watson, 2012; Cunningham et al., 2010; Fooladi, 2006).  
 Giving birth to a child is most often a joyful event, but it can also be overwhelming and 
challenging. During pregnancy and delivery, expectant and new mothers undergo not only many 
physical changes, but also make remarkable emotional, behavioural, cognitive adjustments to 
adapt to the demands of motherhood (Buist et al., 2008; Goyal, Gay, & Lee, 2007). In addition, 
the transition to motherhood represents a time of greater vulnerability for women to develop 
mood-related disturbances, including perinatal depression (Kessler et al., 2003; Milgrom & 
Gemmill, 2014), and postpartum blues and mood swings (Pop et al., 2015). Studies have found 
that perinatal women often experience the highest irritable, euphoric, and depressed moods in 
early pregnancy and again around the time of giving birth (Cunningham et al., 2010; Steiner, 
Dunn, & Born, 2003). This phenomenon is thought to be triggered by the large hormonal 






In a longitudinal study, Bowen, A. et al. (2012) investigated MI in perinatal women. A 
subgroup of 45 perinatal women participated in this study from the Feelings in Pregnancy and 
Motherhood Study (FIP) (Bowen, A., Bowen, Butt, Rahman, & Muhajarine, 2012). Co-currently, 
a control group comprised of normally menstruating non-perinatal women without depressive 
symptoms (n = 31) from a separate study of moods was also recruited (Bowen, R, Mahmood, 
Milani, & Baetz, 2011). The perinatal women’s mood was assessed at early pregnancy (mean 
gestation 16.4 weeks, SD 4.4), late pregnancy (mean gestation 30.4 weeks, SD 2.3), and 
postpartum (mean 4.3 weeks postpartum, SD 1.5). Mood instability was measured by using 
mood diaries with visual analogue scales (VAS) for depressed, irritable, anxious, and euphoric 
moods for both groups in the morning and evening. Depression symptoms were assessed by 
using the Edinburgh Postnatal Depression Scale (EPDS) (Cox, Holden, & Sagovsky, 1987). The 
perinatal women completed three separate mood diaries (each for 7 days) after three interviews, 
while the control group completed the mood diaries for two consecutive menstrual cycles (eight 
weeks). The findings suggested that perinatal women were more likely to experience depressed, 
irritable, anxious, and euphoric mood fluctuation compared to the controls, indicating perinatal 
women were moodier. Contrary to most of the existing literature which predominantly focused 
on depressive mood in the perinatal period, the authors suggested that mood variation is a 
prominent feature in perinatal women.  
Perinatal mood research has focused mostly on depression as diagnostic concepts with 
duration of a week or more, rather than on MI which usually implies mood fluctuations within a 
day. This may be due partly to the perception of MI as a normal part of a woman’s life, and 
partly to the tendency for research to focus on diagnostic entities. However, MI research in the 






associated with a variety of psychiatric disorders and acknowledged by 13.9% of population 
(Marwaha, Parsons, Flanagan, & Broome, 2013). Several of the major risk factors for perinatal 
depression are psychosocial and behavioural in nature (e.g., social support, stress, smoking), and 
emerging literature has suggested that the same factors may also be important in general 
population with MI (Marwaha et al., 2013). In the longitudinal relationship studies, Marwaha et 
al. (2015) found that MI predicts depression inception after 18 months in a population study, 
while Thompson, Berenbaum, and Bredemeier (2011) also found a significant association 
between MI and major depressive disorder (two months later) after controlling a current major 
depressive episode in a student sample.   
3.2 Research hypothesis 
Perinatal MI would be associated with its risk factors at early pregnancy, late pregnancy, 
and postpartum, antenatal MI would be correlated with postpartum depression (PPD), and 
perinatal MI would have its distinct trajectory. 
3.3 Methods 
3.3.1 Participants and procedure 
The current study is a secondary data analysis from the Canadian Institute of Health 
Research Feelings in Pregnancy and Motherhood Study (FIP) (Grant # 145179). The FIP was a 
longitudinal cohort study of maternal mental health from 2006 to 2014. A total of 648 women 
were recruited in early pregnancy from a variety of community settings such as doctors’ offices, 
prenatal classes, maternity stores, and responders to radio and newspaper advertisements. The 
inclusion criteria were English speaking women in early pregnancy (gestation ≤ 20 weeks), and a 
resident in one of two health regions in Saskatchewan (Saskatoon Health Region or Five Hills 






face interviews at three-time points: T1 early pregnancy (17.4 ± 4.9 weeks), T2 late pregnancy 
(30.6 ± 2.7 weeks), and T3 postpartum (4.2 ± 2.1 weeks). Information regarding children’s birth 
outcomes was obtained from the mothers and linked with hospital discharge records, with the 
mother’s permission. If a woman screened positive for depression, she was referred with her 
permission to her family doctor for further investigation and given information about local 
mental health services; if she was deemed at risk of self-harm or harming others, immediate help 
was provided. Ethics approval for the research protocol was obtained from the Behavioural 
Research Ethics Board at the University of Saskatchewan. All participants gave written informed 
consent. 
3.3.2 Measures 
Symptoms of depression were measured with the Edinburgh Postnatal Depression Scale 
(EPDS) (Cox et al., 1987) at T1, T2, and T3. A score of  ≥ 12 (≥12 depressed; <12 indicates not 
depressed) was used in this present study to determine depression status (Smith, Eryigit‐
Madzwamuse, & Barnes, 2013). 
Mood instability was measured by a five item visual analogue scale (VAS): 1 “mood 
frequent ups and downs”, 2 “mood swings occur for no reason”, 3 “other people complain about 
your mood swings”, 4 “having trouble following through with plans because of mood swings”, 
and 5 “not making commitments because moods might change”. Women were asked to mark an 
“X” on with a 10cm line. The X was then measured on a metric ruler by a research assistant. 
This self-reported measure has a total possible score of 50.  
Sociodemographic factors 
 Age: women’s age was calculated based on their birthday at the time of intake. Seventeen 
women were less than 20 years old, and six women were aged older than 40 years, thus the 






 Education attainment: women reported years of education they received from the 
selections of < 12th grade, = 12th grade, some post-secondary/university, to completed 
post-secondary/university. The variable was categorized into < grade 12 and ≥ grade 12. 
 Marital status: participants were in different relationship arrangements; this variable was 
categorized as with a partner (married or cohabiting) or without a partner (single, widowed, 
or divorced). 
 Ethnicity: options included Caucasian, Aboriginal with treaty status, non-status 
Aboriginal, Métis, immigrant, and other. Due to the small number of women who were 
immigrants or other, the ethnicity of women was dichotomized as Aboriginal or non-
Aboriginal. 
 Family income: four levels of family income were identified: social assistance or less 
than $20,000 per year, between $20,000 and $40,000 per year, between $40,000 and 
$60,000 per year, and greater than $60,000 per year. This variable was categorized as 
≤$40,000 or > $40,000. 
Psychosocial factors 
 History of depression: women were asked “Do you have a history of depression?” The 
answer was categorized into “yes” based on women’s positive answer to the question, and 
“no” for a negative answer. 
 Family history of perinatal depression: women were asked “Did your mother or any of 
your sisters have depression before or giving birth?” The answer was categorized into 
“yes” if the answer is positive, and “no” for a negative answer. 
 History of abuse: three questions were used to assess history of abuse, “Has anyone ever 






blame, neglect you?” “Has anyone touched you against your will, raped you?” The 
responses were categorized into a dichotomous variable, “yes” if any type of abuse 
occurred, and “no” if answers for three questions were no.  
 Social support: six questions inquired about the types of support available (emotional 
support, support of a partner, support of the mother, support of friends, support of female 
relatives, and other support). The variable was dichotomized as low-level of support (0-1 
types support) and high-level of support (two or more types of support). 
 Stressors: women were asked to identify their sources of stress including being pregnant, 
health of baby, birth of baby, own health, relationship with partner, housing, money, and 
work. The level of stress was categorized into low-stress level (0-2 stressors) or high-stress 
level (≥ 2 stressors). 
Behavioral factors 
 Smoking: women were asked, “In the last month, how much do you smoke?” Options 
included more than a pack/day, 5-20 cigarettes/day, less than five cigarettes a day, quit 
since pregnant, quit before pregnancy, and never smoked. The variable was categorized 
into a dichotomized variable, “yes” and “no or quit”. 
 Alcohol: alcohol use was assessed by asking, “How often did you drink beer or other 
alcohol?” Potential responses were occasional on a drink or two, 1-2 drinks a day, five or 
more drinks at one time, quit since pregnant, quit before pregnancy, and never drank 
alcohol. The variable was summarized into a dichotomized variable, “yes” and “no or 
quit”. 
 Drugs: Drug use was determined by asking “How often did you use drugs such as marijuana, 






occasionally, quit since pregnancy, quit before pregnancy, and never use such drugs. The 
options were summarized into a dichotomized variable, “yes” and “no or quit”. 
 Exercise: “In the last month, how much do you exercise?” was used to evaluate women’s 
exercise regimen, and women’s answers were every day, 2-3 times per week, 
occasionally, or never. The responses were categorized into a dichotomous variable with 
two levels, “regular exercise” and “never or occasionally exercise.” 
 Obstetric outcome factors 
 Pregnancy intention: intention was categorized into “yes” based on women’s response to 
“intended pregnancy”, and “no” for not intended. 
 Parity: the total number of pregnancies, previous abortions and/or miscarriages, and 
previous preterm and/or full-term deliveries. The variable was summarized into a 
dichotomous variable, “1” for primigravida and “>1” for multigravida. 
3.3.3 Data analyses 
A descriptive statistical analysis was conducted to summarize characteristics of 
participants. At three points, the percentage of depressed women (EPDS ≥12) was calculated. 
Group specific descriptive statistical analyses were also performed to illustrate MI levels in 
depressive and non-depressive women, and both MI and depressive levels in women who 
received antidepressant treatment and who did not take antidepressant at T2 and T3. To measure 
internal reliability consistency, Cronbach α for EPDS score, and MI score were computed. 
3.3.3.1 The association between perinatal mood instability and its risk factors 
To investigate the association between perinatal MI and its risk factors, linear regression 
analysis was used to generate univariate estimate coefficient associated with potential risk 
factors, and multivariate linear regression analysis was employed to arrive at simple, and robust 






The independent variables (IVs) including demographic variable at T1, psychosocial and 
behavioural risk factors at T1, T2, and T3, and obstetric variables were collected at T3 
(Appendix A, Table 3-A.1-3).  
Model selection for multiple linear regression model. In univariate analysis, the DV 
was MI. The IVs included depression, marital status, education level, ethnicity, family income, 
age, history of depression, family history of perinatal depression, history of abuse, stress level, 
social support, parity, pregnant intention, smoking, alcohol use, drug use, and exercise. For 
model selection in multivariate linear regression analysis, the backward elimination model 
building process followed five steps (Montgomery, Peck, & Vining, 2015): 1) keep variables 
with p-value <0.25 in the univariate analysis; 2) fit the multivariable model containing all 
covariates identified from inclusion in step 1; 3) in each step of backward selection procedure in 
step 2, compare the values of the estimated coefficients in the smaller model to their 
corresponding value from the large model. Any variable whose coefficient has changed 
substantially in magnitude (e.g., Δ𝛽 ̂>20%) was put back to refit until all of the important 
variables are included; 4) put each variable not selected in step 1 to the model obtained at step 3, 
one at a time, and check its significance by the Wald statistic and p-value; 5) put all variables 
that were significant (p-value <0.05) at step 4 in the final model. 
3.3.3.2 The association between antenatal mood instability and postpartum depression 
To examine the longitudinal relationship between antenatal MI and PPD, hierarchical 
multiple regression (HMR, one of linear regressions) was used to show if variables of interest 
explain a statistically significant amount of variance in dependent variable after accounting for 
all other variables (Petrocelli, 2003). The reason for using HMR in this study is that there is 






example, in a synthesis of antenatal risk factors for postpartum depression (PPD) from the meta-
analyses of over 24,000 subjects (Robertson, Grace, Wallington, & Stewart, 2004), depression 
during pregnancy, past history of mental illness, life events, and social support were identified as 
strong to moderate risk factors for PPD; moderate risk factors include marital relationship and 
neuroticism; small risk factors included obstetric factors and socioeconomic status. To our 
knowledge, longitudinal relationship between antenatal MI and PPD has not been studied before. 
Therefore, we examined whether antenatal MI is still able to predict an outcome when the effects 
of others variables especially antenatal depression are controlled for. Hierarchical multiple 
regression has been used in longitudinal studies in a variety of fields; for example, Thompson et 
al. (2011) investigated the longitudinal relationship between MI and depression in a community 
sample; antenatal marital relationship and attachment as predictors for postpartum stress, and 
depression symptoms (Clout & Brown, 2016). 
In HMR, IVs are entered into equation in steps specified by the study purpose, each IV is 
assessed in terms of what it adds to the prediction of DV after the previous IVs have been 
controlled for, and overall model and relative contribution of each block of variables is assessed 
(Tabachnick & Fidell, 2007). The DV was depression at T3. The IVs including demographic, 
psychosocial variables, depression, and MI were assessed at T1 and T2. In the HMR analysis, 
demographic variables (age, marital status, education, ethnicity, and family income) were 
entered in step 1, psychosocial variables (history of depression, family history of perinatal 
depression, stress, history of abuse, exercise, smoking, alcohol use, pregnancy intention, partner 
support) and depression were entered in step 2, and in step 3, MI was entered. We built three 
models to investigate the relationship between antenatal variables at T1and PPD in model 1, the 






between antenatal variables during pregnancy (T1 + T2) and PPD in model 3. For IVs during 
pregnancy, MI, as a continuous variable, was averaged ((T1 + T2)/2), and other dichotomous 
variables including sociodemographic, psychosocial, behavioral, obstetric, and neonatal that 
were measured at T1 and T2 were added  (T1 + T2) (for example, a woman experienced 
depression during pregnancy, indicating she was depressed at T1 or at T2, or both) (Anand et al., 
2005; Dotson, Resnick, & Zonderman, 2008). 
3.3.3.3 Trajectory of mood instability 
Descriptive data analysis and linear mixed model (LMM) were employed to examine the 
trajectory of perinatal MI from T1 to T3. Model selection of LMM was followed the steps 
suggested by Montgomery, Peck and Vining (2015). For each risk variable in the final model, we 
started with a null model that allowed individual to have a random intercept but a fixed slope. 
Next, we added risk variable one by one, including time and the interaction term of 
variable*time (Bueno-López & Bevilacqua, 2013). The Akaike’s Information Criterion (AIC) 
and Bayesian’s Information Criterion (BIC) were used to determine the covariance structure and 
the model (Gregoire & Schabenberger, 1996).  
Model selection for linear mixed model. For model selection of LMM, we followed the 
steps suggested by Montgomery et al. (2015) described above. For fixed effects, risk variables in 
the final model were entered one at a time, and interaction between each risk factor and time 
(coded as “1,” “2,” or “3”) into the model. Intercepts were entered as random effect. To identify 
possible choices for the covariance associated with repeated measures models, covariance 
structure selection was conducted by utilizing four different covariance structures suggested by 
West, Welch and Galecki (2014): unstructured, compound symmetry, autoregressive (AR), and 






Akaike’s Information Criterion (AIC) and Bayesian’s Information Criterion (BIC) (West et al., 
2014). 
Results were considered to provide evidence of significance if p-values <0.05 (α level of 
5%). The data were analyzed using SPSS 24 for HMR, and using the SAS 9.3 for the rest of the 
data analysis.  
3.4 Results 
3.4.1 Descriptive data analysis and linear regression (simple and multiple) assumption test 
and model fit diagnostic 
Variables of interest for accuracy of skewness, Kurtosis, and outliers were examined. 
Univariate outliers were detected in some variables (MI and EPDS scores) by using box plot and 
histogram; however, the outliers were included in the study as they represented clinically 
relevant cases (such as EPDS score = 30 or 1). The 5% trimmed means were similar to the 
original means of all variables (Maronna, Martin, & Yohai, 2006). For linear regression model 
and LMM, MI as continuous variable was skewed, with significant (p <0.001) Kolmogorov-
Smirnov and Shapiro-Wilk normality tests, indicating the variable had non-normal distribution. 
Log-transformation and square root transformation were used to normalize the distribution of the 
MI score (Singer & Willett, 2003), which did correct skeweness, but Kolmogorov-Smirnov and 
Shapiro-Wilk normality tests were still significant (p<0.001). Pallant (2007) stated that non-
normal distribution of data is typical in social science studies, and violation of normality 
assumption is not considered to cause biases in data analysis. In this study, log-transformation 
MI was used because it corrected the skewness. After log-transformation MI was implemented, 
normality assumption was tested by examining the normality of residuals, the plot of residual 






showed a linear trend with a slight deviation at the tail, which suggests that the linearity 
assumption was satisfied. Multicollinearity diagnostic statistics (tolerance and variance inflation 
factors (VIF)) were tested, and values of VIF were < 10, indicating that there was no violation of 
multicollinearity assumption (Brown, Giles, & Greenlund, 2007). The model fit was assessed by 
examining the plot of standardized residual versus standardized predicted values, which showed 
that the model fitted the data well (-3, 3) (Montgomery et al., 2015).  
For HMR models, normality and linearity assumptions were tested by examining normal 
probability plot (P-P plot) of the regression standardized residual and the scatter plot. The normal 
P-P plots showed a linear line with a slight deviation at the mid of the line, which indicated 
linearity assumption was satisfied. In the scatterplot, the residuals were rectangularly distributed 
with most of the scores concentrated in the centre, which showed mostly normally distributed. 
Multicollinearity diagnostic statistics (tolerance and variance inflation factors (VIF)) were tested, 
and values of VIF were < 10, indicating that there was no violation of multicollinearity 
assumption (Brown, Giles, & Greenlund, 2007). The model fit was assessed by examining the 
plot of standardized residual versus standardized predicted values, which showed that the model 
fitted the data well (-3, 3) (Tabachnick & Fidell, 2007) 
Missing data is a common issue in longitudinal studies (Twisk & de Vente, 2002), and 
the FIP study is no exception. Missing values in this study at all three time points accounted for 
less than 10%, which is at an acceptable level (Bennett, 2001). At T1, the first 93 women 
participated in the study before the MI assessment was added to the study; therefore, data was 
analyzed on 555 women. 
The mean age of women was 29.0 years (SD=4.85), and first-time mothers represented 






95% (n = 614) of women had education level of high school diploma or higher, 67.1% (n = 430) 
of women’s family income was equal or greater than $40,000 per year, and Aboriginal women 
represented 8.5% (n = 55) in this study (Appendix 3-A, Tables 3-A.1-3).  
By comparing group mean differences between depressed women and not depressed 
women, women with depression displayed a significantly higher level of MI than women without 
depression at T1, T2, and T3 (T1: t(553) = 15.218, p <0.001; T2: t(589) = 13.146, p <0.001; T3: 
t(593) = 12.761, p <0.001). 
Thirteen women (2.0%) reported taking antidepressants at T2, and of those women, 
30.8% (n = 4) were depressed (EPDS score ≥ 12); 26 women (4.4%) took antidepressants at T3 
(two of them were breastfeeding), and in which 34.6% (n = 9) experienced elevated depressive 
symptoms (EPDS score ≥ 12). There was no information at T1. By comparing group mean 
differences in EPDS, women who received antidepressant treatment at T2 and T3 displayed a 
significantly higher level of depressive symptoms than women without antidepressant treatment 
(T2: t(598) = 4.50, p <0.001; T3: (t(586) = 4.47, p < 0.001 respectively). However, by comparing 
group mean differences between depressed women without antidepressant treatment and women 
with the treatment, depressed women without antidepressant treatment at T2 and T3 reported a 
significantly higher level of depressive symptoms than women with the treatment (T2: t(62) = 
3.098, p = 0.003; T3: t(59) = 4.274, p <0.001). The means and standard deviations are presented 
in Table 3.1.  
In a comparison of group mean differences in MI scores, women who received 
antidepressant treatment at T2 and T3 displayed significantly elevated scores in MI than women 
without antidepressant treatment (T2: t(574) = 3.59, p < 0.001; T3: t(588) = 5.16  p <0.001  






between depressed women without antidepressant treatment and depressed women with the 
treatment (T2: t(67) = 0.943, p =0.349; T3: t(57) = 1.262, p = 0.212).  
The results of Cronbach α (ranging from 0.824 to 0.870) indicate high internal 
















*Note: information on medication treatment was not available at T1  
 
3.4.2 The association between perinatal mood instability and its risk factors 
A majority of risk factor variables showed statistically significant association with MI in 
univariate linear regression (Appendix 3-A, Tables 3-A.1-3). The multivariate linear regression 
Table 3.1: Mean scores of EPDS and MI, Cronbach α (n = 555 at T1, n = 603 at T2, and n = 
595 at T3) 
 
Measurements Mean SD Depressed (%) 
(EPDS score ≥ 12) 
Cronbach α 
EPDS score at T1 6.82 4.42 13.53 0.834 
   Depressed ( EPDS score ≥ 12) 14.85 3.13   
   Not depressed (EPDS score < 12) 5.49 3.01   
EPDS  score at T2 6.25 4.31 10.61 0.824 
   Depressed ( EPDS score ≥ 12) 15.20 3.47   
   Not depressed (EPDS score < 12) 5.18 3.00   
   Medication treatment 11.46 7.45 30.80  
   Without treatment 6.13 4.19 8.03  
EPDS  score at T3 5.64 4.12 7.90 0.830 
   Depressed ( EPDS score ≥ 12) 15.43 3.40   
   Not depressed (EPDS score < 12) 4.74 2.91   
   Medication treatment 9.08 7.08 34.62  
   Without treatment 5.43 3.88 3.38  
MI score at T1 14.63 11.00  0.855 
   Depressed ( EPDS score ≥ 12) 29.22 10.29   
   Not depressed (EPDS score < 12) 12.08 9.07   
MI score at T2 14.00 9.42  0.870 
   Depressed ( EPDS score ≥ 12) 27.23 10.24   
   Not depressed (EPDS score < 12) 12.43 8.06   
   Medication treatment 21.91 9.99   
   Without treatment 13.81 9.39   
MI score at T3 12.08 8.24  0.870 
   Depressed ( EPDS score ≥ 12) 24.98 9.90   
   Not depressed (EPDS score <12) 10.93 6.96   
   Medication treatment 18.35 11.00   






results revealed that depression, history of depression, and stress at T1, T2, and T3 were 
significant risk factors for MI1, MI2, and MI3 respectively, and additionally, labour/birth 
complication was a significant risk factor for MI at T3. The overall models at T1, T2, and T3 are 
statistically significant (p <0.0001). These parameter estimates correspond to the estimate 
coefficients presents in Table 3.2, and represent the statistically significant effects of each 
independent variable, holding all other variables constant. Although we found a strong univariate 
association between MI and age, ethnicity, family income, family history of perinatal depression, 
history of any abuse, exercise, smoking, alcohol use, social support, parity, and breastfeeding, 
these were not established as independently operating risk factors in multivariate linear 
regression analysis.  
 
 
Table 3.2: Association between mood instability and its risk factors - cross-sectional 
multivariate linear regression results (n = 555 at T1, n = 603 at T2, and n = 595 at T3) 
 




Antenatal depression (EPDS ≥12) at T1 0.307 (0.242 - 0.372) <0.0001 
History of depression    0.131 (0.073 - 0.189) 0.0002 
Stress at T1   0.116 (0.053 - 0.180) 0.0004 
T2 
Antenatal depression (EPDS ≥12) at T2 0.306 (0.253 – 0.340) <0.0001 
History of depression  0.098 (0.054 – 0.141) <0.0001  
Stress at T2 0.088 (0.036 – 0.140) 0.0010 
T3 
Postpartum depression ( EPDS  ≥12) at T3 0.297 (0.239 - 0.354) <0.0001 
History of depression  0.067 (0.026 - 0.107) 0.0010 
Stress at T3 0.122 (0.059 - 0.186) 0.0002 
Labour/birth complications 0.044 (0.005 – 0.082) 0.0270 






3.4.3 The association between antenatal mood instability and postpartum depression 
Hierarchy multiple regression (HMR) model 1 examined the association between 
independent variables, including demographic variables, psychosocial variables, depression, and 
MI at T1 and PPD at T3. In the first step of HMR, demographic variables of age, marital status, 
education attainment, ethnicity, and income were entered. This model was not statistically 
significant (F (5, 481) = 1.550; p = 0.173), and explained 1.6% of variance in PPD. In the second 
step of HMR, psychosocial variables and depression were entered into the equation. The total 
variance explained by the model was 14.5% (F (12, 474) = 6.704; p < 0.001), and the model was 
statistically significant. After entry of MI at T1 at step 3 the total variance explained by the 
model as a whole was 15.3% (F (13, 473) = 6.567; p < 0.001). The introduction of MI explained 
additional 0.80% of variance in PPD at T3, after controlling for demographic and psychosocial 
variables and depression (R2 change = 0.008; F (1, 473) = 4.349; p = 0.038). In the final adjusted 
model, three variables (stress, depression, and MI) were statistically significant (β = 0.109, p = 
0.024; β = 0.231, p < 0.001; β = 0.115, p = 0.038 respectively) (Appendix 3-B, Table 3-B.1).   
Hierarchy multiple regression (HMR) model 2 investigated the relationship between 
independent variables including demographic variables, psychosocial variables, depression, and 
MI at T2 and PPD at T3. In the first step of HMR, demographic variables of age, marital status, 
education attainment, ethnicity, and income. This model was not statistically significant (F (5, 
454) = 1.102; p = 0.358), and explained 1.2% of variance in depression (PPD). In the second step 
of HMR, psychosocial variables and depression were entered into the equation. The total 
variance explained by the model was 20.8% (F (13, 446) = 8.996; p < 0.0001), and the model 
was statistically significant.  After entry of MI at T2 at step 3, the total variance explained by the 






additional 0.2% of variance in PPD at T3, after controlling for demographic and psychosocial 
variables and depression (R2 change = 0.002; F (1, 445 = 1.325; p = 0.250). In the final adjusted 
model, two variables (stress and depression) were statistically significant (β = 0.176, p < 0.001; β 
= 0.310, p < 0.001 respectively) (Appendix 3-B, Table 3-B.2).   
Hierarchy multiple regression (HMR) model 3 explored the relationship between IVs, 
including demographic variables, psychosocial variables, depression, and MI during pregnancy 
(T1+T2) and PPD at T3. Similarly, in the first step of HMR, demographic variables of age, 
marital status, education attainment, ethnicity, and income. This model was not statistically 
significant (F (5, 456) = 1.288; p = 0.268), and explained 1.4% of variance in depression (PPD). 
In the second step of HMR, psychosocial variables and depression were entered into the 
equation. The total variance explained by the model was 22.1% (F (12, 449) = 10.644; p < 
0.001), and the model was significant. The introduction of MI explained additional 0.2% of 
variance in PPD at T3, after controlling for demographic and psychosocial variables and 
depression (R2 change = 0.002; F (1, 448) = 1.111; p = 0.292). In the final adjusted model, two 
variables (stress and depression) were statistically significant (β = 0.147, p =0.002; β = 0.332, p 
< 0.001 respectively) (Appendix 3-B, Table 3-B.3).   
3.4.4 Trajectory of perinatal mood instability 
Mood instability mean scores displayed a declined course from T1 (mean = 14.63, SD = 
11.0), T2 (mean = 14.00, SD = 9.42) to T3 (mean = 12.08, SD = 8.24). However, the declining of 
MI level from T2 to T3 was statistically significant (t(591) = 4.32, p < 0.001). Similarly, on the 
EPDS, 13.5% of women (n = 92) scored ≥ 12 at T1, 10.6% (n = 64) at T2, and 7.9% (n = 47) at 






For the trajectory of the relationship between MI and depression from T1 to T3, we 
selected IVs that were fitted by LMM based on their level of significance (p-value <0.05). For 
fixed effects, time and risk factors were entered one at a time, including time, depression 
(EPDS), stress level, history of depression, and interaction between each risk factor and time 
(coded as “1,” “2,” or “3”) into the model. Random intercept over time was added to the model 
to account for the correlation of repeated measures on the same individual, so that each 
individual has its own regression equation allowing for evaluating whether individuals differ in 
their means or response patterns over time. We chose the unstructured covariance structure with 
the smallest Akaike’s Information Criterion (AIC) and Bayesian’s Information Criterion (BIC) 
(Gregoire & Schabenberger, 1996). The best model selected was without interaction terms based 
on the smallest AIC and BIC (Appendix 3-C Table 3-C.1). Mood instability was significantly 
elevated in women with depression (EPDS ≥ 12), a higher level of stress, and history of 
depression from T1 to T3 (Table 3.3). A test of depression-by-time, stress-by-time, and history 
of depression-by-time interaction terms was not significant, indicating that there were no 
significant differences in the changes from T1 to T3 of MI values for both groups of depressed 
versus non-depressed, more stressed versus less stressed, and having a history of depression 














This is the first study of investigating the relationship between perinatal MI and its 
relation to PPD and risk factors cross-sectionally and longitudinally. We were able to replicate 
the significant association between depression and MI reported in the general and clinical 
populations cross-sectionally (Berenbaum, Bredemeier, Boden, Thompson, & Milanak, 2011; 
Bowen, R., Wang, Balbuena, Houmphan, & Baetz, 2013). Notably, this relationship had 
persisted throughout the perinatal period at each time point. Prospectively, we found that MI at 
17 weeks of pregnancy was significantly associated with depression at 4 weeks of postpartum, 
while controlling depression at 17 weeks of pregnancy, suggesting MI during early pregnancy is 
an independent risk factor for subsequent PPD. Mood instability at 31 weeks of pregnancy and 
during pregnancy was not associated with PPD, which may be due to the fact that depressive 
symptoms at 31 weeks of pregnancy played a larger role in predicting depressive symptoms at 
postpartum (after adding depression into the model, R2 changed 19.6% of variance explained by 
Table 3.3: Trajectory of mood instability in women with depression vs. without depression, 
with history of depression vs. without history of depression, and with more stress vs. with less 
stress  - estimated regression coefficients and their estimated standard errors from linear 
mixed model (n=555) 
 
Term Estimate coefficient Standard Error P-value 
Fixed effects    
   Intercept 1.412 0.024 <0.0001 
   Time (T1 vs. T2) 0.022 0.014 0.088 
   Time (T2 vs. T3) 0.052 0.012 <0.0001 
   Depression  0.305 0.021 <0.0001 
   More stress 0.079 0.013 <0.0001 
   History of depression 0.118 0.019 <0.0001 
Random effects    
   Intercept 0.027 0.002 <0.0001 
   Residuals 0.042 0.002 <0.0001 






the model, while after adding MI into the model, R2 changed 3.5% of variance explained by the 
model).  
To understand the relationship between MI and depression, the literature proposes that 
affective instability and depression share several associations (Thompson et al., 2011). MI is a 
core feature of neuroticism which in turn is a risk factor for depression (Bowen, R., Balbuena, 
Leuschen, & Baetz, 2012). Individual differences in neuroticism and negative emotionality have 
been indicated as a central factor in explaining comorbidity among psychiatric symptoms (e.g., 
depression, MI) (Beatson & Rao, 2013; Bowen, R et al., 2011; Denollet & De Vries, 2006; 
Miller, D., Vachon, & Lynam, 2009; Miller, J. & Pilkonis, 2006; Quilty, Sellbom, Tackett, & 
Bagby, 2009). A meta-analysis of 175 studies reported a strong association between neuroticism 
and depression (Kotov, Gamez, Schmidt, & Watson, 2010). Stress has been identified as another 
shared association of depression and MI. As extreme shifts in mood that last from a few hours to 
a few days, MI may be a result of interpersonal stress, and high levels of MI may also lead to 
stressful life events (e.g., the break-up of a relationship, loss of a job) (Koenigsberg et al., 2002). 
A significant correlation between depression and stress has been documented in both general and 
perinatal population (Fried, Nesse, Guille, & Sen, 2015; Reid & Taylor, 2015).  
To examine the significant difference in MI between women with a history of depression 
and without a history of depression, we tested whether the relationship was due to the effect of 
including women who were currently depressed (Thompson et al., 2011). Even after excluding 
women with current depression, women with history of depression were experiencing a 
significantly higher level of MI than women without at T1 (t (273) = 2.24, p = 0.026), and at T3 






may suggest that the positive relationship between MI and history of depression is not driven by 
current depressive symptoms during 17 weeks pregnancy and 4 weeks postpartum.  
Stress was identified as an independent risk factor for MI cross-sectionally, which is 
similar to other studies on MI in the non-perinatal women (Ebner-Priemer et al., 2007; Marwaha, 
Parsons, & Broome, 2013). Stress was also associated with PPD in the current study, which is in 
agreement with previous studies (Glover, 2014; Reid & Taylor, 2015). The transition to 
motherhood is often considered to be stressful, which can be related to many factors, such as 
physiological changes, pregnancy and delivery-related stress, role adjustment, and lack of social 
support that could make perinatal women uniquely vulnerable to develop mood symptoms 
(Bottino, Nadanovsky, Moraes, Reichenheim, & Lobato, 2012; Misri et al., 2010). As addressed 
earlier, stress was one factor associated in the relationship between MI and depression. The 
current study confirmed the similar association between stress, depression, and MI in the 
perinatal population, suggesting that pregnancy and postpartum-related stress are not only 
associated with perinatal depression, but also with perinatal MI. 
Among postpartum related risk factors, labour/birth complications exert a statistically 
significant effect on MI. Notably, the relationship between labour/birth complications and MI 
was prospective since MI was assessed at 4 weeks after giving birth, indicating that labour/birth 
complications may be an independent risk factor for MI after 4 weeks postpartum. 
In addition, significant relationships between antenatal depression and PPD, and between 
antenatal stress and PPD were confirmed in the current study which is in agreement with other 
studies. Previous studies suggest that the best predictor for PPD is antenatal depression (O'Hara 






stress has been correlated with an increased risk of PPD (Chojenta, Loxton, & Lucke, 2012; 
Demirchyan, Petrosyan, & Armenian, 2014; Rogers, Kidokoro, Wallendorf, & Inder, 2013).  
Although most women who experience depressive symptoms prefer non-pharmacological 
intervention during pregnancy and postpartum, antidepressant medication remains the most 
common treatment (Pearlstein et al., 2006). The effectiveness of antidepressant medications in 
treating perinatal depression is understudied (Vu & Shaya, 2017). To test whether antidepressant 
medication would improve perinatal depressive symptoms, we examined the depressive levels in 
depressed women (EPDS score ≥ 12) without antidepressant treatment and women with the 
treatment. We found that depressed women (EPDS score ≥ 12) without antidepressant treatment 
experienced a significantly higher level of depressive symptoms than women who received 
antidepressant treatment (T2: t(62) = 3.098, p = 0.003; T3: t(59) = 4.274, p <0.001), suggesting 
that women who are depressed during the perinatal period may benefit from antidepressant 
treatment. However, we had an opposite result; there was no significant difference of mean MI 
scores between depressed women without antidepressant treatment and women with the 
treatment, indicating that antidepressants may not be effective in treating perinatal MI. The 
findings must be interpreted with caution because only 13 women received antidepressant 
treatment at T2, and the following factors were not taken into consideration: severity of 
depressive symptoms, level of women’s compliance with antidepressant treatment, and whether 
women received counseling during this period.   
The current study investigated the trajectory of MI from 17 weeks and 31 weeks 
pregnancy to 4 weeks of postpartum, and found that perinatal women had the highest level of MI 
at 17 weeks of pregnancy, a slightly lower level at 31 weeks of pregnancy, and a 13.71% 






was statistically significant (t(591) = 4.32, p < 0.001). The findings demonstrate that the 
distribution of total scores of MI differed before and after childbirth, but was not significantly 
different from 17 weeks of pregnancy to 31 weeks of pregnancy, suggesting that pregnant 
women are more likely to experience elevated MI symptoms than postpartum women.  
Notably, although overall trajectory of depressive symptoms had declined from 17 weeks 
and 31 weeks of pregnancy to 4 weeks postpartum for entire sample (EPDS score: 6.82 at T1, 
6.25 at T2, and 5.64 at T3), depressive level among depressed women (EPDS ≥12) had remained 
almost at the same level with slightly increasing trend from T1 to T3 (EPDS score: 14.85 at T1, 
15.20 at T2, and 15.43 at T3). However, MI level in depressed women had declined from T1 to 
T3 (6.8% declining from T1 to T2, and 8.3% of declining from T2 to T3), indicating MI has its 
own trajectory among depressed women during the perinatal period. 
3.6 Implications 
 The findings from the current study have several implications. First, the significant 
relationship between MI and depression cross-sectionally and longitudinally indicates the 
importance of early detection and early intervention of perinatal MI. Screening for MI should be 
included in routine perinatal care in primary settings. Second, the identification of risk factors 
that precede and are associated with perinatal MI, and identification of antenatal MI as a risk 
factor for PPD would offer another possible opportunity for early detection and early 
intervention. For example, stress can be alleviated by utilizing coping strategies such as exercise 
and meditation (Bowen, R, Balbuena, Baetz, & Schwartz, 2013; Cairney, Kwan, Veldhuizen, & 
Faulkner, 2014). Third, given normalization of MI during perinatal period, increasing awareness 
of perinatal MI among the health care providers and the general public is essential in terms of 







There are several limitations in the study. First, participants were predominantly 
Caucasian, married, with post-secondary education, and higher family incomes, which limits the 
generalization of the findings. Second, self-reported risk behaviours such as smoking, alcohol 
consumption, and drug use are often under-reported, particularly during the perinatal period 
because of social desirability bias (Alvik, Haldorsen, & Lindemann, 2005; Van de Mortel, 2008). 
Third, the measure of MI and depression relied on participants’ subjective report and 
retrospective recall of symptoms. Retrospective recall can cause bias in different ways, such as it 
can be influenced by cognitive processes used to reconstruct past events (Schwartz & Rapkin, 
2004). Fourth, there is limited literature on MI, especially on perinatal women. 
3.8 Conclusion 
 The current study indicates that perinatal MI as a phenomenon is not a simple “part of the 
normal reproductive process,” rather MI is a serious mental health condition. The study expands 
our understanding of MI in perinatal women, which is important because perinatal MI has a 
potential negative impact on mental and physical health of perinatal women, and consequently, 
their children. In order to improve maternal mental health and the quality of life among perinatal 
women who experience MI, and the health of their children, MI assessment should be included 
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3.10 Appendix 3-A: Tables of summary of the association between MI and risk factors 




Risk factor (N) Frequency (%) Estimate Coefficient (95% CIs) P-value 
  
Marital status (555)  0.253 (0.152 - 0.355) <.0001 
    Without partner 45 (8.1)   
    With partner  510 (91.9)   
Education (554)  0.137 (-0.010 - 0.285) 0.068 
   < high school diploma  24 (4.2)   
   ≥ high school diploma  530 (95.8)   
Ethnicity (545)  0.232 (0.121- 0.342) <.0001 
   Aboriginal 39 (7.2)   
   Non-Aboriginal 506 (92.8)   
Family income (529)  0.055 (-0. 011 - 0.120) 0.100 
   ≤$40,000 158 (29.9)   
   >$40,000  371 (70.1)   
Age (555)  0.032 (-0.008 – 0.117) 0.087 
   <25 90 (16.2)   
   ≥ 25 465 (83.8)   
Depression (544)  0.398 (0. 336 - 0.458) <.0001 
   EPDS ≥12 73 (13.5)   
   EPDS <12 471 (87.5)   
Personal history of depression (545)  0.264 (0. 205 – 0. 322) <.0001 
   Yes 189 (35.0)   
   No  354 (65.0)   
Family history of perinatal 
depression (545) 
 0.148 (0. 082 – 5.201) <.0001 
   Yes 142 (26.1)   
   No  403 (73.9)   
History of abuse (physical or 
emotional or sexual) (545) 
 0.040 (0.022 – 0.178) 0.012 
   Yes 306 (56.1)   
   No 239 (43.9)   
Stress level (549)  0.213 (0.243 - 0.325) <0.0001 
   More (>2) 224 (40.8)   
   Less (0-2) 325 (59.2)   
Social support (544)  0.023 (-0.048 - 0.002) .0.067 
   Less (0-1)  67 (12.7)   





















Table 3-A.1: Summary of the association between MI and risk factors at T1 (N = 555) 
continues  
 
Risk factor (N) Frequency (%) Estimate Coefficient (95% CIs) P-value 
  
Parity at intake (553)  0.103 (0.-13 – 0.136) 0.017 
    Multigravida 342 (61.9)   
    Primigravida 211 (38.1)   
Pregnancy intention (541)  0.115 (0.043 - 0.188) 0.002 
   No 117 (21.6)   
   Yes 424 (78.4)   
Smoking (553)  0.141 (0.061 – 0.243) 0.001 
   Yes 60 (10.9)    
   No or quit 493 (89.1)    
Alcohol use (547)  0.202 (0.153 – 0.368) <0.0001 
   Yes 38 (6.9)   
   No or quit 509 (93.1)   
Drug use (545)  0.031 (-0.111 – 0.242) 0.467 
   Yes  16 (2.9)   
   No or quit  529 (97.1)   
Exercise (553)  0.154 (0.050 – 0.169) <0.0001 
   Never or occasional 255 (46.1)   












Risk factor (N) Frequency (%) Estimate Coefficient (95% CIs) P-value 
  
Marital status (603)  0.126 (0.046  -0.207) 0.020 
    Without partner  49 (8.1)   
    With partner 554 (91.9)   
Education (603)  0.084 (-0.386 - 0.207) 0.176 
   < high school diploma  26 (4.2)   
   ≥ high school diploma  577 (95.8)   
Ethnicity (603)  0. 174 (0.84 - 0.264) <0.001 
   Aboriginal 44 (7.2)   
   Non-Aboriginal 559 (92.8)   
Family income (603)  0. 015 (-0. 044 - 0.075) 0.616 
   ≤$40,000 180 (29.9)   
   >$40,000  423 (70.1)   
Age (603)  0.025 (-0.035 – 0.062) 0.582 
   <25 96 (15.9)   
   ≥ 25 507 (84.1)   
Depression (602)  0.422 (0.341 - 0.503) <.0001 
   EPDS ≥12 64 (10.6)   
   EPDS <12 538 (89.4)   
Personal history of depression (603)  0. 161 (0.113 - 0 208) <.0001 
   Yes 211 (35.0)   
   No  392 (65.0)   
Family history of perinatal 
depression (603) 
 0. 106 (0.053- 0.158) <.0001 
   Yes 158 (26.1)   
   No  445 (73.9)   
History of abuse (physical or 
emotional or sexual) (603) 
 0.019 (-0.032 – 0.059) 0.546 
   Yes 338 (56.1)   
   No 265 (43.9)   
Stress level (598)  0.198 (0.134 – 0.216) <0.0001 
   More (>2) 257 (43.0)   
   Less (0-2) 341 (57.0)   
Social support (603)  0.002 (-0.006- 0.001) 0.572 
   Less (0-1)  77 (12.7)   





















Table 3-A.2:  Summary of the association between MI and risk factors at T2 (N = 603) 
 continues  
 
Risk factor (N) Frequency (%) Estimate Coefficient (95% CIs) P-value 
  
Parity at intake (603)  0.063 (-0.014 – 0.088) 0.154 
    Multigravida 373 (61.9)   
    Primigravida 230 (38.1)   
Pregnancy intention (603)  0. 089 (0.031 - 0.147) 0. 003 
   No 130 (21.6)   
   Yes 473 (78.4)   
Smoking (602)  0.063 (-0022 – 0.137) 0.157 
   Yes 62 (10.3)    
   No or quit 540 (89.7)    
Alcohol use (602)  0.055 (-0.052 – 0.230) 0.219 
   Yes 36 (6.0)   
   No or quit 566 (94.0)   
Drug use (602)  0.013 (-0.214 – 0.286) 0.775 
   Yes  8 (0.7)   
   No or quit  598 (99.3)   
Exercise (602)  0.091 (0.022 – 0.101) 0.002 
   Never or occasional 262 (43.5)   













Risk factor (N) Frequency (%) Estimate Coefficient (95% CIs) P-value 
  
Marital status (595)  0.003 (-0.074 -0.079) 0.949 
    Without partner 45 (8.1)   
    With partner 510 (91.9)   
Education (595)  0.066 (-0.057 - 0.188) 0.291 
   < high school diploma  24 (4.2)   
   ≥ high school diploma  530 (95.8)   
Ethnicity (595)  0.054 (-0.034 - 0.142) 0.231 
   Aboriginal 39 (7.2)   
   Non-Aboriginal 506 (92.8)   
Family income (595)  0. 015 (-0.045- 0.075) 0. 616 
   ≤$40,000 158 (29.9)   
   >$40,000  371 (70.1)   
Age (595)  0.025 (-0.035 – 0.062) 0.582 
   <25 19 (3.2)   
   ≥25 323 (58.3)   
Depression (591)  0.398 (0. 336 - 0.459) <.0001 
   EPDS ≥12 47 (7.9)   
   EPDS <12 544 (92.1)   
Personal history of depression (595)  0.264 (0. 205 – 0.322) <.0001 
   Yes 189 (35.0)   
   No  354 (65.0)   
Family history of perinatal 
depression (595) 
 0.148 (0. 082 - 0.214) <.0001 
   Yes 142 (26.1)   
   No  403 (73.9)   
History of abuse (physical or 
emotional or sexual) (595) 
 0.030 (0.010 – 0.050) 0.004 
   Yes 306 (56.1)   
   No 239 (43.9)   
Stress level (593)  0.251 (0.213 – 0.3.645) <0.001 
   More (>2) 256 (43.0)   
   Less (0-2) 340 (57.0)   
Social support (591)  0. 228 (0. 149 - 0.307) <.0001 
   Less (0-1)  67 (12.7)   
















Table 3-A.3:  Summary of the association between MI and risk factors at T3 (N = 595) 
continues  
 
Risk factor (N) Frequency (%) Estimate Coefficient (95% CIs) P-value 
  
Parity at intake (595)  0.026 (-0.033 – 0.061) 0.562 
    Multigravida 342 (61.9)   
    Primigravida 211 (38.1)   
Pregnancy intention (595)  0.010 (-0.045 - 0.064) 0.730 
   No 117 (21.6)   
   Yes 424 (78.4)   
Smoking (594)  0.032 (-0.048 – 0.104) 0.473 
   Yes 60 (10.1)    
   Never or quit 534 (89.9)    
Alcohol use (591)  0.109 (0.021 – 0.199) 0.016 
   Yes 212 (35.9)   
   Never or quit 379 (64.1)   
Drug use (594)  0.038 (-0.055 - 0.131) 0.424 
   Yes  8 (3.3)   
   No or quit  586 (96.7)   
Exercise (594)  0.089 (0.001 – 0.091) 0.047 
   Never or occasional 262 (43.5)   
   Regular 340 (56.5)   
Labour/birth complications (566)  0.051 (0.007- 0.097) 0.024 
   Yes 322   
   No 214   
Neonatal complication (567)  0.049 (0.005 - 0.947) 0.031 
   Yes 328   
    No 239   
Breastfeeding (566)  0.051 (-0.011 - 0.114) 0.108 
   No  416   






3.11 Appendix 3-B: Tables of hierarchical multiple regression models 
 
 
Table 3-B.1: Association between antenatal MI at T1 and PPD-Hierarchical multiple regression model1  
 
 R R2 R2 change β  SE T 
 
Step 1 0.126 0.016     
Age    0.008 0.344 0.182 
Marital status    0.077 0.683 1.578 
Education attainment     -0.005 0.433 -0.098 
Ethnicity    0.037 0.729 0.781 
Income    0.113* 0.412 2.417 
Step 2 0.381 0.145*** 0.129    
Age    0.028 0.337 0.611 
Marital status    0.064 0.734 1.233 
Education attainment     0.022 0.425 0.492 
Ethnicity    0.006 0.721 0.138 
Income    0.042 0.426 0.871 
History of depression    0.032 0.411 0.721 
Exercise    0.009 0.357 0.216 
Alcohol use    0.022 0.690 0.498 
Smoking    0.007 0.584 0.150 
Stress     0.114* 0.224 2.351 
Social support    0.010 0.546 0.214 
Depression (EPDS)    0.294*** 0.047 5.804 
Step 3 0.391 0.153* 0.008    
Age    0.024 0.333 0.525 
Marital status    0.065 0.724 1.259 
Education attainment     0.008 0.420 0.442 
Ethnicity    0.009 0.713 0.200 
Income    0.043 0.421 0.904 
History of depression    0.027 0.406 0.598 
Exercise    0.003 0.355 0.067 
Alcohol use    0.012 0.730 0.267 
Smoking    0.008 0.577 0.176 
Stress     0.109* 0.225 2.261 
Social support    0.021 0.544 0.454 
Depression (EPDS)    0.231*** 0.055 3.910 
Mood instability    0.115* 0.021 2.085 
 
Note: Statistical significance: * p < 0.05, ** p < 0.01, *** p < 0.001 
R2 = amount of variance explained by IVs 
R2 change – additional variances in DV 
β = standardized coefficient 
SE = Standard error 









Table 3-B.2: Association between antenatal MI at T2 and PPD-Hierarchical multiple regression model2 
 
 R R2 R2 change β  SE T 
 
Step 1 0.110 0.012     
Age    0.014 0.350 0.294 
Marital status    0.045 0.697 0.897 
Education attainment     0.012 0.440 0.243 
Ethnicity    0.037 0.742 0.768 
Income    0.103* 0.451 2.089 
Step 2 0.456 0.208*** 0.196    
Age    0.009 0.337 0.207 
Marital status    0.027 0.757 0.537 
Education attainment     0.024 0.425 0.540 
Ethnicity    0.007 0.821 0.156 
Income    0.032 0.416 0.715 
History of depression    0.043 0.398 0.943 
Exercise    0.047 0.355 1.099 
Alcohol use    0.064 0.952 1.498 
Smoking    0.051 0.603 1.150 
Stress     0.178*** 0.217 3.873 
Social support    0.011 0.626 0.336 
Depression (EPDS)    0.349*** 0.045 7.671 
Step 3 0.458 0.210 0.002    
Age    0.011 0.388 0.246 
Marital status    0.026 0.744 0.521 
Education attainment     0.025 0.418 0.559 
Ethnicity    0.006 0.821 0.135 
Income    0.027 0.412 0.587 
History of depression    0.041 0.399 0.901 
Exercise    0.053 0.357 1.236 
Alcohol use    0.065 0.986 1.534 
Smoking    0.052 0.639 1.167 
Stress     0.216*** 0.217 3.831 
Social support    0.012 0.615 0.259 
Depression (EPDS)    0.310*** 0.057 5.465 
Mood instability    0.064 0.025 1.151 
 
Note: Statistical significance: * p < 0.05, ** p < 0.01, *** p < 0.001 
R2 = amount of variance explained by IVs 
R2 change – additional variances in DV 
β = standardized coefficient 
SE = Standard error 








Table 3-B.3: Association between antenatal MI at T1 + T2 and PPD-Hierarchical multiple regression 
Model 3 
 
 R R2 R2 change β  SE T 
 
Step 1 0.118 0.014     
Age    0.015` 0.374 0.301 
Marital status    0.061 0.754 1.205 
Education attainment     0.006 0.438 0.118 
Ethnicity    0.035 0.840 0.705 
Income    0.108* 0.454 2.242 
Step 2 0.471 0.221*** 0.208    
Age    0.018 0.332 0.406 
Marital status    0.066 0.716 1.361 
Education attainment     0.013 0.420 0.298 
Ethnicity    0.010 0.764 0.213 
Income    0.024 0.421 0.544 
History of depression    0.013 0.391 0.282 
Exercise    0.007 0.357 0.155 
Alcohol use    0.031 0.618 0.729 
Smoking    0.010 0.575 0.234 
Stress     0.149** 0.242 3.162 
Social support    0.005 0.488 0.115 
Depression (EPDS)    0.371*** 0.054 7.635 
Step 3 0.473 0.223 0.002    
Age    0.015 0.340 0.356 
Marital status    0.067 0.716 1.386 
Education attainment     0.007 0.425 0.156 
Ethnicity    0.011 0.764 0.236 
Income    0.021 0.422 0.648 
History of depression    0.011 0.391 0.247 
Exercise    0.001 0.359 0.031 
Alcohol use    0.029 0.619 0.644 
Smoking    0.011 0.614 0.253 
Stress     0.147** 0.242 3.122 
Social support    0.003 0.487 0.068 
Depression (EPDS)    0.332*** 0.068 5.422 
Mood instability    0.061 0.028 1.054 
 
Note: Statistical significance: * p < 0.05, ** p < 0.01, *** p < 0.001 
R2 = amount of variance explained by IVs 
R2 change – additional variances in DV 
β = standardized coefficient 
SE = Standard error 






3.12 Appendix 3-C: Table of covariance structure selection results 
 
Table 3-C.1: Linear mixed model covariance structure selection results 
 
Model Covariance Structures 
Unstructured  Compound 
symmetry  
Autoregressive (1) Heterogeneous 
AR(1) 
 AIC BIC AIC BIC AIC BIC AIC BIC 
Intercept only 398.7 409.6 398.7 416.0 398.7 416.0 398.7 416.0 
Intercept and 
time 
386.8 408.5 388.8 414.8 388.8 414.8 388.8 414.8 
Intercept, time, 
and epds  
145.2 171.1 147.2 177.5 147.2 177.5 147.2 177.5 
Intercept, time, 
epds, epds*time 
145.3 179.9 147.3 186.2 147.3 186.2 147.3 186.2 
Intercept, time,   
and stress   
326.2 352.2 328.2 358.5 328.2 358.5 328.2 358.5 
Intercept, time,   
stress, and 
stress*time   
316.8 351.4 318.8 357.7 318.8 357.7 318.8 357.7 
Intercept, time,   
and history of 
depression   
308.4 334.3 310.4 340.6 310.4 340.6 310.4 340.6 




depression*time   
290.8 325.4 292.8 331.7 292.8 331.7 292.8 331.7 
Intercept, time,  
epds, and stress   
102.0 132.3 104.0 138.6 104.0 138.6 104.0 138.6 
Intercept, time,  
epds, stress,  
epds*time   
103.4 142.5 105.4 148.6 105.4 148.6 105.4 148.6 
Intercept, time,  
epds, stress, and 
stress*time   
98.8 137.7 100.8 144.0 100.8 144.0 100.8 144.0 
Intercept, time,  
epds, stress, and 
stress*time,  
epds*time     
69.4 125.6 103.8 155.7 103.8 155.7 103.8 155.7 
Intercept, time,  
epds, stress, and  
history of 
depression 
64.9 100.5 67.9 106.8 67.8 106.8 67.8 106.8 
Intercept, time,  












Table 3-B.4: Linear mixed model covariance structure selection results continues 
 
Model Covariance Structures 
Unstructured  Compound 
symmetry  
Autoregressive (1) Heterogeneous 
AR(1) 
 AIC BIC AIC BIC AIC BIC AIC BIC 
Intercept, time,  




66.2 107.4 66.2 113.7 66.2 113.7 66.2 113.7 
Intercept, time,  
epds, stress,   
history of 
depression ,   
history of 
depression*time 
66.6 107.8 66.6 114.7 66.6 114.7 66.6 114.7 
Intercept, time,  





67.4 119.2 69.4 125.6 69.4 125.6 69.4 125.6 
Intercept, time,  
epds, stress,   
history of 
depression , 
epds*time, and  
history of 
depression *time   
67.7 119.6 69.7 125.9 69.7 125.9 69.7 125.9 
Intercept, time,  
epds, stress,   
history of 
depression , 
stress*time, and  
history of 
depression *time   
65.3 117.2 67.3 123.5 67.3 123.5 67.3 123.5 
Intercept, time,  




stress*time, and  
history of 
depression *time   






Transition Note 2 
In Chapter 3, several MI risk factors were identified in pregnant and postpartum women. 
While controlling other risk factors, the association of antenatal MI with PPD was found to be 
significant, and the trajectory of MI from early pregnancy, to late pregnancy and to postpartum 
had a declining trend. The study revealed that depression, history of depression, and elevated 
stress were risk factors for perinatal MI at T1, T2, and T3, and labour/birth complications were 
associated with MI at T3. The longitudinal relationship between antenatal MI and PPD was 
observed at T1, but not at T2, suggesting that MI during the early pregnancy was correlated with 
PPD at four weeks of delivery. Although the overall trajectory of MI from T1 to T3 had a 
decreased trend, the declining trend from T2 to T3 was significant, indicating that pregnant 
women experienced a significantly higher level of MI compared to postpartum women. The 
study also examined the trajectory of perinatal MI among groups (e.g., depressed vs. non-
depressed, having a history of depression vs. no history of depression, more stress vs. less stress), 
and found that women who had depressive symptoms, a history of depression, or who reported 
more stress showed a significantly elevated level of MI from T1 to T3.  
As indicated in our systematic review (Chapter 2), the research gap of perinatal MI was 
identified. Therefore, in Chapter 4, a third manuscript is presented to explore the effects of 
antenatal MI, depression, and anxiety on neonatal outcomes including 1-minute and 5-minute 
















Chapter 4: Manuscript Three 


















Objective: To investigate whether antenatal mood instability (MI), depression, and 
anxiety are risk factors for adverse neonatal outcomes. Method: a total of 555 women 
participated in a longitudinal study of maternal depression at two points: early pregnancy (T1, 
17.4 ± 4.9 weeks), and late pregnancy (T2, 30.6 ± 2.7 weeks). Mood instability, depression, 
anxiety, psychosocial, and behaviour variables were measured at T1 and T2, other social 
demographic data were collected at T1, and obstetrical and neonatal information were obtained 
at T3. Binary logistic regression was utilized to explore the association between antenatal MI, 
depression, and anxiety at T1, T2, and during pregnancy and neonatal outcomes. Results: In the 
current longitudinal study, antenatal MI and depression were found not significantly associated 
with adverse neonatal outcomes (low 1-minute and 5-minute Apgar scores, low birth weight 
(LBW), small for gestational age (SGA), and preterm birth (PTB). Antenatal anxiety was 
significantly associated with low 1-minute and 5-minute Apgar scores and LBW. Smoking and 
experiencing stress during pregnancy were found to be an independent risk factor for SGA, and 
being first time mothers was at a significantly higher risk for having babies with SGA and LBW. 
Conclusion: Antenatal MI and depressive symptoms do not seem to be associated with neonatal 
outcomes. Anxiety was found to be independently associated with neonatal outcomes. Our 
findings provide further evidence of the benefits of treating antenatal anxiety, encouraging 
smoking cessation, and the crucial need to support women in alleviating stress and maintaining 
mental health during pregnancy. 










Pregnancy and childbirth are often viewed as joyful events, but can also be overwhelming 
and challenging for some mothers. The transition to motherhood represents a time of substantial 
vulnerability for women to develop mood related disturbances, including perinatal depression, 
anxiety (Kessler et al., 2003; Milgrom & Gemmill, 2014), postpartum blues, and mood  
instability (MI) (Pop et al., 2015; Reck, Stehle, Reinig, & Mundt, 2009). A meta-analysis of 102 
studies determined a prevalence rate of 18.2% for antenatal anxiety in the first trimester, 19.1% 
in the second trimester, and 24.6% in the third trimester of pregnancy (Dennis, Falah-Hassani, & 
Shiri, 2017). Antenatal depressive symptoms are estimated to range from 7% to 50%, depending 
on the instrument used and the demographic characteristics of the study population (Gavin et al., 
2005; Goedhart et al., 2010; Husain et al., 2011; Lee et al., 2007; Melville, Gavin, Guo, Fan, & 
Katon, 2010). 
Studies have found that perinatal women often experience the highest irritable, euphoric, 
and depressed moods in early pregnancy and again around the time of giving birth (Cunningham 
et al., 2010; Steiner, Dunn, & Born, 2003). This phenomenon is thought to be triggered by the 
large hormonal changes that occur at these times (Buttner, O’Hara, & Watson, 2012; 
Cunningham et al., 2010; Fooladi, 2006). In a longitudinal study, Bowen, A. et al. (2012) 
investigated MI in perinatal women (n=45) and a control group consisting of normally 
menstruating non-pregnant women (n=31). Perinatal MI was assessed through mood diaries with 
visual analogue scales that measured depressed, irritable, anxious, and euphoric moods twice a 
day for one week at 16 weeks and 30 weeks of pregnancy, and the control group kept the diaries 






significantly experienced higher levels of depressed, irritable, anxious, and euphoric mood 
fluctuation compared to the controls.  
The monitoring of MI is a relatively new development, but a significant correlation 
between MI and depression or anxiety have been documented in general and clinical populations 
(Bowen, R., Baetz, Hawkes, & Bowen, 2006; Bowen, R, Mahmood, Milani, & Baetz, 2011; 
Marwaha, Balbuena, Winsper, & Bowen, 2015; Thompson, Berenbaum, & Bredemeier, 2011). 
The British Adult Psychiatric Morbidity Survey of 2007 (n = 7,403) found that the prevalence of 
MI was 13.9% among adult population, co-occurrence between MI and a depressive episode of 
any severity was 60.9%, and comorbidity between MI and generalized anxiety disorder was 
49.2% (Marwaha, Parsons, Flanagan, & Broome, 2013).   
To explain the relationship between MI and depression and anxiety, existing literature 
proposes that MI, depression, and anxiety share some correlates (Thompson et al., 2011). MI is a 
core feature of neuroticism which in turn is a risk factor for depression and anxiety (Bowen, R., 
Balbuena, Leuschen, & Baetz, 2012). Some have suggested that individual differences in 
neuroticism and negative emotionality, that are central to understanding comorbidity among 
psychopathologies (e.g., depression, anxiety) (Beatson & Rao, 2013; Bowen, R et al., 2011; 
Denollet & De Vries, 2006; Miller, D., Vachon, & Lynam, 2009; Miller, J. & Pilkonis, 2006; 
Quilty, Sellbom, Tackett, & Bagby, 2009). A meta-analysis of 175 studies reported a strong 
association between neuroticism and depression, and between neuroticism and anxiety (Kotov, 
Gamez, Schmidt, & Watson, 2010), while other studies indicate that negative emotionality is 
significantly correlated with depression and anxiety (Bekh B.et al., 2011; Nolen-Hoeksema, 
Wisco, & Lyubomirsky, 2008). As extreme shifts in mood that last from a few hours to a few 






life events (e.g., the break-up of a relationship, loss of a job) (Koenigsberg et al., 2002). The 
possible bidirectional effects of the relationship between stress and depression, and between 
stress and anxiety have been confirmed by Cui and Vaillant (1997) and Hammen (2005).  
One UK study of 83,545 participants investigated the relationship between LBW and 
maternal neuroticism, and found that they are significantly associated, and the positive 
correlation between LBW and major depression disorder is partially mediated by higher maternal 
neuroticism (Lyall et al., 2016). However, the neonatal outcome variables were not based on 
clinical records, rather based on the mothers’ retrospective recall. Research has identified the 
association between neonatal outcomes and antenatal depression and/or anxiety. However, the 
findings are inconsistent. While some studies have found a significant relationship between 
antenatal depression and/or anxiety and LBW, PTB, SGA, and/or low Apgar score (Field et al., 
2008; Goedhart et al., 2010; Nasreen, Kabir, Forsell, & Edhborg, 2010; Saeed, Raana, Saeed, & 
Humayun, 2016), while others have not (Andersson, Sundström-Poromaa, Wulff, Åström, & 
Bixo, 2004; Evans, J., Heron, Patel, & Wiles, 2007; Flynn, McBride, Cely, Wang, & DeCesare, 
2015; Neggers, Goldenberg, Cliver, & Hauth, 2006). A literature review (Chapter 2 in this 
dissertation) was unable to locate research that identified an association between antenatal MI 
and neonatal outcomes.  
4.2 Research hypothesis 
Antenatal MI, depression, and anxiety would be associated with neonatal outcomes 
(LBW, SGA, PTB, low 1-minute and 5-minute Apgar score) at 17 and 31 weeks of pregnancy.  
4.3 Methods 
4.3.1 Participants and procedure  






Motherhood Study (FIP), which was funded by the Canadian Institutes of Health Research, and 
the subsequent Feelings in Pregnancy and Motherhood Study: Child and Maternal Outcomes 
(Grant # 145179). The FIP is a longitudinal cohort study of maternal mental health and the 
associated factors from 2006 to 2014. A total of 648 women were recruited in early pregnancy 
from a variety of community settings such as doctors’ offices, prenatal classes, maternity stores, 
and responders to radio and newspaper advertisements. The inclusion criteria were English 
speaking women in early pregnancy (gestation ≤ 20 weeks), and a resident in one of two health 
regions in Saskatchewan (Saskatoon Health Region or Five Hills Health Region). Data collection 
was conducted by trained research assistants through a face-to-face interviews at three-time 
points: T1 early pregnancy (17.4 ± 4.9 weeks), T2 late pregnancy (30.6 ± 2.7 weeks), and T3 
postpartum (4.2 ± 2.1 weeks). Information regarding children’s birth outcomes were obtained 
from the mothers and linked with hospital discharge records, with the mother’s permission. 
Ethics approval for the research protocol was obtained from the Behavioural Research Ethics 
Board at the University of Saskatchewan. All participants gave written informed consent. If a 
woman screened positive for depression, she was referred with her permission to her family 
doctor for further investigation and given information about local mental health services; if she 
was deemed at risk of self-harm or harming others, immediate help was provided.  
4.3.2 Measures 
Depression. Depressive symptoms were measured using the Edinburgh Postnatal 
Depression Scale (EPDS) (Cox, Holden, & Sagovsky, 1987). The EPDS is the most widely used 
self-report measure for screening postnatal depression (Matthey, S, Henshaw, Elliott, & Barnett, 
2006). Respondents select one of four possible responses (0-3) to each of ten questions to 






possible maximum score of 30 (range 0-30; 0 = not depressed, 30 = highest score of depressive 
mood). Validation studies of the EPDS have been conducted in different cultures, languages, 
and settings, including in Saskatchewan (Clarke, 2008; Cox & Holden, 2003). The EPDS has 
been found to have a sensitivity of 80% and specificity of 87% (Matijasevich et al., 2014). A 
cut-off score of ≥12 depressed was used in this present study to determine depressive symptoms 
(Husain et al., 2014; Murray & Cox, 1990; Smith, Eryigit‐Madzwamuse, & Barnes, 2013).  
The EPDS has been extensively validated as a screening tool for perinatal depression 
(Clarke, 2008; Matijasevich et al., 2014), and it was assumed to be a uni-dimensional 
instrument for assessing depressive symptoms (Cox et al., 1987). However, studies have 
indicated that there is underlying factor structure of the EPDS, which suggests that the EPDS 
also measures anxiety symptoms (Bowen, A., Bowen, Maslany, & Muhajarine, 2008; Ross, 
Evans, Sellers, & Romach, 2003). Psychometric properties of EPDS have been investigated by 
utilizing exploratory factor analysis (EFA) and confirmatory factor analysis (CFA). For 
example, Brouwers et al. (2001) conducted an EFA on the EPDS in 197 women at 24 weeks 
gestation, and found that the instrument is comprised of three-factors: “depression ” (items 1, 2, 
and 8), “anxiety” (items 3, 4, and 5), and a single item factor “self-harm” (item 10). 
A subsequent study of 402 socially high-risk women at 15 weeks of gestation identified 
the similar factor structure (Bowen, A. et al., 2008). Other studies also found a three-factor 
model, but the factor representing depression included different sets of items. For example, 
Jomeen and Martin (2005) carried out EFA and CFA on the EPDS among an antenatal cohort of 
101 women at 14 weeks of gestation, and found that the factor of depression consists of items 1, 
2, 6, 7, 8, and 9 and the factor of anxiety includes items, 3, 4, and 5, and single item 10 for the 






weeks of pregnancy, and 6 and 16 weeks of postpartum, and found that the factor of depression 
is comprised of items 1, 2, 8, and 9 and the factor for anxiety includes items 3, 4, and 5, and the 
third factor includes item 10 for self-harm. Although the items for depression varied across 
studies, the items of the factor for anxiety were relatively consistent.  
Anxiety. Anxiety symptoms were measured at T1, and T2 using the EPDS anxiety 
subscale (items 3, 4, and 5) (Bowen, A. et al., 2008; Buist, Gotman, & Yonkers, 2011; Kabir, 
Sheeder, & Kelly, 2008; Tuohy & McVey, 2008). Jomeen and Martin (2005) found that factor 
loadings for items 3, 4, and 5 were 0.73, 0.85, and 0.75 respectively. Cronbach α of 0.77 
indicates an acceptable level of internal consistency (Phillips, Charles, Sharpe, & Matthey, 
2009). In clinical settings, a cut-off score of  ≥4 is used to indicate significant anxiety symptoms 
(Phillips, Charles, Sharpe, & Matthey, 2009); however, a cut-off score of ≥ 6 has been used in 
community samples (Matthey, Stephen, 2008). Consequently, a cut-off score of ≥ 6 was used to 
measure anxiety symptoms in the current study.  
Mood instability. Mood instability was measured using a five-item visual analogue scale 
(VAS) at T1 and T2: 1 “mood frequent ups and downs”, 2 “mood swings occur for no reason”, 3 
“other people complain about your mood swings”, 4 “having trouble following through with 
plans because of mood swings”, and 5 “not making commitments because moods might change”. 
Women were asked to mark an “X” on a 10cm line to indicate their level of MI. The X was then 
interpreted on a metric ruler by a trained research assistant, with random audit by a second 
trained research assistant to assure accuracy. This self-reported measure has a total possible score 
of 50 (0-50).  
Sociodemographic factors 
 Age: women’s ages were calculated based on their birthday at the time of intake. 






age, thus the variable was dichotomized as either <25 years or > 25 years old. 
 Education attainment: women reported years of education they received as < 12th grade, 
completed 12th grade, some post-secondary/university, and completed post-
secondary/university. The variable was categorized into < grade 12 and ≥ grade 12. 
 Marital status: participants were in different relationship arrangements, and this variable 
was categorized as with a partner (married or cohabiting) or without a partner (single, 
widowed, or divorced). 
 Ethnicity: options included Caucasian, Aboriginal with treaty status, non-status 
Aboriginal, Métis, immigrant, and other. Due to the small number of women who were 
immigrants or other, the ethnicity of women was dichotomized as Aboriginal or non-
Aboriginal. 
 Family income: four levels of family income were identified: social assistance or less 
than $20,000 per year, between $20,000 and $40,000 per year, between $40,000 and 
$60,000 per year, and greater than $60,000 per year. This variable was categorized as 
≤$40,000 or > $40,000. 
Psychosocial factors 
 Social support: six questions inquired about the types of support available (emotional 
support, support of a partner, support of the mother, support of friends, support of female 
relatives, and other support). The variable was dichotomized as low-level of support (0-1 
types support) and high-level of support (two or more types of support). 
 Stressors: women were asked to identify their sources of stress including being pregnant, 
health of baby, birth of baby, own health, relationship with partner, housing, money, and 






level (≥ 2 stressors). 
Behavioral factors 
 Smoking: women were asked, “In the last month, how much do you smoke?” Options 
included more than a pack/day, 5-20 cigarettes/day, less than five cigarettes a day, quit 
since pregnant, quit before pregnancy, and never smoked. The variable was categorized 
into a dichotomized variable, “yes” and “no or quit”. 
 Alcohol: alcohol use was assessed by asking, “How often did you drink beer or other 
alcohol?” Potential responses were occasional on a drink or two, 1-2 drinks a day, five or 
more drinks at one time, quit since pregnant, quit before pregnancy, and never drank 
alcohol. The variable was summarized into a dichotomized variable, “yes” and “no or 
quit”. 
 Drug: Drug use behaviour was determined by asking “How often did you use drugs such as 
marijuana, crystal meth, and cocaine?” Potential responses included regularly (every day), 
occasionally, quit since pregnancy, quit before pregnancy, and never use such drugs. The 
options were summarized into a dichotomized variable, “yes” and “no or quit”. 
 Exercise: “In the last month, how much do you exercise?” was used to evaluate women’s 
exercise regimen, and women’s answers were every day, 2-3 times per week, 
occasionally, or never. The responses were categorized into a dichotomous variable with 
two levels, “regular exercise” and “never or occasionally exercise.” 
 Obstetric outcome factors 
 Pregnancy intention: intention was categorized into “yes” based on women’s response to 
“intended pregnancy”, and “no” for not intended. 
 Parity: the total number of pregnancies, previous abortions and/or miscarriages, and 






dichotomous variable, “1” for primigravida and “>1” for multigravida. 
Neonatal outcome factors 
 One and five minute Apgar scores: the Apgar scores measures a baby’s wellbeing at birth 
by assessing five areas at 1, 5, and sometimes 10 minutes after birth: activity, pulse, 
grimace, appearance, and respiration (Apgar & Beck, 1972). Each area is rated from 0 to 
2 with a possible total score of 10 (scores above 7 indicate that baby is doing well). 
Apgar scores were dichotomized as  <7 or ≥ 7 (Apgar & Beck, 1972). 
 Birth weight (BW): weight was measured in grams and dichotomized into two levels: 
<2500 g and ≥2500 g (Wardlaw, 2004). 
 BW for gestational age: if the baby’s weight is within the 10th and 90th percentiles for 
its gestational age, it is considered appropriate for gestational age (AGA), while SGA is 
indicated if the baby’s weight is below the 10th percentile for gestational age, and large 
for gestational age (LGA) if baby’s weight is above the 90th percentile for gestational 
age (Kramer et al., 2001). Birth weight for gestational age was dichotomized into two 
levels (original score categories above 10th percentile were collapsed to obtain a 
manageable number to perform logistic regression): AGA/LGA and SGA. 
 PTB: preterm is based on the duration of pregnancy in completed weeks from the first 
day of the last normal menstrual period to birth. The variable was dichotomized into two 
levels: pre-term birth (< 37 weeks) and non-pre-term birth (≥ 37 weeks) (Eisfeld, 2014). 
4.3.3 Data Analysis 
We summarized with descriptive statistics the characteristics of mothers and babies (e.g., 
PTB, BW, BW for gestational age, 1-minute Apgar score, and 5-minute Apgar score). At T1, the 






therefore, they were excluded in the study, and data were analyzed on 555 women. For group 
comparison, depressive and anxiety levels were cross-tabulated against the baby’s Apgar scores, 
BW, BW for gestational age, and PTB at T1 and T2.  
To examine the relationship between EPDS anxiety subscale, EPDS depression subscale 
with three items, EPDS depression subscale with six items, and MI at T1 and T2, Pearson’s 
correlation coefficients were conducted on anxiety (EPDS subscale: items 3, 4, and 5), 
depression (EPDS subscales: items 1, 2, and 8, and items 1, 2, 6, 7, 8, and 9), and MI at T1 and 
T2. To evaluate internal reliability consistency, a Cronbach α for EPDS score (10 items, 6 items, 
and 3 items), EPDS anxiety subscale score, and MI score was computed. 
Model selection and model fit diagnostic. Binary logistic regression was used to predict 
probabilities that variables fall into one of two categories as a function of explanatory variables 
(Kleinbaum & Klein, 2010). We conducted the data analysis for T1, T2, and during pregnancy 
(T1 + T2). Neonatal outcomes were dependent variables (DVs), and MI, depressive, and anxiety 
symptoms, and other variables (demographic, psychosocial, and behavioural) were independent 
variables (IVs). For IVs during pregnancy, MI, as a continuous variable, was averaged ((T1 + 
T2)/2), and other dichotomous variables including sociodemographic, psychosocial, behavioral, 
obstetric, and neonatal variables that were measured at T1 and T2) were added  (T1 + T2) (for 
example, a woman experienced depression during pregnancy, indicating she was depressed at T1 
or at T2, or both) (Anand et al., 2005; Dotson, Resnick, & Zonderman, 2008). We also 
conducted the data analysis on anxiety (EPDS subscale) as a continuous variable at T1 and T2, 
and for depressive symptoms (EPDS) as continuous variable including 10 items, 6 items (items 
1, 2, 6, 7, 8, and 9), and 3 items (items 1, 2, and 8) at T1 and T2 based on literature search. For 






MI, depression, anxiety, and other risk factors was investigated. In particular, we determined 
whether MI, depression, anxiety symptoms, and other risk factors were associated with (i) 1-
minute Apgar, (ii) 5-minute Apgar, (iii) BW, (iv) BW for gestational age, and (v) PTB. 
For model selection in binary logistic regression analysis, the backward elimination 
model building process followed five steps (Montgomery, Peck, & Vining, 2015): 1) keep 
variables with p-value <0.25 in the univariate analysis; 2) fit the multivariable model containing 
all covariates identified from inclusion in step 1; 3) in each step of backward selection procedure 
in step 2, compare the values of the estimated coefficients in the smaller model to their 
corresponding value from the large model. Any variable whose coefficient has changed 
substantially in magnitude (e.g., Δ𝛽 ̂>20%) was put back to refit until the important variables are 
included; 4) put each variable not selected in step 1 to the model obtained at step 3, one at a time, 
and check its significance by the Wald statistic and p-value; 5) put all variables that were 
significant (p-value <0.05) at Step 4 in the final model.  
Multicollinearity diagnostic statistics (tolerance and variance inflation factors (VIF)) 
were tested, and the values of VIF were < 10, indicating that there was no violation of 
multicollinearity assumption (Brown, Giles, & Greenlund, 2007). The Hosmer and Lemeshow 
goodness-of-fit test was utilized in assessing model fit, and non-significant values (p > 0.05) 
indicates that the model prediction does not significantly differ from the observed (Kleinbaum & 
Klein, 2010). 
Coefficients in logistic regression models were exponentiated to yield odds ratios (OR) 
and their 95% confidence intervals (CI) were calculated accordingly. Results were considered to 
provide evidence of significance if p-values <0.05 (α level of 5%). The data were analyzed using 







4.4.1 Descriptive data analysis 
Variables of interest for accuracy of skewness, Kurtosis, and outliers were examined. 
Univariate outliers were detected in some variables (MI and EPDS scores) by using box plot and 
histogram. Univariate outliers were detected in all study variables, but the outliers were not 
excluded as they represented clinically relevant cases of depression, anxiety, and MI (such as 
EPDS = 30 or EPDS = 1). The 5% trimmed means were similar to the original means of all 
variables (Maronna, Martin, & Yohai, 2006).  
 The mean age of participants was 29.0 years (SD =4.85) and 38.1% (n = 211) of women 
were primiparaous. The majority of the women lived with a partner (91.9%, n = 510), 95.8% (n 
= 530) of women had education level of high school diploma or higher, 70.1% (n = 371) of the 
family income was equal or greater than $40,000 per year, and Aboriginal women represented 
7.2% (n = 39) of the women. Almost half of the women (49.3%, n = 271) reported experiencing 
more stress at T1, and 234 (45.7%) at T2; 67 (12.7%) women reported receiving low social 
support, and 11.9% (n = 61) at T2; Sixty (10.9%) women smoked at T1, and 10.7% (n = 55) at 
T2; 38 (6.9%) women used alcohol at T1, and 3.6% (n = 20) at T2; 16 (2.9%) women used drugs 
at T1, and 1% (n = 5) at T2; 298 (53.9%) women reported having a regular exercise routine at 
T1, and 283 (55.1%) at T2.  
The mean score and standard deviation of EPDS (10 items, 6 items, and 3 items), EPDS 
anxiety subscale, and MI at T1 and T2 are presented in Table 4.1. The Cronbach α for EPDS (10 
items and 6 items for depression subscale) and MI measurements indicates high internal 
consistency at T1 and T2, and an acceptable level of internal consistency for EPDS anxiety 









Sixty-eight (13.2%) babies had a 1-minute Apgar score < 7, while 15 (2.9%) babies had a 
5-minute Apgar of <7. Only 20 (3.9%) of the baby’s BW were <2500g, while 44 (8.6%) of 
baby’s BW were 10th percentile for gestational age, indicating SGA. Thirty-two babies were 






Table 4.1: Mean scores of EPDS, EPDS anxiety subscale, and MI, and Cronbach α  
 
Measurements (N) Mean SD Depression (%) 
/Anxiety (%) 
Cronbach α 
EPDS score at T1 (10 items) (554) 6.8 4.6 12.5 0.832 
EPDS score at T2 (10 items) (523) 6.3 4.3 10.7 0.825 
EPDS score at T1 (6 items) (554) 3.4 2.9  0.818 
EPDS score at T2 (6 items) (523) 3.2 2.8  0.797 
EPDS score at T1 (3 items) (554) 1.3 1.5  0.711 
EPDS score at T2 (3 items) (523) 1.3 1.4  0.633 
Anxiety score at T1 (554) 3.3 2.1 10.2 0.722 
Anxiety score at T2 (523) 3.0 1.9 8.6 0.703 
MI score at T1 (554) 14.2 11.0  0.845 
MI score at T2 (513) 14.1 9.4  0.867 
Table 4.2: Birth outcomes characteristics  
 
Birth outcome (N) Mean SD Categorical  
thresholds 
N (%) 
1-minute Apgar score (515)   7.83 1.47 < 7 68 (13.2) 
5-minute Apgar score (517) 8.73 0.94 < 7 15 (2.9) 
Birth weight (grams) (513) 3459 588 < 2,500 g  20 (3.9) 
Birth weight for gestational age 
(512) 










For group comparison, depressive and anxiety levels were cross-tabulated against baby’s 
Apgar scores, BW, BW for gestational age, and PTB at T1 and T2, and only anxiety at T1 and 
T2 were significantly associated with low 1-minute and 5-minute Apgar score (X2 (1, N = 507) = 
11.459, p = 0.003; X2 (1, N = 506), p = 0.035 respectively) (Appendix 4-A, Table 4-A.1). 
The Pearson correlation coefficients between the EPDS anxiety subscale, EPDS-3 item 
depression subscale, EPDS-6 item depression subscale, and MI at T1 and T2, and means and 
standard deviations of above variable are provided in Table 4.2. The EPDS anxiety subscale at 
T1 was moderately correlated with EPDS-6 items depression subscale, and was weakly 
correlated with EPDS-3 items depression subscale and MI (Ghassemzadeh, Mojtabai, 
Karamghadiri, & Ebrahimkhani, 2005). The EPDS anxiety subscale at T2 was moderately 
correlated with EPDS-6 items depression subscale and MI, and a weak correlation between 
EPDS-3 items depression subscale and EPDS anxiety subscale was displayed. Mood instability 
at T1 was weakly correlated with both EPDS-6 and EPDS-3 items depression subscales, while 
MI at T2 was moderately correlated with both EPDS-6 and EPDS-3 items depression subscales 
(Table 4.3).  
Missing values were examined. At T1, MI data was not available on 93 women because 
MI assessment was not yet available in the study. Logistic regression data analysis was carried 
out with 555 women. Missing values in this study at T1 and T2 accounted for less than 10%, 






Table 4.3: Mean, standard deviation, and correlations for the key study variables (EPDS, GAD7, MDQ, ALS-18 three factors, and ALS-18 six 
factors) 
 








































3.40 2.98 0.57** 0.38** 1.00      
MI1 
 














3.25 2.82 0.36** 0.90** 0.44** 0.36** 0.57** 0.90** 1.00  
MI2 
 
14.11 9.38 0.38** 0.57** 0.41** 0.56** 0.53** 0.57** 0.63** 1.00 
Note: Anxiety1, EPDS1 and MI = Time 1, Anxiety2, EPDS2, and MI2 = Time 2, Anxiety = EPDS anxiety subscale (item 3, 4, and 5), EPDS subscale 
depression 3 items (1, 2, and 8), EPDS subscale depression 6 items (1, 2, 6. 7, 8 and 9) 






4.4.2 Effects of antenatal mood instability, depression, and anxiety on neonatal outcomes  
Univariate logistic regression showed that anxiety as a dichotomous variable was 
significantly associated with 1-minute Apgar and 5-minute Apgar scores at T1, T2, and during 
pregnancy (during pregnancy = T1 + T2, as described earlier); unintended pregnancy was linked 
to SGA at T1, T2, and during pregnancy; first time pregnancy was correlated with LBW, and 
SGA at T1, T2, and during pregnancy; higher education attainment seemed to protect women 
against preterm birth. More stressors in late pregnancy were associated with SGA; smoking at T1 
and T2 was linked to SGA; regular exercise during pregnancy showed as a protective factor for 
LBW. Finally, illicit drug use was identified as a risk factor for LBW at T1, and PTB at T1 and 
during pregnancy. The univariate analysis for drug use was carried out at T1, but not at T2, due 
to insufficient data (only 5 women used drug at T2). The results of univariate logistic regression 
are reported in Appendix 4-B, Table 4-B.1-15.  
Univariate logistic regression for anxiety as a continuous variable revealed no significant 
association between anxiety and neonatal outcomes at T1 and T2 (Appendix 4-B, Table 4-B.1-
15). For depressive symptoms (EPDS) treated as a continuous variable including 10 items, 6 
items (item 1, 2, 6, 7, 8, and 9), and 3 items (item 1, 2, and 8) at T1 and T2, no significant 
associations were found with neonatal outcomes (Appendix 4-B, Table 4-B.1-15). 
The multivariate logistic regression revealed that in early pregnancy, primiparity was 
significantly associated with LBW and SGA, and smoking was a significant risk factor for SGA. 
At 31 weeks of pregnancy, anxiety as a dichotomous variable was significantly associated with 
Apgar scores <7 at 1-minute and 5-minutes after birth and LBW, parity was significantly 
associated with LBW and SGA, and smoking and stress were significantly linked to SGA. 






score <7 at 1-minute and 5-minutes after birth, parity was strongly linked to LBW and SGA, and 
smoking was identified as a risk factor for SGA. No risk factor was significantly correlated with 
PTB at T1, T2, and during pregnancy. 
Although unintended pregnancy was significantly associated with SGA at T1, T2, and 
during pregnancy, and regular exercise was a protective factor for LBW during pregnancy in 
univariate logistic regression, they did not reach significance in the multivariate logistic 
regression. Table 4.4 summarizes the statistically significant effects of independent variables on 
1-minute Apgar, 5-minute Apgar score, BW, BW, and PTB while holding all other variables 
constant.  
The values of VIF for the multivariate logistic models were < 10, indicating that there 
was no violation of multicollinearity assumption (Brown et al., 2007). The model fit was 
assessed by examining Hosmer and Lemeshow goodness-of-fit tests, which were non-significant 
(p > 0.05) indicating that the multivariate logistic regression models prediction does not 
















Table 4.4: Association of MI, depression, anxiety, and other risk factors with 1-minute and 5-
minute Apgar score, LBW, SGA and PTB at T1, T2, and T1+T2  (multiple logistic regression 
results)  
 
T1 (N = 501) 
 
Measure (N) Risk factor 
 
Odds ratio (95%CIs) p-value 
1-minute Apgar (< 7)  No risk factor was significant 
5-minute Apgar (<7)  No risk factor was significant 
LBW (< 2500g)  Parity (primigravida vs.  
multigravida) 
 2.604 (1.045 - 6.491) 0.040 
SGA (<10th percentile)  Smoking (smoker vs. non-
smoker) 
5.472 (2.392 - 2.520) <0.0001 
SGA (<10th percentile)  Parity (primigravida vs.  
multigravida) 
3.905 (1.963 - 7.767) <0.0001 
PTB (< 37 weeks) No risk factor was significant 
 
T2 (N = 498) 
 
1-minute Apgar (< 7)  Anxiety 3.344 (1.609 - 6.950) 0.001 
5-minute Apgar (< 7)  Anxiety 4.103 (1.223 - 3.764) 0.022 
LBW (< 2500g)  Anxiety 3.949 (1.144 -13.630) 0.030 
LBW (< 2500g)  Parity (primigravida vs.  
multigravida) 
2.967 (1.063 – 8.283) 0.038 
SGA (<10th percentile)  Smoking (smoker vs. non-
smoker) 
5.316 (2.241 -12.612) <0.0001 
SGA (<10th percentile)  Parity (primigravida vs.  
multigravida) 
3.848 (1913 - 7.741) <0.0001 
SGA (<10th percentile)  Stressors (more stressors 
vs. less stressors) 
2.255 (1.104 - 4.606) 0.026 
PTB (< 37 weeks)  No risk factor was significant 
 
T1 + T2 (N = 505) 
 
1-minute Apgar (< 7)  Anxiety 2.875 (1.122 – 7.364) 0.028 
5-minute Apgar (< 7)  Anxiety  6.174 (1.569 – 14.293) 0.009 
LBW (< 2500g)  Parity (primigravida vs.  
multigravida) 
2.882 (1.029 – 8.070) 0.044 
SGA (<10th percentile)  Smoking (smoker vs. non-
smoker) 
5.486 (2.398 – 12.551) <0.0001 
SGA (<10th percentile)  Parity (primigravida vs.  
multigravida) 
     3.917(1.970 – 
7.790) 
<0.0001 







To the best of our knowledge, this is the first study to report the relationship between 
antenatal MI and neonatal outcomes. The positive relationship between MI and depression or 
anxiety in general and clinical samples has explained by alluding to shared correlates: 
neuroticism, negative emotionality, and stress (Thompson et al., 2011). Marwaha et al. (2013) 
revealed high comorbidity among MI, depression, and anxiety in a large population-based 
survey. The lack of research on perinatal MI and its effects on the developing fetus limits our 
ability to discuss the findings in relation to other literature, but the growing research on the 
relationship between MI and depression, anxiety, and stress, and the extensive studies on 
mechanisms of the relationship between neonatal outcomes and maternal depression, anxiety, 
and stress serve as a basis for examining the reason that MI might have an impact on the fetus 
and newborn. 
One study investigated the relationship between LBW and neuroticism in 83,545 
participants in the UK, and found that they are significantly associated, and the positive 
correlation between LBW and major depressive disorder is partially mediated by higher 
neuroticism (Lyall et al., 2016). The association between neonatal outcomes and maternal 
depression and/or anxiety has been well documented; therefore, the findings will be discussed in 
relation to mood problems in general.   
Studies have postulated potential causal pathways of the relationship between fetal 
exposure to stress and antenatal depression, anxiety, and stress. Maternal hypothalamic-pituitary-
adrenal (HPA) axis changes have been proposed in the etiology of adverse birth outcomes. Over 
the course of gestation, maternal HPA axis activity increases (King, Nicholson, & Smith, 2001). 






increase in stress hormones such as cortisol and catecholamines. Fetal exposure to the elevated 
level of stress hormones has been associated with fetal growth restriction and LBW (Bloom, 
Sheffield, McIntire, & Leveno, 2001; Murphy, Smith, Giles, & Clifton, 2006). In addition, 
placental enzyme 11β-hydroxysteroid dehydrogenase-2 (11β-HSD-2) may account for decreased 
transfer of maternal cortisol to the fetus by converting cortisol to its inactive form of cortisone, 
which served as a physiological ‘barrier’ to maternal glucocorticoids (O’Donnell et al., 2012). 
Overexposure to maternal glucocorticoids induced by downregulation of 11β-HSD2 mRNA 
expression leads to LBW and disruptions in fetal growth (Ellman et al., 2008).  
Studies of the relationship between antenatal depression and neonatal outcomes have 
been inconsistent. The positive relationship in developing countries was proposed to be related to 
low socioeconomic status (SES) in women who face a greater challenge of comorbid risk factors 
(e.g., maternal undernutrition) (Black et al., 2008; Diego et al., 2009). A meta-analysis by Grote 
et al. of 29 studies (2010) investigated possible moderators of neonatal outcomes, and found the 
country in which the study was conducted (developed or developing country) was a significant 
moderator of the association between antenatal depression and LBW. However, Goedhart et al. 
(2010) conducted a study of 8,050 women at 12 weeks of pregnancy in Holland (developed 
country), and found a positive relationship between perinatal depression and neonatal outcomes. 
Furthermore, in a study by Nasreen et al. (2010), 720 women in their 3rd trimester from two rural 
subdistricts of Bangladesh (developing country) were assessed by using EPDS to determine 
depressive status, and the finding showed a significant relationship between antenatal depression 
and LBW while controlling for poverty and maternal nutritional status.  
The relationship between antenatal depression and SGA/PTB/LBW/Apgar score was not 






Berle et al., 2005; Flynn et al., 2015; Larsson, Sydsjö, & Josefsson, 2004), whereas other studies 
have reported a positive association (Dayan et al., 2006; Goedhart et al., 2010; Li, Liu, & Odouli, 
2008). The major reasons for the divergent findings might be related to differences in 
measurement of depression, gestational age, and the samples. For example, in Li, Liu and 
Odouli’s study (2008), 791 women in their early pregnancy (around 10 weeks gestation) from 
the US were assessed for depression using the Center for Epidemiological Studies Depression 
Scale (CESD). Studies found that CESD tends to produce higher scores and more false-positive 
results in symptomatic pregnant and postpartum women (Gaynes et al., 2005; Logsdon & Myers, 
2010; Mosack & Shore, 2006). In this diverse sample of 38.1% Caucasian, 28.6% Asian or 
Pacific Island, 21.0% Hispanic, and 6.8% African American women, a positive association 
between depression and PTB was found. Similar findings were reported in a study including 959 
Chinese women in late pregnancy using the Beck Depression Inventory to assess women’s 
depressive status (Chung, Lau, Yip, Chiu, & Lee, 2001). Berle et al. (2005) found a negative 
association between depression and PTB in 680 Norwegian women at 16 weeks gestation by the 
Hospital Anxiety and Depression Rating Scale.  
Elevated anxiety level at 31 weeks of pregnancy has been associated with LBW, and 1-
minute and 5-minute Apgar scores, and experiencing higher level of stress at 31 weeks of 
pregnancy was correlated with SGA, which replicates other studies (Andersson et al., 2004; 
Khashan et al., 2014; Loomans et al., 2012; Nasreen et al., 2010). However, not all studies have 
demonstrated such an association (Andersson et al., 2004; Berle et al., 2005), which might be 
related to the timing of when antenatal anxiety and stress were measured in pregnancy (Glover, 






of the association between stress and neonatal outcomes are not well understood (Beijers, 
Buitelaar, & de Weerth, 2014; Zijlmans, Riksen-Walraven, & de Weerth, 2015).  
Smoking at T1 and T2 was a risk factor for SGA, which is in agreement with other 
studies (Chiolero, Bovet, & Paccaud, 2005; Raatikainen, Huurinainen, & Heinonen, 2007; 
Suzuki et al., 2008). Antenatal cigarette smoking leads to fetal exposure to nicotine, which 
crosses the placenta and leads to a 15% higher concentration than in maternal blood (Bruin, 
Gerstein, & Holloway, 2010; Cnattingius, 2004). Nicotine interferes with normal placental 
function, and reduces uterine blood flow by an average of 30 to 49%, which causes deprivation 
of nutrients and oxygen, resulting in fetal hypoxia and malnutrition, and may lead to intrauterine 
growth restriction (Bruin, Gerstein, & Holloway, 2010; Florescu et al., 2009). 
Being primiparous was associated with LBW and SGA in the current study, which is 
consistent with some studies (Shah, 2010). A meta-analysis of 41 studies found that being 
primiparous increased a woman’s risk of having a baby with LBW and SGA (Shah, 2010). Parity 
influences growth of the placenta and its efficiency, which is related to uterine blood flow, 
oxygen availability, nutrient exchange, and endocrine regulation of the fetus (Fowden, Sferruzzi‐
Perri, Coan, Constancia, & Burton, 2009; Roland et al., 2012).  
4.6 Limitations 
Although this is a relatively large sample, the participants were predominantly Caucasian, 
married, with post-secondary education, and higher family income. According to the 2016 
Census of Canada (Statistic Canadian, 2018), 25.8% of females between 25 and 34 years old, 
and 24.4% of females between 35 and 44 years old in Saskatchewan have a high school diploma 
or higher education (there was no information on women 18-25 years old, and only had 15 years 






accounted for 15.6% of the total population of Saskatchewan compared with 7.2% in this sample 
(Statistic Canadian, 2018). This limits the generalizability of the results to women who have 
lower education attainment, and who are aboriginal. Reports of MI, depression, and anxiety 
relied on participants’ subjective, and retrospective recall, which can be influenced by cognitive 
processes used to reconstruct past events (Schwartz & Rapkin, 2004).  
4.7 Conclusion 
 We believe that this prospective study is the first known reported study of the relationship 
between MI in pregnancy and neonatal outcomes. Our analysis identified no association between 
antenatal MI or depression and neonatal outcomes, however, antenatal anxiety was associated 
with an increased risk of LBW and low 1 and 5-minute Apgar scores. Other key findings confirm 
previous research that less stress during late pregnancy is a protective factor for SGA, non-
smoking or quitting smoking during pregnancy decreases the odds of having a baby with SGA, 
and being primiparous was significantly associated with LBW and SGA. While the inconsistent 
research findings have been documented in the relationship between mood disorders such as 
depression and anxiety and neonatal outcomes, the current study of MI and its relationship with 
anxiety and depression contribute to the discussion. Our findings provide further evidence of the 
benefits of smoking cessation, and the crucial need to support women in alleviating stress and 
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Table 4-A.1: Group comparisons (women with depression vs. without; women with anxiety vs. 





Apgar (<7)  
Birth Weight  
(<2500g) 









Anxiety X2 (1, N = 509) 
= 0.007, p = 
1.000 
X2 (1, N = 513), 
p = 0.240* 
X2 (1, N = 508),  
p = 0.494* 
 
X2 (1, N = 510) = 
0.295, p = 0.658 
X2 (1, N = 
500),  
p = 0.801* 
Depressio
n  
X2 (1, N = 510) 
= 105, p = 
0.745 
X2 (1, N = 515), 
p = 0.427 
X2 (1, N = 509),  
p = 0.494 
X2 (1, N = 509) = 
0.070, p = 0.792 
X2 (1, N = 
501),  
p = 0.586 
T2 
 
Anxiety X2 (1, N = 507) 
= 11.459, p = 
0.003 
X2 (1, N = 506), 
p = 0.035* 
X2 (1, N = 505),  
p = 0.077* 
 
X2 (1, N = 504),  
p = 0.242* 
X2 (1, N = 
500),  
p = 0.323* 
Depressio
n  
X2 (1, N = 509) 
= 0.395, p = 
0.529 
X2 (1, N = 508), 
p = 0.640* 
X2 (1, N = 507),  
p = 0.677* 
X2 (1, N = 503), 
 p = 0.579* 
X2 (1, N = 
501),  
p = 0.328 









4.10 Appendix 4-B: Tables of association between antenatal MI and neonatal outcomes  
 
Table 4-B.1: Summary of univariate association between antenatal MI and other risk factors at T1 and 
Apgar at 1 minute  
 
Variables (N) Frequency (%) Odds ratio (95% CI) P value 
Mood instability (continuous ) (513) 513 1.008 (0.974 – 1.023) 0.957 
Marital status (515)  1.678 (0.733 – 3.845) 0.221 
    Without partner 42 (8.1)   
    With partner 473 (91.9)   
Education (515)  1.013 (0.552 – 1.859) 0.967 
   < high school diploma  22 (4.2)   
   ≥ high school diploma  493 (95.8)   
Ethnicity (515)  1.594 (0.470 – 5.408) 0.454 
   Aboriginal 37 (7.2)   
   Non-Aboriginal 478 (92.8)   
Family income (515)  1.347 (0.766 – 2.367) 0.301 
   ≤$40,000 154 (29.9)   
   >$40,000  361 (70.1)   
Age (515)  1.243 (0.564 -  2.738) 0.590 
   <25 83 (16.2)   
   ≥ 25 432 (83.8)   
Depression (510)  1.025 (0.916 - 1.041) 0.746 
   EPDS ≥12 64 (12.5)   
   EPDS <12 446 (87.5)   
Depression as continuous variable 
(10 items) (510)  
 1.012 (0.952 – 1.076) 0.707 
Depression as continuous variable  
(6 items) (510) 
 1.047 (0.948 – 1.156) 0.365 
Depression as continuous variable  
(3 items) (510) 
 0.984 (0.816 – 1.187) 0.869 
Anxiety (509)  1.032 (0.496 – 2.145) 0.934 
   EPDS subscale ≥6 52 (10.2)   
   EPDS subscale  <6 457 (89.8)   
Anxiety as continuous variable (509)    0.978 (0.860 – 1.113) 0.739 
Stress level (509)  1.167 (0.695 – 1.960) 0.560 
   More (>2) 251 (49.3)   
   Less (0-2) 258 (50.7)   
Social support (510)  1.387 (0.679 – 2.834) 0.476 
   Less (0-1)  65 (12.7)   








Table 4-B.1: Summary of univariate association between antenatal MI and other risk factors at T1 and 
Apgar at 1 minute continues 
 
Variables (N) Frequency (%) Odds ratio (95% CI) P value 
Parity at intake (515)  1.156 (0.682 – 1.958) 0.590 
    Multigravida 319 (61.9)   
    Primigravida 196 (38.1)   
Pregnancy intention (515)  1.245 (0.665 – 2.330) 0.494 
   No 111 (21.6)   
   Yes 404 (78.4)    Yes 404 (78.4) 
Smoking (508)  2.169 (0.148 – 1.543) 0.198 
   Yes 55 (10.9)    
   No or quit 453 (89.1)    
Alcohol use (509)  1.368 (0.541 – 3.457) 0.558 
   Yes 35 (6.9)   
   No or quit 474 (93.1)   
Drug use (510)  1.293 (0.273 – 6.118) 0.746 
   Yes  15 (2.9)   
   No or quit  495 (97.1)    No or quit  495 (97.1) 
Exercise (513)  1.021 (0.576 – 1.664) 0.717 
   Never or occasional 236 (46.1)   








Table 4-B.2: Summary of univariate association between  antenatal MI and other risk factors at T1 and 
Apgar at 5 minutes  
 
Variables (N) Frequency (%) Odds ratio (95% CI) p value 
Mood instability (continuous ) (516) 516 1.021 (0.919 – 1.027) 0.917 
Marital status (517)  1.811 (0.393 – 8.348) 0.446 
    Without partner 42 (8.1)   
    With partner 475 (91.9)   
Education (517)  1.604 (0.536 – 4.769) 0.398 
   < high school diploma  22 (4.2)   
   ≥ high school diploma  495 (95.8)   
Ethnicity (517)  1.674 (0.370 – 7.574) 0.598 
   Aboriginal 37 (7.2)   
   Non-Aboriginal 480 (92.8)   
Family income (517)  1.201 (0.310 – 2.236) 0.263 
   ≤$40,000 155 (29.9)   
   >$40,000  362 (70.1)   
Age (517)  1.047 (0.231 -  4.751) 0.953 
   <25 84 (16.2)   
   ≥ 25 433 (83.8)   
Depression (515)  1.014 (0.901 - 1.140) 0.417 
   EPDS ≥12 64 (12.5)   
   EPDS <12 451 (87.5)   
Depression as continuous variable  
(10 items) (515)  
 0.988 (0.877 – 1.113) 0.846 
Depression as continuous variable  
(6 items) (515) 
 0.933 (0.825 – 1.196) 0.938 
Depression as continuous variable  
(3 items) (515) 
 0.863 (0.634 – 1.174) 0.348 
Anxiety (513)  2.375 (0.710 – 7.946) 0.160 
   EPDS subscale ≥6 51 (10.0)   
   EPDS subscale  <6 462 (90.0)   
Anxiety as continuous variable (513)    0.949 (0.733 – 1.227) 0.688 
Stress level (514)  1.730 (0.582 – 5.147) 0.324 
   More (>2) 253 (49.3)   
   Less (0-2) 261 (50.7)    Less (0-2) 261 (50.7) 
Social support (512)  1.218 (0.187 – 4.173) 0.445 
   Less (0-1)  65 (12.7)   









Table 4-B.2: Summary of univariate association between  antenatal MI and other risk factors at T1 and 
Apgar at 5 minutes continues 
 
Parity at intake (517)  1.150 (0.402 – 3.290) 0.794 
    Multigravida 320 (61.9)   
    Primigravida 197 (38.1)   
Pregnancy intention (517)  1.548 (0.343 – 6.990) 0.570 
   No 112 (21.6)   
   Yes 405 (78.4)   
Smoking (516)  1.385 (0.171 – 3.449) 0.781 
   Yes 56 (10.9)    
   No or quit 460 (89.1)    
Alcohol use (512)  1.520 (0.149 – 3.013) 0.576 
   Yes 35 (6.9)   
   No or quit 477 (93.1)   
Drug use (513)  3.114 (0.373 – 26..034) 0.294 
   Yes  15 (2.9)   
   No or quit  498 (97.1)   
Exercise (515)  1.700 (0.595 – 4.857) 0.334 
   Never or occasional 237 (46.1)   








Table 4-B.3: Summary of univariate association between  antenatal MI and other risk factors at T1 and 
birth weight  
 
Variables (N) Frequency (%) Odds ratio (95% CI) p value 
Mood instability (continuous ) (512) 512 1.004 (0.944 – 1.035) 0.973 
Marital status (513)  1.293 (0.334 – 2.732) 0.574 
    Without partner 42 (8.1)   
    With partner 471 (91.9)   
Education (513)  2.126 (0.849 – 5.328) 0.107 
   < high school diploma  22 (4.2)   
   ≥ high school diploma  491 (95.8)   
Ethnicity (513)  1.674 (0.370 – 7.574) 0.522 
   Aboriginal 37 (7.2)   
   Non-Aboriginal 476 (92.8)   
Family income (513)  1.201 (0.310 – 2.236) 0.512 
   ≤$40,000 153 (29.9)   
   >$40,000  360 (70.1)   
Age (513)  1.206 (0.301 -  2.280) 0.220 
   <25 83 (16.2)   
   ≥ 25 430 (83.8)   
Depression (509)  1.020 (0.357 -  3.722) 0.307 
   EPDS ≥12 64 (12.5)   
   EPDS <12 445 (87.5)   
Depression as continuous variable  
(10 items) (509)  
 1.000 (0.905 – 1.106) 0.966 
Depression as continuous variable  
(6 items) (509) 
 0.979 (0.843 – 1.137) 0.783 
Depression as continuous variable  
(3 items) (509) 
 1.064 (0.729 – 1.553) 0.747 
Anxiety (508)  1.030 (0.291 – 3.647) 0.963 
   EPDS subscale ≥6 50 (9.8)   
   EPDS subscale  <6 458 (90.2)   
Anxiety as continuous variable (508)    1.057 (0.846 – 1.321) 0.627 
Stress level (509)  1.594 (0.578 – 4.401) 0.068 
   More (>2) 251 (49.3)   
   Less (0-2) 258 (50.7)   
Social support (512)  1.133 (0.322 – 3.995) 0.920 
   Less (0-1)  65 (12.7)   









Table 4-B.3: Summary of univariate association between  antenatal MI and other risk factors at T1 and 
birth weight continues 
 
Variables (N) Frequency (%) Odds ratio (95% CI) p value 
Parity at intake (513)  2.604 (1.045 – 6.491) 0.040 
    Multigravida 318 (61.9)   
    Primigravida 195 (38.1)   
Pregnancy intention (513)  2.222 (0.863 – 5.721) 0.098 
   No 111 (21.6)   
   Yes 402 (78.4)   
Smoking (510)  1.656 (0.466 – 5.890) 0.458 
   Yes 56 (10.9)    
   No or quit 454 (89.1)    
Alcohol use (509)  1.449 (0.090 – 5.350) 0.701 
   Yes 35 (6.9)   
   No or quit 474 (93.1)   
Drug use (507)  1.254 (0.598 – 11.314) 0.040 
   Yes  15 (2.9)   
   No or quit  492 (97.1)   
Exercise (512)  2.700 (0.868 – 8.401) 0.125 
   Never or occasional 236 (46.1)   








Table 4-B.4: Summary of univariate association between  antenatal MI and other risk factors at T1 and 
birthweight for gestation age 
  
Variables (N) Frequency (%) Odds ratio (95% CI) p value 
Mood instability (continuous ) (512) 512 1.010 (0.947 – 1.012) 0.961 
Marital status (512)  1.838 (0.728 – 4.638) 0.198 
    Without partner 42 (8.1)   
    With partner 470 (91.9)   
Education (512)  1.513 (0.774 – 2.959) 0.226 
   < high school diploma  22 (4.2)   
   ≥ high school diploma  490 (95.8)   
Ethnicity (512)  1.469 (0.492 – 4.389) 0.491 
   Aboriginal 37 (7.2)   
   Non-Aboriginal 475 (92.8)   
Family income (512)  1.201 (0.310 – 2.236) 0.332 
   ≤$40,000 153 (29.9)   
   >$40,000  359 (70.1)   
Age (512)  1.206 (0.301 -  2.280) 0.541 
   <25 83 (16.2)   
   ≥ 25 429 (83.8)   
Depression (509)  1.044 (0.977 - 1.116) 0.792 
   EPDS ≥12 64 (12.5)   
   EPDS <12 445 (87.5)   
Depression as continuous variable  
(10 items) (509)  
 0.956 (0.896 – 1.020) 0.176 
Depression as continuous variable  
(6 items) (509) 
 0.932 (0.845 – 1.027) 0.152 
Depression as continuous variable  
(3 items) (509) 
 1.278 (0.950 – 1.719) 0.106 
Anxiety (510)  1.701 (0.352 – 1.806) 0.588 
   EPDS subscale ≥6 52 (10.1)   
   EPDS subscale  <6 458 (89.9)   
Anxiety as continuous variable (510)    0.924 (0.795 – 1.075) 0.305 
Stress level (509)  1.186 (0.634 – 2.218) 0.593 
   More (>2) 251 (49.3)   
   Less (0-2) 258 (50.7)   
Social support (508)  2.141 (0.997 - 4.599) 0.079 
   Less (0-1)  65 (12.7)   









Table 4-B.4: Summary of univariate association between  antenatal MI and other risk factors at T1 and 
birthweight for gestation age continues 
  
Variables (N) Frequency (%) Odds ratio (95% CI) p value 
Parity at intake (512)  2.985 (1.579 – 5.644) 0.001 
    Multigravida 317 (61.9)   
    Primigravida 195 (38.1)   
Pregnancy intention (512)  2.061 (1.047 – 4.057) 0.036 
   No 111 (21.6)   
   Yes 401 (78.4)   
Smoking (510)  3.908 (1.815 - 8.412) 0.001 
   Yes 56 (10.9)    
   No or quit 454 (89.1)    
Alcohol use (507)  1.517 (0.152 – 2.853) 0.546 
   Yes 35 (6.9)   
   No or quit 572 (93.1)   
Drug use (508)  1.089 (0.089 – 2.030) 0.284 
   Yes  15 (2.9)   
   No or quit  493 (97.1)   
Exercise (512)  1.116 (0.588 - 2.117) 0.645 
   Never or occasional 236 (46.1)   








Table 4-B.5: Summary of univariate association  antenatal MI and other risk factors at T1 and preterm 
birth  
 
Variables (N) Frequency (%) Odds ratio (95% CI) p value 
Mood instability (continuous ) (508) 508 1.014 (0.982 – 1.047) 0.909 
Marital status (508)  1.440 (0.332 – 6.244) 0.626 
    Without partner 41 (8.1)   
    With partner 467(91.9)   
Education (508)  2.247 (1.075 – 4.697) 0.031 
   < high school diploma  21 (4.2)   
   ≥ high school diploma  487 (95.8)   
Ethnicity (508)  1.674 (0.370 – 7.574) 0.561 
   Aboriginal 37 (7.2)   
   Non-Aboriginal 471 (92.8)   
Family income (508)  1.201 (0.310 – 2.236) 0.969 
   ≤$40,000 152 (29.9)   
   >$40,000  356 (70.1)   
Age (508)  1.206 (0.301 -  2.280) 0.540 
   <25 82 (16.2)   
   ≥ 25 426 (83.8)   
Depression (501)  1.017 (0.940 - 1.100) 0.622 
   EPDS ≥12 63 (12.5)   
   EPDS <12 438 (87.5)   
Depression as continuous variable  
(10 items) (501)  
 0.981 (0.908 – 1.060) 0.627 
Depression as continuous variable  
(6 items) (501) 
 0.948 (0.846 – 1.062) 0.355 
Depression as continuous variable  
(3 items) (501) 
 0.961 (0.739 – 1.250) 0.769 
Anxiety (500)  1.311 (0.258 – 2.247) 0.625 
   EPDS subscale ≥6 51 (10.2)   
   EPDS subscale  <6 449 (89.8)   
Anxiety as continuous variable (500)    1.024 (0.857 – 1.222) 0.788 
Stress level (506)  1.346 (0.358 – 1.539) 0.423 
   More (>2) 249 (49.3)   
   Less (0-2) 257 (50.7)   
Social support (507)  1.493 (0.589 – 3.784) 0.381 
   Less (0-1)  64 (12.7)   









Table 4-B.5: Summary of univariate association  antenatal MI and other risk factors at T1 and preterm 
birth continues 
 
Variables (N) Frequency (%) Odds ratio (95% CI) p value 
Parity at intake (508)  1.351 (0.655 – 2.785) 0.415 
    Multigravida 314 (61.9)   
    Primigravida 194 (38.1)   
Pregnancy intention (508)  1.643 (0.735 – 3.673) 0.226 
   No 110 (21.6)   
   Yes 398 (78.4)   
Smoking (507)  1.318 (0.442 – 3.932) 0.627 
   Yes 55 (10.9)    
   No or quit 452 (89.1)    
Alcohol use (505)  2.026 (0.667 – 6.159) 0.225 
   Yes 35 (6.9)   
   No or quit 470 (93.1)   
Drug use (502)  5.935 (1.495 – 23.568) 0.011 
   Yes  15 (2.9)   
   No or quit  487 (97.1)   
Exercise (508)  1.392 (0.340 – 1.513) 0.279 
   Never or occasional 234 (46.1)   








Table 4-B.6: Summary of univariate association between  antenatal MI and other risk factors at T2 and 
Apgar at 1 minute  
 
Variables (N) Frequency (%) Odds ratio (95% CI) p value 
Mood instability (continuous ) (513) 513 1.016 (0.988 – 1.045) 0.943 
Marital status (515)  1.678 (0.733 – 3.845) 0.221 
    Without partner 42 (8.1)   
    With partner 473 (91.9)   
Education (515)  1.013 (0.552 – 1.859) 0.967 
   < high school diploma  22 (4.2)   
   ≥ high school diploma  493 (95.8)   
Ethnicity (515)  1.594 (0.470 – 5.408) 0.454 
   Aboriginal 37 (7.2)   
   Non-Aboriginal 478 (92.8)   
Family income (515)  1.347 (0.766 – 2.367) 0.301 
   ≤$40,000 154 (29.9)   
   >$40,000  361 (70.1)   
Age (515)  1.243 (0.564 -  2.738) 0.590 
   <25 83 (16.2)   
   ≥ 25 432 (83.8)   
Depression (509)  1.011 (0.948 - 1.078) 0.530 
   EPDS ≥12 55 (10.7)   
   EPDS <12 454 (89.3)   
Depression as continuous variable  
(10 items) (509)  
 0.981 (0.923 – 1.044) 0.554 
Depression as continuous variable  
(6 items) (509) 
 0.985 (0.896 – 1.083) 0.752 
Depression as continuous variable 
(3 items) (509) 
 0.984 (0.816 – 1.187) 0.869 
Anxiety (507)  3.344 (1.609 – 6.950) 0.001 
   EPDS subscale ≥6 44 (8.6)   
   EPDS subscale  <6 463 (91.4)   
Anxiety as continuous variable (507)    0.957 (0.833 – 1.099) 0.530 
Stress level (505)  1.421 (0.842 – 2.399) 0.188 
   More (>2) 231 (45.7)   
   Less (0-2) 274 (54.3)   
Social support (501)  1.175 (0.523 – 2.641) 0.695 
   Less (0-1)  60 (11.9)   









Table 4-B.6: Summary of univariate association between  antenatal MI and other risk factors at T2 and 
Apgar at 1 minute continues 
 
Variables (N) Frequency (%) Odds ratio (95% CI) p value 
Parity at intake (515)  1.156 (0.682 – 1.958) 0.590 
    Multigravida 319 (61.9)   
    Primigravida 196 (38.1)   
Pregnancy intention (515)  1.245 (0.665 – 2.330) 0.494 
   No 111 (21.6)   
   Yes 404 (78.4)   
Smoking (500)  1.497 (0.513 – 4.367) 0.460 
   Yes 53 (10.7)    
   No or quit 447 (89.3)    
Alcohol use (505)  1.984 (0.621 – 6.344) 0.248 
   Yes 18 (3.6)   
   No or quit 487 (96.4)   
Drug use (501)    
   Yes  5 (1.0)*(Inadequate)   
   No or quit  496 (99.0)   
Exercise (502)  1.048 (0.620 – 1.774) 0.862 
   Never or occasional 225 (44.9)   








Table 4-B.7: Summary of univariate association between  antenatal MI and other risk factors at T2 and 
Apgar at 5 minutes 
 
Variables (N) Frequency (%) Odds ratio (95% CI) p value 
Mood instability (continuous ) (512) 512 1.023 (0.974 – 1.023) 0.893 
Marital status (517)  1.811 (0.393 – 8.348) 0.446 
    Without partner 42 (8.1)   
    With partner 475 (91.9)   
Education (517)  1.604 (0.536 – 4.769) 0.398 
   < high school diploma  22 (4.2)   
   ≥ high school diploma  495 (95.8)   
Ethnicity (517)  1.674 (0.370 – 7.574) 0.598 
   Aboriginal 37 (7.2)   
   Non-Aboriginal 480 (92.8)   
Family income (517)  1.201 (0.310 – 2.236) 0.263 
   ≤$40,000 155 (29.9)   
   >$40,000  362 (70.1)   
Age (517)  1.047 (0.231 -  4.751) 0.953 
   <25 84 (16.2)   
   ≥ 25 433 (83.8)   
Depression (508)  1.527 (0.331 – 7.050) 0.587 
   EPDS ≥12 54 (10.7)   
   EPDS <12 454 (89.3)   
Depression as continuous variable  
(10 items) (508)  
 0.933 (0.832 – 1.045) 0.229 
Depression as continuous variable  
(6 items) (508) 
 0.928 (0.779 – 1.106) 0.404 
Depression as continuous variable  
(3 items) (508) 
 0.863 (0.634 – 1.174) 0.348 
Anxiety (506)  4.103 (1.223 –13.764) 0.022 
   EPDS subscale ≥6 43 (8.5)   
   EPDS subscale  <6 463 (91.5)   
Anxiety as continuous variable (506)    0.837 (0.637 – 1.100) 0.202 
Stress level (510)  1.167 (0.695 – 1.960) 0.735 
   More (>2) 235 (45.7)   
   Less (0-2) 275 (54.3)   
Social support (508)  2.111 (0.574 – 7.764) 0.261 
   Less (0-1)  60 (11.9)   









Table 4-B.7: Summary of univariate association between  antenatal MI and other risk factors at T2 and 
Apgar at 5 minutes continues 
 
Variables (N) Frequency (%) Odds ratio (95% CI) p value 
Parity at intake (517)  1.150 (0.402 – 3.290) 0.794 
    Multigravida 320 (61.9)   
    Primigravida 197 (38.1)   
Pregnancy intention (517)  1.548 (0.343 – 6.990) 0.570 
   No 112 (21.6)   
   Yes 405 (78.4)   
Smoking (501)  1.200 (0.153 – 9.427) 0.863 
   Yes 54 (10.7)    
   No or quit 447 (89.3)    
Alcohol use (502)  1.537 (0.550 – 5.081) 0.583 
   Yes 18 (3.6)   
   No or quit 484 (96.4)   
Drug use (500)    
   Yes  5(1.0)*(Inadequate)   
   No or quit  495 (99.0)   
Exercise (503)  1.070 (0.365 – 3.315) 0.902 
   Never or occasional 226 (44.9)   








Table 4-B.8: Summary of univariate association between  antenatal MI and other risk factors at T2 and 
birth weight  
 
Variables (N) Frequency (%) Odds ratio (95% CI) p value 
Mood instability (continuous ) (502) 502 1.002 (0.951 – 1.057) 0.903 
Marital status (513)  1.293 (0.334 – 2.732) 0.574 
    Without partner 42 (8.1)   
    With partner 471 (91.9)   
Education (513)  2.126 (0.849 – 5.328) 0.107 
   < high school diploma  22 (4.2)   
   ≥ high school diploma  491 (95.8)   
Ethnicity (513)  1.674 (0.370 – 7.574) 0.522 
   Aboriginal 37 (7.2)   
   Non-Aboriginal 476 (92.8)   
Family income (v)  1.201 (0.310 – 2.236) 0.512 
   ≤$40,000 153 (29.9)   
   >$40,000  360 (70.1)   
Age (513)  1.206 (0.301 -  2.280) 0.220 
   <25 83 (16.2)   
   ≥ 25 430 (83.8)   
Depression (507)  1.014 (0.903 - 1.139) 0.777 
   EPDS ≥12 54 (10.7)   
   EPDS <12 453 (89.3)   
Depression as continuous variable  
(10 items) (507)  
 0.998 (0.889 – 1.120) 0.973 
Depression as continuous variable  
(6 items) (507) 
 1.051 (0.866 – 1.275) 0.613 
Depression as continuous variable  
(3 items) (507) 
 1.064 (0.729 – 1.553) 0.747 
Anxiety (505)  2.977 (0.927 – 9.563) 0.067 
   EPDS subscale ≥6 43 (8.6)   
   EPDS subscale  <6 462 (91.4)   
Anxiety as continuous variable (509)    0.889 (0.695 – 1.139) 0.353 
Stress level (505)  1.196 (0.448 – 3.195) 0.721 
   More (>2) 231 (45.7)   
   Less (0-2) 274 (54.3)   
Social support (502)  1.010 (0.226 – 4.516) 0.990 
   Less (0-1)  60 (11.9)   









Table 4-B.8: Summary of univariate association between  antenatal MI and other risk factors at T2 and 
birth weight continues  
 
Variables (N) Frequency (%) Odds ratio (95% CI) p value 
Parity at intake (513)  2.604 (1.045 – 6.491) 0.040 
    Multigravida 318 (61.9)   
    Primigravida 195 (38.1)   
Pregnancy intention (513)  2.222 (0.863 – 5.721) 0.098 
   No 111 (21.6)   
   Yes 402 (78.4)   
Smoking (502)  1.277 (0.283 – 5.764) 0.750 
   Yes 54 (10.7)    
   No or quit 448 (89.3)    
Alcohol use (504)  1.452 (0.184 – 11.487) 0.724 
   Yes 18 (3.6)   
   No or quit 486 (96.4)   
Drug use (500)    
   Yes  5 (1.0)* (inadequate)   
   No or quit  495 (99.0)   
Exercise (505)  2.700 (0.868 – 8.401) 0.086 
   Never or occasional 227 (44.9)   








Table 4-B.9: Summary of univariate association between  antenatal MI and other risk factors at T2 and 
birth weight for gestational age  
 
Variables (N) Frequency (%) Odds ratio (95% CI) p value 
Mood instability (continuous ) (507) 507 1.009 (0.947 – 1.026) 0.935 
Marital status (512)  1.838 (0.728 – 4.638) 0.198 
    Without partner 42 (8.1)   
    With partner 470 (91.9)   
Education (512)  1.513 (0.774 – 2.959) 0.226 
   < high school diploma  22 (4.2)   
   ≥ high school diploma  490 (95.8)   
Ethnicity (512)  1.469 (0.492 – 4.389) 0.491 
   Aboriginal 37 (7.2)   
   Non-Aboriginal 475 (92.8)   
Family income (512)  1.201 (0.310 – 2.236) 0.332 
   ≤$40,000 153 (29.9)   
   >$40,000  359 (70.1)   
Age (512)  1.206 (0.301 -  2.280) 0.541 
   <25 83 (16.2)   
   ≥ 25 429 (83.8)   
Depression (503)  1.326 (0.494 – 3.561) 0.576 
   EPDS ≥12 54 (10.7)   
   EPDS <12 449 (89.3)   
Depression as continuous variable  
(10 items) (503)  
 1.017 (0.939 – 1.100) 0.683 
Depression as continuous variable  
(6 items) (503) 
 1.062 (0.934 – 1.210) 0.352 
Depression as continuous variable  
(3 items) (503) 
 1.201 (0.924 – 1.627) 0.213 
Anxiety (504)  1.891 (0.741 – 4.824) 0.183 
   EPDS subscale ≥6 43 (8.5)   
   EPDS subscale  <6 461 (91.5)   
Anxiety as continuous variable (504)    0.974 (0.824 – 1.151) 0.755 
Stress level (502)  2.212 (1.104 – 4.432) 0.025 
   More (>2) 229 (45.7)   
   Less (0-2) 273 (54.3)   
Social support (503)  1.488 (0.593 – 3.376) 0.397 
   Less (0-1)  60 (11.9)   









Table 4-B.9: Summary of univariate association between  antenatal MI and other risk factors at T2 and 
birth weight for gestational age continues 
 
Variables (N) Frequency (%) Odds ratio (95% CI) p value 
Parity at intake (512)  2.985 (1.579 – 5.644) 0.001 
    Multigravida 317 (61.9)   
    Primigravida 195 (38.1)   
Pregnancy intention (512)  2.061 (1.047 – 4.057) 0.036 
   No 111 (21.6)   
   Yes 401 (78.4)   
Smoking (500)  3.643 (1.645 – 8.026) 0.001 
   Yes 54 (10.7)    
   No or quit 446 (89.3)    
Alcohol use (501)  1.304 (0.290 – 5.864) 0.730 
   Yes 18 (3.6)   
   No or quit 483 (96.4)   
Drug use (500)    
   Yes  5 (1.0)* ( inadequate)   
   No or quit  395 (99.0)   
Exercise (502)  1.859 (0.918 – 3.766) 0.071 
   Never or occasional 225 (44.9)   








Table 4-B.10: Summary of univariate association between  antenatal MI and other risk factors at T2 and 
preterm  birth  
 
Variables (N) Frequency (%) Odds ratio (95% CI) p value 
Mood instability (continuous ) (503) 503 1.014 (0.974 – 1.057) 0.948 
Marital status (508)  1.440 (0.332 – 6.244) 0.626 
    Without partner 41 (8.1)   
    With partner 467(91.9)   
Education (508)  2.247 (1.075 – 4.697) 0.031 
   < high school diploma  21 (4.2)   
   ≥ high school diploma  487 (95.8)   
Ethnicity (508)  1.674 (0.370 – 7.574) 0.561 
   Aboriginal 37 (7.2)   
   Non-Aboriginal 471 (92.8)   
Family income (508)  1.201 (0.310 – 2.236) 0.969 
   ≤$40,000 152 (29.9)   
   >$40,000  356 (70.1)   
Age (508)  1.206 (0.301 -  2.280) 0.540 
   <25 82 (16.2)   
   ≥ 25 426 (83.8)   
Depression (501)  1.038 (0.953 - 1.134) 0.383 
   EPDS ≥12 54 (10.7)   
   EPDS <12 447 (89.3)   
Depression as continuous variable  
(10 items) (501)  
 0.968 (0.888 – 1.056) 0.467 
Depression as continuous variable  
(6 items) (501) 
 0.980 (0.854 – 1.124) 0.772 
Depression as continuous variable  
(3 items) (501) 
 0.961 (0.739 – 1.250) 0.769 
Anxiety (500)  1.659 (0.546 – 5.043) 0.372 
   EPDS subscale ≥6 43 (8.6)   
   EPDS subscale  <6 457 (91.4)   
Anxiety as continuous variable (500)    0.870 (0.714 – 1.061) 0.170 
Stress level (501)  1.131 (0.520 – 2.461) 0.755 
   More (>2) 229 (45.7)   
   Less (0-2) 272 (54.3)   
Social support (504)  1.354 (0.451 – 4.064) 0.589 
   Less (0-1)  60 (11.9)   











Table 4-B.10: Summary of univariate association between  antenatal MI and other risk factors at T2 and 
preterm  birth continues  
 
Variables (N) Frequency (%) Odds ratio (95% CI) p value 
Parity at intake (508)  1.351 (0.655 – 2.785) 0.415 
    Multigravida 314 (61.9)   
    Primigravida 194 (38.1)   
Pregnancy intention (508)  1.643 (0.735 – 3.673) 0.226 
   No 110 (21.6)   
   Yes 398 (78.4)   
Smoking (501)  1.727 (0.570 – 5.230) 0.334 
   Yes 54 (10.7)    
   No or quit 447 (89.3)    
Alcohol use (502)  1.879 (0.431 – 8.555) 0.415 
   Yes 18 (3.6)   
   No or quit 484 (96.4)   
Drug use (500)     
   Yes  5 (1.0)*(Inadequate)   
   No or quit  495 (99.0)   
Exercise (505)  1.643 (0.723 – 3.734) 0.236 
   Never or occasional 227 (44.9)   










Table 4-B.11: Summary of univariate association between  antenatal MI and other risk factors during 
pregnancy and Apgar at 1 minute  
 
Variables (N) Frequency (%) Odds ratio (95% CI) p value 
Mood instability (continuous ) (508) 508 1.006 (0.977 – 1.037) 0.949 
Marital status (515)  1.678 (0.733 – 3.845) 0.221 
    Without partner 42 (8.1)   
    With partner 473 (91.9)   
Education (515)  1.013 (0.552 – 1.859) 0.967 
   < high school diploma  22 (4.2)   
   ≥ high school diploma  493 (95.8)   
Ethnicity (515)  1.594 (0.470 – 5.408) 0.454 
   Aboriginal 37 (7.2)   
   Non-Aboriginal 478 (92.8)   
Family income (515)  1.347 (0.766 – 2.367) 0.301 
   ≤$40,000 154 (29.9)   
   >$40,000  361 (70.1)   
Age (515)  1.243 (0.564 -  2.738) 0.590 
   <25 83 (16.2)   
   ≥ 25 432 (83.8)   
Depression (510)  1.150 (0.357 -  20.722) 0.799 
   EPDS ≥12 70 (13.8)   
   EPDS <12 440 (86.2)   
Anxiety (508)  2.875 (1.122 – 7.364) 0.028 
   EPDS subscale ≥6 48 (9.5)   
   EPDS subscale  <6 460 (90.5)   
Stress level (509)  1.280 (0.667 – 2.458) 0.458 
   More (>2) 389(76.4)   
   Less (0-2) 120 (23.6)   
Social support (508)  1.303 (0.584 – 2.908) 0.462 
   Less (0-2)  90 (17.7)   
   More (≥2) 418 (82.3)   
Parity at intake (515)  1.156 (0.682 – 1.958) 0.590 
    Multigravida 319 (61.9)   
    Primigravida 196 (38.1)   
Pregnancy intention (515)  1.245 (0.665 – 2.330) 0.494 
   No 111 (21.6)   












Table 4-B.11: Summary of univariate association between  antenatal MI and other risk factors during 
pregnancy and Apgar at 1 minute continues  
 
Variables (N) Frequency (%) Odds ratio (95% CI) p value 
Smoking (510)  1.613 (0.555 – 4.688) 0.479 
   Yes 63 (12.3)    
   No or quit 447 (87.7)    
Alcohol use (507)  1.364 (0.604 – 3.082) 0.456 
   Yes 46 (9.0)   
   No or quit 461 (91.0)   
Drug use (509)  1.159 (0.248 – 5.414) 0.851 
   Yes  18 (3.5)   
   No or quit  491 (96.5)   
Exercise (512)  1.032 (0.613 – 1.737) 0.906 
   Never or occasional 218 (42.7)   








Table 4-B.12: Summary of univariate association between  antenatal MI and other risk factors during 
pregnancy and Apgar at 5 minutes  
 
Variables (N) Frequency (%) Odds ratio (95% CI) p value 
Mood instability (continuous ) (510) 510 1.003 (0.938 – 1.061) 0.937 
Marital status (517)  1.811 (0.393 – 8.348) 0.446 
    Without partner 42 (8.1)   
    With partner 475 (91.9)   
Education (517)  1.604 (0.536 – 4.769) 0.398 
   < high school diploma  22 (4.2)   
   ≥ high school diploma  495 (95.8)   
Ethnicity (517)  1.674 (0.370 – 7.574) 0.598 
   Aboriginal 37 (7.2)   
   Non-Aboriginal 480 (92.8)   
Family income (517)  1.201 (0.310 – 2.236) 0.263 
   ≤$40,000 155 (29.9)   
   >$40,000  362 (70.1)   
Age (517)  1.047 (0.231 -  4.751) 0.953 
   <25 84 (16.2)   
   ≥ 25 433 (83.8)   
Depression (515)  1.847 (0.398 -  8.576) 0.433 
   EPDS ≥12 71 (13.8)   
   EPDS <12 444 (86.2)   
Anxiety (514)  6.174 (1.569 – 24.293) 0.009 
   EPDS subscale ≥6 50 (9.7)   
   EPDS subscale  <6 464 (90.3)   
Stress level (514)  1.162 (0.318 – 4.246) 0.802 
   More (>2) 393 (76.4)   
   Less (0-2) 121 (23.6)   
Social support (512)  1.007 (0.213 – 4.769) 0.993 
   Less (0-2)  91 (17.7)   
   More (≥2) 421 (82.3)   
Parity at intake (517)  1.150 (0.402 – 3.290) 0.794 
    Multigravida 320 (61.9)   
    Primigravida 197 (38.1)   
Pregnancy intention (517)  1.548 (0.343 – 6.990) 0.570 
   No 112 (21.6)   











Table 4-B.12: Summary of univariate association between  antenatal MI and other risk factors during 
pregnancy and Apgar at 5 minutes continues 
 
Variables (N) Frequency (%) Odds ratio (95% CI) p value 
Smoking (516)  1.342 (0.172 – 10.475) 0.779 
   Yes 64 (12.3)    
   No or quit 452 (87.7)    
Alcohol use (512)  1.209 (0.502 – 5.708) 0.998 
   Yes 46 (9.0)   
   No or quit 466 (91.0)   
Drug use (513)  2.951 (0.354 – 24.591) 0.317 
   Yes  18 (3.5)   
   No or quit  495 (96.5)   
Exercise (515)  1.465 (0.493 – 4.357) 0.492 
   Never or occasional 220 (42.7)   











Table 4-B.13: Summary of univariate association between  antenatal MI and other risk factors during 
pregnancy and birth weight 
 
Variables (N) Frequency (%) Odds ratio (95% CI) p value 
Mood instability (continuous ) (513) 513 1.007 (0.923 – 1.042) 0.921 
Marital status (513)  1.293 (0.334 – 2.732) 0.574 
    Without partner 42 (8.1)   
    With partner 471 (91.9)   
Education (513)  2.126 (0.849 – 5.328) 0.107 
   < high school diploma  22 (4.2)   
   ≥ high school diploma  491 (95.8)   
Ethnicity (513)  1.674 (0.370 – 7.574) 0.522 
   Aboriginal 37 (7.2)   
   Non-Aboriginal 476 (92.8)   
Family income (513)  1.201 (0.310 – 2.236) 0.512 
   ≤$40,000 153 (29.9)   
   >$40,000  360 (70.1)   
Age (513)  1.206 (0.301 -  2.280) 0.220 
   <25 83 (16.2)   
   ≥ 25 430 (83.8)   
Depression (509)  1.519 (0.405 -  6.743) 0.689 
   EPDS ≥12 70 (13.8)   
   EPDS <12 439 (86.2)   
Anxiety (508)  2.406 (0.318 – 8.172) 0.263 
   EPDS subscale ≥6 48 (9.5)   
   EPDS subscale  <6 460 (90.5)   
Stress level (509)  1.914 (0.680 – 5.383) 0.219 
   More (>2) 389 (76.4)   
   Less (0-2) 120 (23.6)   
Social support (512)  1.432 (0.401 – 3.312) 0.319 
   Less (0-2)  91 (17.7)   
   More (≥2) 421 (82.3)   
Parity at intake (513)  2.604 (1.045 – 6.491) 0.040 
    Multigravida 318 (61.9)   
    Primigravida 195 (38.1)   
Pregnancy intention (513)  2.222 (0.863 – 5.721) 0.098 
   No 111 (21.6)   











Table 4-B.13: Summary of univariate association between  antenatal MI and other risk factors during 
pregnancy and birth weight continues 
 
Variables (N) Frequency (%) Odds ratio (95% CI) p value 
Smoking (510)  1.610 (0.455 – 5.694) 0.460 
   Yes 63 (12.3)    
   No or quit 447 (87.7)    
Alcohol use (509)  1.403 (0.399 – 6.350) 0.876 
   Yes 46 (9.0)   
   No or quit 463 (91.0)   
Drug use (507)  1.573 (0.586 – 7.821) 0.587 
   Yes  18 (3.5)   
   No or quit  489 (96.5)   
Exercise (512)  2.620 (1.027 – 6.683) 0.044 
   Never or occasional 219 (42.7)   










Table 4-B.14: Summary of univariate association between  antenatal MI and other risk factors during 
pregnancy and birth weight for gestational age 
  
Variables (N) Frequency (%) Odds ratio (95% CI) p value 
Mood instability (continuous ) (512) 512 1.011 (0.947 – 1.023) 0.975 
Marital status (512)  1.838 (0.728 – 4.638) 0.198 
    Without partner 42 (8.1)   
    With partner 470 (91.9)   
Education (512)  1.513 (0.774 – 2.959) 0.226 
   < high school diploma  22 (4.2)   
   ≥ high school diploma  490 (95.8)   
Ethnicity (512)  1.469 (0.492 – 4.389) 0.491 
   Aboriginal 37 (7.2)   
   Non-Aboriginal 475 (92.8)   
Family income (512)  1.201 (0.310 – 2.236) 0.332 
   ≤$40,000 153 (29.9)   
   >$40,000  359 (70.1)   
Age (512)  1.206 (0.301 -  2.280) 0.541 
   <25 83 (16.2)   
   ≥ 25 429 (83.8)   
Depression (509)  1.180 (0.389 -  3.494) 0.764 
   EPDS ≥12 70 (13.8)   
   EPDS <12 439 (86.2)   
Anxiety (510)  2.673 (0.950 – 7.524) 0.063 
   EPDS subscale ≥6 48 (9.4)   
   EPDS subscale  <6 462 (90.6)   
Stress level (509)  1.483 (0.741 – 2.969) 0.266 
   More (>2) 389 (76.4)   
   Less (0-2) 120 (23.6)   
Social support (508)  1.122 (0.443 – 2.846) 0.808 
   Less (0-2)  90 (17.7)   
   More (≥2) 418 (82.3)   
Parity at intake (512)  2.985 (1.579 – 5.644) 0.001 
    Multigravida 317 (61.9)   
    Primigravida 195 (38.1)   
Pregnancy intention (512)  2.061 (1.047 – 4.057) 0.036 
   No 111 (21.6)   











Table 4-B.14: Summary of univariate association between  antenatal MI and other risk factors during 
pregnancy and birth weight for gestational age continues 
  
Variables (N) Frequency (%) Odds ratio (95% CI) p value 
Smoking (510)  3.648 (1.708 – 7.794) 0.001 
   Yes 63 (12.3)    
   No or quit 447 (87.7)    
Alcohol use (508)  1.393 (0.414 – 4.693) 0.593 
   Yes 46 (9.0)   
   No or quit 462 (91.0)   
Drug use (508)  2.088 (0.442 – 9.853) 0.352 
   Yes  18 (3.5)   
   No or quit  490 (96.5)   
Exercise (512)  1.370 (0.737 – 2.545) 0.320 
   Never or occasional 219 (42.7)   











Table 4-B.15: Summary of univariate association between  antenatal MI and other risk factors during 
pregnancy and preterm birth 
  
Variables (N) Frequency (%) Odds ratio (95% CI) p value 
Mood instability (continuous ) (508) 508 1.019 (0.978 – 1.062) 0.971 
Marital status (508)  1.440 (0.332 – 6.244) 0.626 
    Without partner 41 (8.1)   
    With partner 467(91.9)   
Education (508)  2.247 (1.075 – 4.697) 0.031 
   < high school diploma  21 (4.2)   
   ≥ high school diploma  487 (95.8)   
Ethnicity (508)  1.674 (0.370 – 7.574) 0.561 
   Aboriginal 37 (7.2)   
   Non-Aboriginal 471 (92.8)   
Family income (508)  1.201 (0.310 – 2.236) 0.969 
   ≤$40,000 152 (29.9)   
   >$40,000  356 (70.1)   
Age (508)  1.206 (0.301 -  2.280) 0.540 
   <25 82 (16.2)   
   ≥ 25 426 (83.8)   
Depression (502)  2.913 (0.629 -  5.819) 0.253 
   EPDS ≥12 69 (13.8)   
   EPDS <12 433 (86.2)   
Anxiety (501)  2.201 (0.617 – 7.851) 0.224 
   EPDS subscale ≥6 47 (9.4)   
   EPDS subscale  <6 454 (90.6)   
Stress level (506)  1.403 (0.594 – 3.318) 0.441 
   More (>2) 387 (76.4)   
   Less (0-2) 119 (23.6)   
Social support (507)  1.084 (0.359 – 3.275) 0.886 
   Less (0-2)  90 (17.7)   
   More (≥2) 417 (82.3)   
Parity at intake (508)  1.351 (0.655 – 2.785) 0.415 
    Multigravida 314 (61.9)   
    Primigravida 194 (38.1)   
Pregnancy intention (508)  1.643 (0.735 – 3.673) 0.226 
   No 110 (21.6)   






Table 4-B.15: Summary of univariate association between  antenatal MI and other risk factors during 
pregnancy and preterm birth continues 
  
Variables (N) Frequency (%) Odds ratio (95% CI) p value 
Smoking (507)  1.737 (0.637 – 4.733) 0.281 
   Yes 62 (12.3)    
   No or quit 445 (87.7)    
Alcohol use (505)  1.446 (0.484 – 4.319) 0.509 
   Yes 45 (9.0)   
   No or quit 460 (91.0)   
Drug use (502)  5.933 (1.512 – 23.288) 0.011 
   Yes  18 (3.5)   
   No or quit  484 (96.5)   
Exercise (508)  1.193 (0.582 – 2.466) 0.630 
   Never or occasional 217 (42.7)   






Transition Note 3 
In Chapter 4, perinatal MI and depression at T1, T2, and during pregnancy did not show 
significant effects on neonatal outcomes (1-minute Apgar, 5-minute Apgar, BW, BW for 
gestational age, and PTB). However, antenatal anxiety, and several other measures were 
associated with an increased risk of LBW, and low 1 and 5-minute Apgar scores, and SGA. 
Elevated anxiety symptoms at T2 was found to be significantly associated with LBW, and low 1-
minute and 5-minute Apgar, and a higher level of stress at T2 was identified to increase the risk 
of having a baby with SGA, and non-smoking during pregnancy was recognized as a protective 
factor for SGA. Finally, being primiparous was significantly associated with LBW and SGA in 
the current study.  
In addition to investigating the relationship between perinatal MI and its risk factors, its 
association with PPD, and its effects on neonatal outcomes, another important issue that requires 
much-needed attention is determining which instruments are effective in measuring perinatal MI. 
In the selected articles in our systematic review, a majority of measures in assessing perinatal MI 
had been either one single question about mood fluctuation or VAS measures for perinatal MI, of 
which the psychometric properties were not examined. The ALS-18, an instrument for measuring 
affective lability, has been widely used in general and clinical populations, and its psychometric 
properties have been investigated in non-clinical and clinical samples with various psychiatric 
disorders. However, its psychometric properties have not been examined in perinatal women. 
Therefore, in Chapter 5, a fourth manuscript is presented to explore factor structure and 























Chapter 5: Manuscript Four 



























Objective: Investigating the dimensions of affective lability may help to explain possible 
etiology and outcomes for mental disorders. The Affective Lability Scale-18 (ALS-18) is a 
widely utilized measure of labile affect, and its psychometric properties have been studied in 
non-clinical and clinical populations. However, the psychometric properties have not previously 
been examined in pregnant and postpartum women despite the fact that affective lability is a 
prominent feature in pregnant and postpartum women. In this study, we used a sample comprised 
of pregnant and postpartum women with various mood symptoms to explore the psychometric 
properties of the ALS-18. Method: 113 pregnant and postpartum women with mood symptoms 
participated in this study. Confirmatory factor analyses (CFA) were performed to compare the fit 
of alternative models. Results: The three-factor structure of the ALS-18 presented a nearly 
acceptable model fit and a high internal consistency, while the six-factor model of the ALS-18 
displayed a good model fit and an acceptable to high internal consistency. Conclusions: Our 
findings from pregnant and postpartum women with mood symptoms showed evidence for six 
underlying factors of ALS-18, and a close to acceptable model fit of three-factor ALS-18. ALS-
18 can be used as an instrument of measuring affective lability in perinatal women. Further 
research is needed to test the three-factor substructure of the ALS-18 against alternative factor 
models in a larger sample of pregnant and postpartum women.  













Fluctuations in mood are a known feature of women during their reproductive years, 
particularly during pregnancy and postpartum (Bowen, A, Bowen, Balbuena, & Muhajarine, 
2012; Mitchell, 2017; Toffol, Heikinheimo, & Partonen, 2015). The transition to motherhood is 
one of the most challenging times in a woman’s life. Expectant and new mothers undergo many 
physical and biological changes, but also face remarkable emotional, behavioural, and cognitive 
adjustments to adapt to the demands of motherhood during postpartum and infant care (Goyal, 
Gay, & Lee, 2007). In addition, the transition to motherhood represents a time of greater 
vulnerability to develop mood related disorders and disturbances, including perinatal depression 
(Kessler et al., 2003), and postpartum blues and mood swings (Steiner, 1998).  
Studies have found that perinatal women often experience the highest irritable, euphoric, 
and depressed mood in early pregnancy and again at the time of delivery (Cunningham et al., 
2010; Steiner, Dunn, & Born, 2003). In the early postpartum, emotional lability is prominent 
(Hapgood, Elkind, & Wright, 1988; Nott, Franklin, Armitage, & Gelder, 1976), and some 
women experience both elation and dysphoria at the same time, with mood changes occurring 
several times a day (Hapgood et al., 1988). This phenomenon is thought to be triggered by the 
large hormonal changes during this period (Buttner, O’Hara, & Watson, 2012; Cunningham et 
al., 2010; Fooladi, 2006).   
Bowen, A. et al. (2012) investigated MI in a group of pregnant women into early 
postpartum (n=45) compared to a control group of normally menstruating non-pregnant women 
(n=31). Mood instability was measured by using mood diaries with visual analogue scales (VAS) 
for depressed, irritable, anxious, and euphoric moods for both groups in the morning and 






(EPDS) (Cox, Holden, & Sagovsky, 1987). The perinatal women completed three separate mood 
diaries (each for 7 days) after three interviews (16 weeks and 30 weeks of pregnancy, and 4 
weeks postpartum, while the control group completed the mood diaries for two consecutive 
menstrual cycles (eight weeks). The findings suggest that perinatal women were more likely to 
experience depressed, irritable, anxious, and euphoric mood fluctuation in comparison to the 
controls, indicating increased moodiness in perinatal women. Furthermore, the findings except 
depression still held when depressed perinatal women were removed from the comparison. 
Contrary to most of the existing literature which predominantly focuses on depressive mood in 
perinatal period, the authors suggested that mood variation is a prominent feature in perinatal 
women.  
Affective lability can be defined as the rapid fluctuation in the valence and intensity of an 
individual’s emotional experiences (Anestis et al., 2009). Labile affect constitutes a primary 
feature of several different diagnostic conceptions in psychopathology, including borderline 
personality disorder, bipolar disorder, and intermittent explosive disorder (Harvey, 1989). 
Affective lability has been associated with a variety of psychiatric disorders. To explain the 
relationship between depression and emotional regulation, Barlow (2000) suggested that 
depression involves dysregulation, not only of cognitions, but also of emotions and behaviours. 
Berking, Wirtz, Svaldi, and Hofmann (2014) reported that deficits of emotion regulation at 
baseline negatively predicted depressive symptom severity five years later while controlling for 
baseline levels of depressive symptoms.  
Identifying the number of dimensions that underlie a particular mental disorder may help 
elucidate its etiology and outcomes (Cosgrove et al., 2011). For example, the Hospital Anxiety 






study, while insomnia is a characteristic of people in a depressed state, insomnia is a trait marker 
for developing future anxiety (Neckelmann, Mykletun, & Dahl, 2007). This suggests that sleep 
intervention therapies may be important for preventing anxiety disorders. A finding such as this 
might not have been possible if anxiety and depression were conceptualized as a single 
dimension. 
Developing a health measurement scale may follow the steps suggested by Streiner, 
Norman and Cairney (2015): 1) Creating a scale questionnaire, the items of a scale can be 
devised from focus groups, research, or expert opinion. 2) Content validation, which includes 
ensuring each item falls into at least one content area represented by the objective, and each 
objective should be represented by at least one question. 3) Scaling responses which may take 
many forms, ranging from dichotomous to continuous, such as visual analogue scales, Likert 
scales, or adjective scales. 4) Selecting the items, the criteria for selection include being 
comprehensible to the target audience, unambiguous, and checking internal consistency of the 
scale using coefficient α. 5) Testing reliability, a primary way to reflect the amount of error, both 
random and systematic, inherent in any measurement. The Pearson correlation, Cohen’s Kappa 
or the intraclass correlation are often used to examine the reliability of a scale. 6) Testing 
validity. Validity test includes three main types: content validity, criterion validity, and construct 
validity. Content validity refers that a scale represents all facets of a given construct. Criterion 
validity tests a measure related to an outcome including concurrent validity and predictive 
validity. Concurrent validation is often used when an existing measure will be replaced by a 
simpler, or less invasive one, while predictive validity is used when we develop instruments that 
allow us to get answers earlier than current instruments allow. Construct validity examines 






developed by researchers in order to conceptualize the latent variable, which are variables that 
are not directly observed but are rather inferred (Borsboom, Mellenbergh, & Van Heerden, 
2003). Construct validity includes convergent validity and discriminant validity. Convergent 
validity refers how well a test agrees with other previously validated tests that measure the same 
construct while discriminant (divergent) validity is the extent to which a test measures what it is 
supposed to and not theoretically unrelated construct (Streiner et al., 2015).  
Various instruments have been used in measuring affect lability labeled by different 
combinations of the words: affective, mood, emotion, instability, lability, swings and 
dysregulation (Marwaha et al., 2014). A total of 24 distinct measures were identified in a 
systematic review, and they have been utilized in a variety of mental disorders (Marwaha et al., 
2014). For assessing rapid shift of affect, the Affective Lability Scale (ALS-54) (Harvey, 
Greenberg, & Serper, 1989), the Affective Lability Scale Short Form (ALS-18) (Oliver & 
Simons, 2004), Mood Lability Scale (MLS) (Akiskal et al., 1995), the Ecological Momentary 
Assessment (EMA) (Stone & Shiffman, 1994), and the Impulsivity/Emotional Lability Scale 
(I/ELS) (Erhardt, Epstein, Conners, Parker, & Sitarenios, 1999) were used in different studies 
(Marwaha et al., 2014). The ALS-54 was utilized in bipolar disorder, borderline personality 
disorder, depression, personality disorder, and post-traumatic stress disorder; the ALS-18 was 
used in depression, personality disorder, bipolar disorder, and attention deficit hyperactivity 
disorder (ADHD); the MLS was used in bipolar disorder and depression; the EMA was used in 
borderline personality disorder and depression; the I/ELS was used in ADHD (Marwaha et al., 
2014). Marwaha et al. (2014) found that the ALS-54 has good internal consistency and is the 






Harvey, Greenberg and Serper (1989) developed a 54-item Affective Lability Scale 
(ALS-54) to measure the tendency for rapid shifts in emotion. The ALS-54 focused on 
depression, anxiety, elation, and anger as well as the proneness to shift between depression and 
elation, and between depression and anxiety. Items were created to capture subjective 
experience, physiological perceptions, and behaviours using the six subscales (Harvey et al., 
1989). In a series of four studies with a total of 577 undergraduate students in the US (two 
independent samples: 218 undergraduate students were enrolled at term one, and 359 
undergraduate students participated in term two). Harvey et al. (1989) created the items utilizing 
expert opinion and previous research evidence, and the items were individually rated by the 
subjects with a four-point (0-3) Likert scale to descript the self-reported level of affect. An item 
was rejected when it was uncorrelated with its own scale (r <0.20), or that was more strongly 
correlated with another scale than with its own scale. In the first study, Cronbach α coefficient 
was conducted on two independent samples to test internal consistency of the scale, and the six 
subscales’ Cronbach α were all > 0.80, except anger (Cronbach α > 0.70). The second study 
examined stability of the scales by re-testing the scales at a one-month interval, and found that 
retest reliability of the scales was acceptable. In the third study, discriminant validity was 
provided for the ALS-54 by examining the association between ALS-54 scores and a measure of 
affect intensity (the Affect Intensity Measures (AIM) (Larsen & Diener, 1987)), and it suggests 
that affective lability utilizing the ALS-54 scale and affect intensity are independent dimensions 
(Harvey et al., 1989). The final study examined the relationship between labile affect and current 
depression using the Beck Depression Inventory (BDI) as measuring depressive symptoms 
(Beck, Steer, & Brown, 1996), and found that the ALS-54 depression subscale was negatively 






level of depressive symptoms of this sample of undergraduates, and also might be because scores 
on the ALS-54 are not a straightforward function of individuals who experience depressive 
symptoms also revealing themselves to the labile affect (Harvey et al., 1989).   
To make this self-reported instrument less time consuming, Oliver and Simons (2004) 
developed an 18-item short form (ALS-18) of the 54-item ALS through a series of three studies 
with 592 first and second-year undergraduate students in Austria. The ALS-18 item version is 
rested on a three-factor model of affective lability (anxiety/depression, depression/elation, and 
anger), and each factor includes at least two items from each of the original six subscale version. 
ALS-18 has been found to be highly correlated with the original version of ALS-54 (r =.94) 
(Look, Flory, Harvey, & Siever, 2010).  
The first study presented the development of the ALS-18 by conducting an exploratory 
factor analysis (EFA) of the ALS-54, evaluation of congruence between the ALS-54 and ALS-
18, and relationship between the ALS-18 and other measures including affect intensity, 
depression, and impulsivity (Oliver & Simons, 2004). Selection of items was conducted through 
an iterative elimination process. At first, selecting items from ALS-54 was based on their 
contribution to the internal consistency of each subscale, meaning each scale maintaining a scale 
α > 0.75, which resulted in a 33-items scale. Another factor analysis on the 33-item scale was 
conducted, and the selection was based on maintaining a scale α > 0.80, which resulted in 18 
items. A convergent validity was conducted by correlating the ALS-18 total score with ALS-54 
scale total score as well as with other related measures (affect intensity, impulsivity, depression), 
and found that ALS-18 was highly correlated with ALS-54 (r = 0.94), as well as highly similar 
relationship between the two ALS scales (ALS-54 and ALS-18) and their correlations with the 






a CFA of ALS-18 with an independent sample was conducted. The three-factor model 
demonstrated a good fit, however, a six-factor structure of ALS-18 provided a better fit. Finally, 
study 3 conducted test-retest reliability of ALS-18 by administrating the ALS-18 questionnaire to 
the participants twice with one month apart, and found that the correlation from T1 to T2 ranged 
from 0.55 to 0.73 for the sample overall, and paired t-test of mean scores did not differ from T1 
to T2 for all scales (Oliver & Simons, 2004).  
The ALS-18 was tested in nonclinical samples of undergraduate students, and its 
psychometric properties have been studied in clinical populations: personality disorders (Look et 
al., 2010), bipolar disorder (Aas et al., 2015), and ADHD (Weibel et al., 2017). However, there is 
no known research on affective lability in perinatal women, and specifically, what instruments 
are most accurate for measuring affective lability in this population. Our study is the only study 
known to us that examines the psychometric properties of the ALS-18 among pregnant and 
postpartum women with mood symptoms.  
5.2 Research Hypothesis 
The ALS-18 would be a valid instrument for measuring affective lability in pregnant and 
postpartum women with various mood symptoms. 
5.3 Methods 
5.3.1 Participants and procedure 
One hundred and thirteen pregnant and postpartum women with mood symptoms 
participated in this study. Women were recruited from a local maternal mental health program 
(MMHP) funded by the Saskatchewan Health Research Foundation (Grant# 1834). The MMHP 
was developed to improve the mental health of pregnant and postpartum women in the Saskatoon 






The women came to the MMHP via referral by their family physician or nurse practitioners, then 
were contacted by a MMHP nurse who triaged them to appropriate services – counseling, 
facilitated educational and peer support group or psychiatric consultation. Only women who 
received psychiatric consultation were invited to participate the study. Women were mailed 
arrangements for their initial appointment with psychiatric consultation along with the intake 
questionnaire. Then they either brought the completed intake questionnaire to the MMHP when 
they attended their first appointment or completed it while waiting to be seen by a health care 
provider.  
After receiving a detailed description of the study, women gave their written informed 
consent. Women were informed that refusal to participate in the study did not change the care 
and services provided to them by the program. Ethics approval was obtained from the 
Behavioural Research Ethics Board of the University of Saskatchewan and operational approval 
of the SHR.    
5.3.2 Measures 
Assessment of affective lability. The Affect Lability Scale-18 (Oliver & Simon, 2004) 
was used to measure perinatal affective instability. The scale is an 18-item, self-reported 
measure, and each item is rated on a 4-point (0-3) scale ranging from “very uncharacteristic of 
me” to “very characteristic of me” and with a maximum score of 54. Factor analysis has 
confirmed good fit for three dimensions in the ALS-18: anxiety/depression shift (5 items), 
depression/elation shift (8 items), and anger (5 items) (Oliver & Simons, 2004). The ALS-18 
showed good psychometric properties in patients with personality disorders, bipolar disorder, 






Assessment of other mood symptoms. Depression symptoms were measured using the 
Edinburgh Postnatal Depression Scale (EPDS) (Cox et al., 1987). A cut-off score of 12 (≥12 
depressed; <12 indicates not depressed) was used in this present study to determine depression 
status (Husain et al., 2014; Murray & Cox, 1990; Smith, Eryigit-Madzwamuse, & Barnes, 2013). 
The 7-item Generalized Anxiety Disorder Scale (GAD-7) (Spitzer, Kroenke, Williams, & Löwe, 
2006) was utilized to determine participating women’s anxiety status. A cut-off point of 10 or 
greater was identified with optimized sensitivity (89%) and specificity (82%), and was used in 
the current study (Spitzer et al., 2006). The validation studies of GAD-7 indicated that the GAD-
7 is a useful instrument for assessing GAD in pregnant and postpartum women (Simpson, 
Glazer, Michalski, Steiner, & Frey, 2014; Zhong et al., 2015). The Mood Disorder Questionnaire 
(MDQ) (Hirschfeld et al., 2000) was administrated to evaluate participating women’s 
hypomania, or bipolar symptoms. A cut-off score of 7 or more yielded good sensitivity (0.73) 
and very good specificity (0.90), and was used in this study (Hirschfeld et al., 2000). The MDQ 
was validated in pregnant and postpartum women with bipolar disorder or major depressive 
disorder, and studies suggested that the MDQ is a useful screening instrument for bipolar 
disorder in perinatal women (Chessick & Dimidjian, 2010; Sharma & Xie, 2011).   
5.3.3 Data Analysis 
Descriptive statistics of the data included frequencies and percentage of variables 
together with means and standard deviations. For the validation process, we analyzed the 
psychometric properties of the ALS-18 in perinatal women including construct validity, and 
internal validity. To measure internal reliability consistency, Cronbach α for ALS-18 factor 
scores were computed. Statistical analysis were conducted using Stata version 15. Results were 






5.3.3.1 Construct validity  
To examine the psychometric properties of ALS-18, Confirmatory factor analyses (CFA) 
was performed to evaluate the factor structure within a measurement model and to determine 
how well the measurement model fits to its data. Structural equation modeling (SEM) was used 
to analyze the structural relationship between measured variables and latent constructs in models 
(Oliver & Simons, 2004; Ullman & Bentler, 2003). Structural equation modeling is a largely 
confirmatory, rather than exploratory, to determine whether a certain model is valid, and CFA is 
one of the major applications of SEM (Ullman & Bentler, 2003). Therefore, CFA was used to 
compare the goodness-of-fit between the following models: one-factor, three-factors 
(anxiety/depression, depression/elation, and anger), and six-factors (anxiety, anxiety/depression, 
depression, elation, depression/elation, and anger) (Oliver & Simons, 2004).  
5.3.3.2 Model fit diagnostic 
Goodness-of-fit was assessed in all models using normed chi-square (χ2/degrees of 
freedom, df), Tucker Lewis Index (TLI), Comparative Fit Index (CFI), and root mean square 
error of approximation (RMSEA). To reduce the impact of sample size on the model chi-Square, 
a good fit is suggested when the χ2/df is 2 or lower (Tabachnick & Fidell, 2007). RMSEA values 
up to 0.05 indicate a close fit, values between 0.05 and 0.08 indicate an acceptable fit, values 
between 0.08 and 0.10 indicate a mediocre fit, and those greater than 0.10 indicate a poor fit 
(Wijenberg, Stapert, Köhler, & Bol, 2016). CFI and TLI values > 0.95 indicate a good fit and 
values between 0.90 and 0.95 indicate an acceptable fit (Wijenberg et al., 2016). However, in 
sample sizes < 500, it is recommended that less stringent goodness of fit indices be used when 
evaluating factor structure (CFI and TLI values ≥ 0.90 and RMSEA < 1.0 are acceptable) 






The Chi-Square value is used to evaluate overall model fit by assessing the degree of 
discrepancy between the observed sample covariance matrix and fitted covariance matrix (Hu & 
Bentler, 1999). To reduce the impact of sample size on the model, normed chi-square (χ2/df) was 
used to assess goodness-of-fit. A good fit is suggested when the χ2/df is 2 or lower (Tabachnick 
& Fidell, 2007). The RMSEA was used to assess how well the model with chosen parameter 
estimates would fit the sample covariance matrix (Byrne, 2013). Comparative Fit Index and TLI 
evaluate the model by comparing the chi-square value of the null model to the chi-square of the 
model while CFI takes into account of sample size, and TLI adjusts for degree of freedom 
(Byrne, 2013).  
Confirmatory factor analyses (CFA) models were evaluated using the maximum 
likelihood estimate with Satorra-Bentler scaled chi square statistic for non-normally distributed 
data to provide an improved estimate of the fit of a model (Satorra & Bentler, 2001). We 
compared models using the Akaike Information Criteria (AIC) and the Bayesian Information 
Criteria (BIC), in which lower values indicate better fit (Levy & Hancock, 2007). The difference 
between the two models was calculated as ΔAIC and ΔBIC. Values of ΔAIC or ΔBIC equal to or 
greater than 10 indicate overwhelming support for the lower AIC and BIC model (Burnham & 
Anderson, 2004). In a factor analysis, a sample size in a range of 100 to 200 is considered 
acceptable (MacCallum, Widaman, Zhang, & Hong, 1999). 
5.3.3.3 Internal structure validity.  
Item internal consistency (IIC) was investigated by correlating each item with its related 
factor using Pearson correlation coefficient, and an acceptable level of IIC is recommended at 






by determining whether the correlation between items and their presenting factor is better than 
the correlation between items and other factors (Campbell & Fiske, 1998).  
Factor loadings represent the relationship of each item or variable to the underlying latent 
factor (Thompson, 2004). There is no consensus on whether an item or a variable belongs to a 
factor based on factor loading in general. Traditionally, in the social and behavioural sciences, 
factor loading of 0.30 as the minimum has been used (Merenda, 1997). Hair, Anderson, Tatham 
and Black (1998) suggested that factor loadings ≥ 0.30 satisfy the minimum threshold, factor 
loadings ≥ 0.40 are good, and factor loadings of 0.50 or greater are considered practically 
significant. For each factor, internal consistency was assessed by Cronbach’s α coefficient. To 
confirm consistency, a coefficient of at least 0.7 was expected for each dimension (Cronbach, 
1951). 
5.3.3.4 Relationship between affective lability and current depression, anxiety, and 
hypomania or bipolar symptoms 
To investigate if labile affects as identified on the ALS-18 were determined by current 
depressive, anxiety, hypomania or bipolar symptoms, we examined the correlations between 
lability of affect and level of current depressive (EPDS score), anxiety (GAD-7 score), and 
hypomanic mood or bipolar symptoms (MDQ score). Since some ALS-18 factors are also highly 
correlated with each other (Appendix 5-A Table 5-A.1), a regression design was used to control 
for the interrelationships. Factor scores of three factor ALS-18, and factor scores of six factor 
ALS-18 were entered into a stepwise regression, predicting EPDS, GAD-7, and MDQ scores 
respectively (Harvey, Greenberg, & Serper, 1989). Finally, the correlations between ALS-18 







Variables of interest for accuracy of skewness, Kurtosis, missing values, and outliers 
were examined. Univariate outliers were not detected. Items of ALS-18 were skewed, with 
significant (p<0.001) Kolmogorov-Smirnov and Shapiro-Wilk normality tests, indicating the 
variable had non-normal distribution. Satorra-Bentler scaled chi square statistic for non-normally 
distributed data was used to provide an improved estimate of the fit of a model (Satorra & 
Bentler, 2001). There is no missing data in ALS-18. 
5.4.1 Sample characteristics 
The 113 pregnant and postpartum women participants had a mean age of 29.17 (SD = 
4.91; range = 19-42 years old), 49.5% (n = 56) were pregnant (mean = 23.46 weeks, SD = 8.80), 
and 50.5% (n = 57) were postpartum (mean = 19.41 weeks, SD = 12.8). Over 90% of women 
lived with a partner (n = 99), nearly 80% of women had post-secondary education (n = 90), and 
81.4% of participating women were Caucasian (n= 92), while 13 (11.5%) Aboriginal women 
were involved in this study. 
 All the participating women exhibited mood symptoms to varying degree. The mean of 
EPDS score was 16.02 (SD = 5.50), and 75.9% of women (n = 88) screened positive for 
depression (EPDS ≥ 12). The GAD-7 mean score = 8.88 (SD = 5.83), with anxiety symptoms 
presented in 37.9% of women (n = 44) (GAD-7 ≥ 10); the mean score of MDQ = 4.71 (SD = 
3.31), and 23.3% of women (n = 27) reported hypomania symptoms (MDQ ≥ 7); finally, the 
mean score of ALS-18 = 23.39 (SD = 12.25). Additionally, 97.7% of women who experienced 
anxiety and 88.89% of women who presented hypomania symptoms also concurrently showed 







5.4.2 Construct validity 
A CFA was utilized to compare the goodness-of-fit of the three competing models. The 
factor loading for three-factor model and six-factor model are presented in Appendix 5-B Table 
5-B.1 and 5-B.2. The results of CFA for each model are displayed in Table 5.1. The upper part of 
Table 5.1 presents the goodness-of-fit parameters for each model. For one-factor model, 
goodness-of-fit information suggested a poor fit to the data, χ2/df = 3.65, p<0.001; TLI = 0.649; 
CFI = 0.641; RMSEA = 0.153; p<0.001. Model fit indices for the three-factor model indicated a 
near acceptable fit to the data, χ2/df = 2.10, p<0.001; TLI = 0.855; CFI = 0.875; RMSEA = 
0.098; p<0.001. The six-factor model showed a good fit to the data, χ2/df = 1.82, p<0.001; TLI = 
0.891; CFI = 0.914; RMSEA = 0.085; p<0.001. The lower part of Table 5.1 displays the results 
for the comparisons between models. The three-factor model structured by anxiety/depression, 
depression/elation, and anger was superior to the one-factor model (ΔAIC = 228.655 and ΔBIC = 
220.473). The six-factor model structured by anxiety, anxiety/depression, depression, elation, 
depression/elation, and anger was also superior to the one-factor model (ΔAIC = 265.291 and 
ΔBIC = 224.380), and better than the three-factor model (ΔAIC = 36.636 and ΔBIC = 3.907) 
(Table 5.1). 
All items presented standardized loadings of > 0.50 for all three models except item 1 in 












5.4.3 Internal structure validity 
The IIC was adequate for the three and six factors of ALS-18 as each item attained above 
the standard threshold value of 0.40 (Appendix 5-C Table 5-C.1-2). The IDV was adequate: the 
correlation of items with their contributive factor was higher than items with the other factors 
(Appendix 5-C Table 5-C.1-2). The Cronbach α for factor anxiety/depression was 0.811, factor 
depression/elation was 0.893, and factor anger was 0.912, indicating high internal consistency 
for all three factors model. The Cronbach α for factor anxiety was 0.796, factor 
anxiety/depression was 0.775, factor depression was 0.796, factor Elation was 0.713, and factor 
Table 5.1: Confirmatory factorial analysis of three different models of ALS-18 
 















χ2 492.166 276.543 218.916 
Degrees of freedom (df) 135 132 120 
 χ2/df  3.65 2.10 1.82 
AIC 5104.017 4875.362 4838.726 
BIC 5251.296 5030.823 5026.916 
CFI 0.691 0.875 0.914 
TLI 0.649 0.855 0.891 
RMSEA 0.153 0.098 0.085 
Comparisons ΔAIC a ΔBIC a  
1F vs. 3F 228.655 220.473 3-factor model better than 
1-factor model 
1F vs. 6F 265.291 224.380 6-factor model better than 
1-factor model 
3F vs. 6F 36.636 3.907 6-factor model better than 
3-factor model 
    
Note: 1F = one-factor model; 3F = three-factor model; 6F = six-factor model; AIC = Akaike Information Criteria; 
BIC = Bayesian Information Criteria; CFI = Comparative Fit Index; TLI = Tucker-Lewis Index; RMSEA = root 
mean square error of approximation. 
aΔAIC and ΔBIC were calculated as the difference between a candidate model and the best (i.e., lowest AIC and 
BIC model). Values equal to or greater than 10 for ΔAIC or ΔBIC indicate overwhelming support for the lower 








depression/elation was 0.820, and factor anger was 0.912, indicating acceptable or high internal 
consistency for all six factors model. The overall internal consistency reliability was satisfactory, 
and removing any item did not increase the Cronbach’s α coefficient.  
5.4.4 Relationship between labile affect and current depression, anxiety, and hypomania or 
bipolar symptoms 
The means and standard deviation for EPDS, GAD-7, and MDQ scores, as well as 
correlations between the factors of ALS-18 scores and EPDS, GAD-7, and MDQ, are presented 
in Table 5.2 and 5.3. The results of the correlations between ALS-18 and EPDS, GAD-7, and 
MDQ showed that ALS-18 was weakly correlated with EPDS and GAD-7 (r = 0.33, 0.34 




















Table 5.2: Correlations between ALS-18 three factor scores and EPDS, GAD-7, and MDQ scores 
 Mean SD Correlation 
with EPDS 
Mean SD Correlation 
with GAD-7 
Mean SD Correlation 
with MDQ 
A/D 8.00 3.59 0.46* 8.00 3.57 0.46* 8.02 3.57 0.09 
D/E 9.41 6.15 -0.14 9.40 6.16 0.02 9.32 6.20 0.39* 
Anger 6.06 4.77 0.04 6.05 4.72 -0.04 5.95 4.79 0.25* 
EPDS (N = 111) 16.02 5.5        
GAD-7 (N = 112)    8.88 5.83     
MDQ (N = 105)       4.71 3.31  
Note: * p < 0.05. A/D: Anxiety/Depression, D/E: Depression/Elation  
 
 
Table 5.3: Correlations between ALS-18 six factor scores and EPDS, GAD-7, and MDQ scores 
 Mean SD Correlation 
with EPDS 
Mean SD Correlation 
with GAD-7 
Mean SD Correlation 
with MDQ 
Anxiety 4.38 2.48 0.24* 4.40 2.46 0.43* 4.38 2.47 -0.22* 
A/D 3.62 1.61 0.39* 3.60 1.62 0.19 3.64 1.61 0.11 
Depression 5.38 3.13 0.13 5.34 3.15 0.08 5.31 3.17 -0.02 
Elation 1.86 1.78 -0.48* 1.89 1.77 0.04 1.87 1.77 0.27* 
D/E 2.16 1.99 0.32* 2.17 1.99 0.11 2.14 2.00 0.32* 
Anger 6.06 4.77 0.05 6.05 4.72 0.03 5.95 4.79 0.35* 
EPDS (N = 111) 16.02 5.5        
GAD-7 (N = 112)    8.88 5.83     
MDQ (N = 105)       4.71 3.31  







In regards to ALS-18 three factor model, correlations between ALS-18 factors scores and 
EPDS score were calculated and the overall regression was significant, F(1, 109) = 29.81, p < 
0.0001. All correlations were positive, except factor depression/elation. Only factor 
anxiety/depression predicted EPDS score that accounted for 20.8% of variance (adjusted R2) in 
EPDS score, with the standardized regression coefficient = 0.46. Regression coefficients of 
depression and anger factors were nonsignificant. For the correlations between ALS-18 factors 
scores and GAD-7 score, the overall regression was significant, F(1, 110) = 30.03, p < 0.0001. 
Only factor anxiety/depression predicted GAD-7 score that accounted for 20.7% of variance 
(adjusted R2) in GAD-7 score, with the standardized regression coefficient = 0.46. Regression 
coefficients of rest of factors were nonsignificant. Finally, for the correlations between ALS-18 
factors scores and MDQ score, the overall regression was significant, F(1, 102) = 13.67, p < 
0.0001. Factors anger, and depression/elation predicted MDQ score that accounted for 45.2% of 
variance (adjusted R2) in MDQ score, with the standardized regression coefficient = 0.39, and 
0.25 respectively. Regression coefficient of anxiety/depression factors was nonsignificant. 
For the six factor ALS-18 model, in regards to correlations between ALS-18 factors 
scores and EPDS score, the overall regression was significant, F(4, 106) = 13.40, p < 0.0001. 
The relationships were positive, except factor elation. Factors anxiety/depression, anxiety, 
elation, and depression/elation predicted EPDS score that accounted for 31.1% of variance 
(adjusted R2) in EPDS score, with the standardized regression coefficient = 0.39, 0.24, -0.48, and 
0.32 respectively. Regression coefficients of depression and anger factors were nonsignificant. 
For the correlations between ALS-18 factors scores and GAD-7 score, the overall regression was 
significant, F(1, 110) = 25.58, p < 0.0001. Only factor anxiety predicted GAD-7 score that 






coefficient = 0.43. Regression coefficients of rest of factors were nonsignificant. Finally, for the 
correlations between ALS-18 factors scores and MDQ score, the overall regression was 
significant, F(4, 100) = 26.71, p < 0.0001. Factors anger, depression/elation, anxiety, and elation 
predicted MDQ score that accounted for 49.7% of variance (adjusted R2) in MDQ score, with the 
standardized regression coefficient = 0.35, 32, -0.22, and 0.27 respectively. Regression 
coefficients of depression, and anxiety/depression factors were nonsignificant. 
5.5 Discussion 
The study evaluated the psychometric properties of the ALS-18 in a group of pregnant 
and postpartum women with various mood symptoms. The aim was to determine whether ALS-
18 could serve as an efficient measure of affective lability in pregnant and postpartum women 
with mood symptoms. Our study demonstrated both the three-factor model and six-factor model 
provided better fit beyond a single factor model as an ALS-18 measure. The three-factor model 
demonstrated a close to acceptable fit while the six-factor model, where ALS-18 items were 
assigned to their original ALS scale, indicated a better fit over the three-factor model, which 
replicated findings from the original ALS-18 study by Oliver and Simons (2004). Similarly, the 
current study also reproduced the similar findings from Oliver and Simons that the alpha 
estimates for the six-factor model were somewhat lower than those for the three-factor model. 
Oliver and Simons suggested considering the trade-offs between increased scale specificity and 
weaker scale reliability while doing research. In Oliver and Simons’ study (2004), both the three-
factor model and six-factor model showed good fit in undergraduate students, although the six-
factor model produced a better fit. In the current study, the internal consistency reliability for 






each of six dimensions of ALS-18 showed to be from acceptable to high (Cronbach’s α from 
0.713 to 0.912). The IIC and IDV were satisfactory for both models. 
We found that the level of depressive symptoms (EPDS score) is significantly correlated 
with shift between anxiety and depression of affective lability in both ALS-18 three factor and 
six factor models. The findings are in agreement with the aspect that the EPDS is a bi-
dimensional instrument that measures both depression and anxiety (Bowen, A., Bowen, Maslany, 
& Muhajarine, 2008; Ross, Evans, Sellers, & Romach, 2003). In addition, it may partially 
explain the high comorbidity of anxiety and depression that presented in the form of shift 
between them. However, depressive symptoms (EPDS score) was not significantly associated 
with depression factor in ALS-18 six factor models, which may indicate that depression factor of 
ALS is not a straightforward function of women who experience depression, and also report 
labile affect (Harvey, 1989).  
The level of anxiety (GAD-7 score) was significantly correlated with shift between 
anxiety and depression of affective lability in ALS-18 three factor model, but the correlation was 
not significant in ALS-18 six factor model. However, level of anxiety (GAD-7 score) was 
significantly correlated with anxiety factor in ALS-18 six factor model. The findings may be due 
to that the factor anxiety/depression in three factor ALS-18 combines items of anxiety factor and 
anxiety/depression factor of six factor ALS-18 model. The results suggest that six factor ALS-18 
model captures symptoms of affective lability in perinatal women more accurately, which is in 
agreement with our CFA model fit results. Additionally, GAD-7 has not been found to be a bi-
dimensional measurement that assesses both anxiety and depression.  
The level of hypomania symptoms or bipolar symptoms (MDQ score) was significantly 






three factor model, and with shift between depression and elation, elation, and anger of labile 
affect in ALS-18 six factor model, which is consistent with the fact that MDQ has been used to 
detect hypomania symptoms, and bipolar disorder in community and clinical samples 
(Hirschfeld, Cass, Holt, & Carlson, 2005; Vieta et al., 2007). In terms of the correlation between 
MDQ and anger factor of ALS-18, factor analysis of the MDQ identified a two-factor structure 
in samples with mood disorders: elevated mood overactivity factor, and irritable behaviour factor 
(Castelo et al., 2010; Lin et al., 2011), but MDQ has not been indicated for detecting anger. 
Future studies could further investigate the relationship between MDQ and ALS-18.  
The findings suggest that most labile affects as identified on the ALS-18 were determined 
by current depressive, anxiety, hypomania or bipolar symptoms, which has an important 
implication on clinical practice. For example, when perinatal women’s moods are evaluated, 
clinicians tend to assess diagnosable symptoms, such as anxiety, depressive, or bipolar 
symptoms based on women’s self-report. However, the results of the current study showed that 
perinatal women’s affects were depicted in a labile fashion. Thus assessment tools that only 
measure single diagnosable disorder may not be able to capture all aspects of perinatal women’s 
affects, and shift between affects.  
5.6 Limitations 
There are some limitations of the current study. First, our sample size was relatively 
small (n = 113), although some suggested that 100-200 sample size is enough for factor analysis 
(MacCallum et al., 1999). Others indicate that at least 10 observations for each item in the 
instrument being used is necessary (Bernstein & Nunnally, 1994). Second, due to our relatively 
smaller sample size, the current study did not conduct a cross-validation test to evaluate our 






affective lability relied on participants’ subjective report and retrospective recall. Retrospective 
recall can be influenced by cognitive processes used to reconstruct past events (Schwartz & 
Rapkin, 2004). Individuals are more likely to recall or report the experiences that seem more 
personally relevant, and are more likely to recall memory that is congruent rather than 
incongruent with their current feelings (Fredrickson, 2000). Additionally, affective lability holds 
a temporal property since affect state can change from moment to moment, which is unlikely to 
be recalled accurately, such as which day and what hour during the day it occurred (Fredrickson, 
2000). Ecological momentary assessment (EMA) showed the ability to capture immediate 
experience without relying on recall by utilizing diaries (Trull et al., 2008) or more recently by 
using smartphone (Faurholt-Jepsen et al., 2015). Future research on affective lability in perinatal 
women using EMA would capture the labile affect more accurately.  
5.7 Conclusion 
We found that the ALS-18 can be an effective instrument of measuring affective lability 
in perinatal women with various mood symptoms, and six-factor ALS-18 demonstrates better 
psychometric properties than the three-factor ALS-18. The current study also showed that ALS-
18 scores were higher in women who experienced anxiety, and elevated mood, in addition, 
almost all women who experienced anxiety and a very high percentage of women who presented 
hypomania symptoms also concurrently showed depressive symptoms, suggesting affective 
lability is a prominent feature of in perinatal women who experience anxiety, depressive, and 
hypomania symptoms. Therefore, in order to evaluate perinatal women’s mood symptoms in a 
more comprehensive way, affective lability assessment using ALS-18 should be utilized in 
routine screening in perinatal care.  







Aas, M., Pedersen, G., Henry, C., Bjella, T., Bellivier, F., Leboyer, M., . . . Aminoff, S. R. 
(2015). Psychometric properties of the Affective Lability Scale (54 and 18-item version) 
in patients with bipolar disorder, first-degree relatives, and healthy controls. Journal of 
American Journal of Epidemiology Affective Disorders, 172, 375-380.  
Akiskal, H. S., Maser, J. D., Zeller, P. J., Endicott, J., Coryell, W., Keller, M., . . . Goodwin, F. 
(1995). Switching from'unipolar'to bipolar II: an 11-year prospective study of clinical and 
temperamental predictors in 559 patients. Archives of General Psychiatry, 52(2), 114-
123.  
Anestis, M. D., Peterson, C. B., Bardone‐Cone, A. M., Klein, M. H., Mitchell, J. E., Crosby, R. 
D., . . . Joiner, T. E. (2009). Affective lability and impulsivity in a clinical sample of 
women with bulimia nervosa: the role of affect in severely dysregulated behavior. 
International Journal of Eating Disorders, 42(3), 259-266.  
Barlow, D. H. (2000). Unraveling the mysteries of anxiety and its disorders from the perspective 
of emotion theory. American Psychologist, 55(11), 1247-1253.  
Beck, A. T., Steer, R. A., & Brown, G. K. (1996). Beck depression inventory-II. San Antonio, 
US: Psychological Corporation.  
Berking, M., Wirtz, C. M., Svaldi, J., & Hofmann, S. G. (2014). Emotion regulation predicts 
symptoms of depression over five years. Behaviour Research and Therapy, 57, 13-20.  
Bernstein, I. H., & Nunnally, J. (1994). Psychometric theory. New York: McGraw-Hill. 
Borsboom, D., Mellenbergh, G. J., & Van Heerden, J. (2003). The theoretical status of latent 
variables. Psychological Review, 110(2), 203-208.  
Bowen, A., Baetz, M., McKee, N., & Klebaum, N. (2009). Optimizing maternal mental health 
within a primary health care centre: a model program. Canadian Journal of Community 
Mental Health, 27(2), 105-116.  
Bowen, A., Bowen, R., Balbuena, L., & Muhajarine, N. (2012). Are pregnant and postpartum 
women moodier? Understanding perinatal mood instability. Journal of Obstetrics and 
Gynaecololy Canada, 34(11), 1038-1042.  
Burnham, K. P., & Anderson, D. R. (2004). Multimodel inference: understanding AIC and BIC 
in model selection. Sociological Methods & Research, 33(2), 261-304.  
Buttner, M. M., O’Hara, M. W., & Watson, D. (2012). The structure of women’s mood in the 
early postpartum. Assessment, 19(2), 247-256.  
Byrne, B. M. (2013). Structural equation modeling with LISREL, PRELIS, and SIMPLIS: Basic 
concepts, applications, and programming. New York, US: Psychology Press. 
Campbell, D., & Fiske, D. (1998). Convergent and discriminant validation by the multitrait-
multimethods matrix. Personality, 56, 162-170.  
Carey, R. G., & Seibert, J. H. (1993). A patient survey system to measure quality improvement: 
questionnaire reliability and validity. Medical Care, 31(9), 834-845.  
Castelo, M. S., Carvalho, E. R., Gerhard, E. S., Costa, C. M. C., Ferreira, E. D., & Carvalho, A. 
F. (2010). Validity of the Mood Disorder Questionnaire in a Brazilian psychiatric 
population. Revista Brasileira de Psiquiatria, 32(4), 424-428.  
Chessick, C. A., & Dimidjian, S. (2010). Screening for bipolar disorder during pregnancy and 
the postpartum period. Archives of Women's Mental Health, 13(3), 233-248.  
Cosgrove, V. E., Rhee, S. H., Gelhorn, H. L., Boeldt, D., Corley, R. C., Ehringer, M. A., . . . 






externalizing disorders in adolescents. Journal of Abnormal Child Psychology, 39(1), 
109-123.  
Cox, J., Holden, J. M., & Sagovsky, R. (1987). Detection of postnatal depression. Development 
of the 10-item Edinburgh Postnatal Depression Scale. The British Journal of Psychiatry, 
150(6), 782-786.  
Cronbach, L. J. (1951). Coefficient alpha and the internal structure of tests. Psychometrika, 
16(3), 297-334.  
Cunningham, F., Leveno, K., Bloom, S., Hauth, J., Rouse, D., & Spong, C. (2010). Williams  
Obstetrics 23rd Edition (Vol. 872). New York, US: McGraw Hill 
Erhardt, D., Epstein, J., Conners, C., Parker, J., & Sitarenios, G. (1999). Self-ratings of ADHD 
symptomas in auts II: reliability, validity, and diagnostic sensitivity. Journal of Attention 
Disorders, 3(3), 153-158.  
Faurholt-Jepsen, M., Ritz, C., Frost, M., Mikkelsen, R. L., Christensen, E. M., Bardram, J., . . . 
Kessing, L. V. (2015). Mood instability in bipolar disorder type I versus type II-
continuous daily electronic self-monitoring of illness activity using smartphones. Journal 
of Affective Disorders, 186, 342-349.  
Fooladi, M. M. (2006). Therapeutic tears and postpartum blues. Holistic Nursing Practice, 20(4), 
204-211.  
Fredrickson, B. L. (2000). Extracting meaning from past affective experiences: the importance of 
peaks, ends, and specific emotions. Cognition & Emotion, 14(4), 577-606.  
Goyal, D., Gay, C. L., & Lee, K. A. (2007). Patterns of sleep disruption and depressive 
symptoms in new mothers. The Journal of Perinatal & Neonatal Nursing, 21(2), 123-
129.  
Hair, J. F., Black, W. C., Babin, B. J., Anderson, R. E., & Tatham, R. L. (1998). Multivariate 
data analysis. New Jersey, US: Prentice hall Upper Saddle River. 
Hapgood, C. C., Elkind, G. S., & Wright, J. J. (1988). Maternity blues: phenomena and 
relationship to later post partum depression. Australian and New Zealand Journal of 
Psychiatry, 22(3), 299-306.  
Harvey, P. D., Greenberg, B. R., & Serper, M. R. (1989). The affective lability scales: 
development, reliability, and validity. Journal of Clinical Psychology, 45(5), 786-793.  
Hirschfeld, R. M., Williams, J. B., Spitzer, R. L., Calabrese, J. R., Flynn, L., Keck Jr, P. E., . . . 
Rapport, D. J. (2000). Development and validation of a screening instrument for bipolar 
spectrum disorder: the Mood Disorder Questionnaire. American Journal of Psychiatry, 
157(11), 1873-1875.  
Hu, L., & Bentler, P. M. (1999). Cutoff criteria for fit indexes in covariance structure analysis: 
conventional criteria versus new alternatives. Structural Equation Modeling: a 
Multidisciplinary Journal, 6(1), 1-55.  
Husain, N., Rahman, A., Husain, M., Khan, S. M., Vyas, A., Tomenson, B., & Cruickshank, K. 
J. (2014). Detecting depression in pregnancy: validation of EPDS in British Pakistanian  
mothers. Journal of Immigrant and Minority Health, 16(6), 1085-1092.  
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., . . . Wang, P. S. 
(2003). The epidemiology of major depressive disorder: results from the National 
Comorbidity Survey Replication (NCS-R). Journal of the American Medical Association, 
289(23), 3095-3105.  
Larsen, R. J., & Diener, E. (1987). Affect intensity as an individual difference characteristic: a 






Levy, R., & Hancock, G. R. (2007). A framework of statistical tests for comparing mean and 
covariance structure models. Multivariate Behavioral Research, 42(1), 33-66.  
Lin, C.-J., Shiah, I.-S., Chu, H., Tsai, P.-S., Chen, C.-H., Chang, Y.-C., & Chou, K.-R. (2011). 
Reliability and validity of the Chinese version of the Mood Disorder Questionnaire. 
Archives of Psychiatric Nursing, 25(1), 53-62.  
Look, A. E., Flory, J. D., Harvey, P. D., & Siever, L. J. (2010). Psychometric properties of a 
short form of the Affective Lability Scale (ALS-18). Personality and Individual 
Differences, 49(3), 187-191.  
MacCallum, R. C., Widaman, K. F., Zhang, S., & Hong, S. (1999). Sample size in factor 
analysis. Psychological Methods, 4(1), 84-89.  
Marwaha, S., He, Z., Broome, M., Singh, S. P., Scott, J., Eyden, J., & Wolke, D. (2014). How is 
affective instability defined and measured? A systematic review. Psychological 
Medicine, 44(09), 1793-1808.  
Merenda, P. F. (1997). Methods, plainly speaking: a guide to the proper use of factor analysis in 
the conduct and reporting of research: pitfalls to avoid. Measurement and Evaluation in 
counseling and Development, 30(3), 156-161.  
Mitchell, C. (2017). Mood Swings: The Mindful Way: Managing Anger, Anxiety And Low Mood. 
London, UK: Sheldon Press. 
Murray, D., & Cox, J. L. (1990). Screening for depression during pregnancy with the Edinburgh 
Depression Scale (EDDS). Journal of Reproductive and Infant psychology, 8(2), 99-107.  
Neckelmann, D., Mykletun, A., & Dahl, A. A. (2007). Chronic insomnia as a risk factor for 
developing anxiety and depression. Sleep, 30(7), 873-880.  
Nott, P., Franklin, M., Armitage, C., & Gelder, M. (1976). Hormonal changes and mood in the 
puerperium. The British Journal of Psychiatry, 128(4), 379-383.  
Oliver, M. N., & Simons, J. S. (2004). The affective lability scales: development of a short-form 
measure. Personality and Individual Differences, 37(6), 1279-1288.  
Satorra, A., & Bentler, P. M. (2001). A scaled difference chi-square test statistic for moment 
structure analysis. Psychometrika, 66(4), 507-514.  
Schwartz, C. E., & Rapkin, B. D. (2004). Reconsidering the psychometrics of quality of life 
assessment in light of response shift and appraisal. Health and Quality of Life Outcomes, 
2(1), 16-21.  
Sharma, V., & Xie, B. (2011). Screening for postpartum bipolar disorder: validation of the Mood 
Disorder Questionnaire. Journal of Affective Disorders, 131(1), 408-411. 
Simpson, W., Glazer, M., Michalski, N., Steiner, M., & Frey, B. N. (2014). Comparative efficacy 
of the generalized anxiety disorder 7-item scale and the Edinburgh Postnatal Depression 
Scale as screening tools for generalized anxiety disorder in pregnancy and the postpartum 
period. The Canadian Journal of Psychiatry, 59(8), 434-440.   
Smith, H. R., Eryigit‐Madzwamuse, S., & Barnes, J. (2013). Paternal postnatal and subsequent  
mental health symptoms and child socio‐emotional and behavioural problems at school 
entry. Infant and Child Development, 22(4), 335-348.  
Snaith, R. P. (2003). The hospital anxiety and depression scale. Health and Quality of Life 
Outcomes, 1(1), 29-33.  
Spitzer, R. L., Kroenke, K., Williams, J. B., & Löwe, B. (2006). A brief measure for assessing 







Steiner, M. (1998). Perinatal mood disorders: position paper. Psychopharmacology Bulletin, 
34(3), 301-307.  
Steiner, M., Dunn, E., & Born, L. (2003). Hormones and mood: from menarche to menopause 
and beyond. Journal of Affective Disorders, 74(1), 67-83.  
Stone, A. A., & Shiffman, S. (1994). Ecological momentary assessment (EMA) in behavorial 
medicine. Annals of Behavioral Medicine.  
Streiner, D. L., Norman, G. R., & Cairney, J. (2015). Health measurement scales: a practical 
guide to their development and use. New York, New York: Oxford University Press. 
Tabachnick, B., & Fidell, L. (2007). Multivariate analysis of variance and covariance. Using 
Multivariate Statistics, 3, 402-407.  
Thompson, B. (2004). Exploratory and confirmatory factor analysis: understanding concepts 
and applications. Washington, DC: American Psychological Association. 
Toffol, E., Heikinheimo, O., & Partonen, T. (2015). Hormone therapy and mood in 
perimenopausal and postmenopausal women: a narrative review. Menopause, 22(5), 564-
578.  
Trull, T. J., Solhan, M. B., Tragesser, S. L., Jahng, S., Wood, P. K., Piasecki, T. M., & Watson, 
D. (2008). Affective instability: measuring a core feature of borderline personality 
disorder with ecological momentary assessment. Journal of Abnormal Psychology, 
117(3), 647-652.  
Ullman, J. B., & Bentler, P. M. (2003). Structural equation modeling. New York, NY: Wiley 
Online Library. 
Weibel, S., Micoulaud-Franchi, J.-A., Brandejsky, L., Lopez, R., Prada, P., Nicastro, R., . . .  
Perroud, N. (2017). Psychometric properties and factor structure of the short form of the 
Affective Lability Scale in adult patients with ADHD. Journal of Attention Disorders, 
1(11), 1-10.  
Weston, R., & Gore Jr, P. A. (2006). A brief guide to structural equation modeling. The 
Counseling Psychologist, 34(5), 719-751.  
Wijenberg, M. L., Stapert, S. Z., Köhler, S., & Bol, Y. (2016). Explaining fatigue in multiple 
sclerosis: cross-validation of a biopsychosocial model. Journal of Behavioral Medicine, 
39(5), 815-822.  
Zhong, Q.-Y., Gelaye, B., Zaslavsky, A. M., Fann, J. R., Rondon, M. B., Sánchez, S. E., & 
Williams, M. A. (2015). Diagnostic validity of the Generalized Anxiety Disorder-7 










5.9 Appendix 5-A: Table of correlations across scales and factors of ALS-18 






















ALS-18 1.00            
EPDS 0.33** 1.00           
GAD 0.34** 0.51** 1.00          
MDQ 0.65** 0.18 0.15 1.00         
A/D_3 0.77** 0.45** 0.46** 0.45** 1.00        
D/E_3 0.92** 0.23 0.28** 0.63** 0.60** 1.00       
Anger 0.84** 0.22** 0.18 0.61** 0.47** 0.66** 1.00      
Anxiety_6 0.66** 0.38** 0.43** 0.22 0.92** 0.52** 0.35** 1.00     
A/D_6 0.69** 0.42** 0.35** 0.43** 0.80** 0.54** 0.49** 0.51** 1.00    
Depression_6 0.82** 0.15 0.21 0.52** 0.46** 0.92** 0.60** 0.38** 0.44** 1.00   
Elation_6 0.80** 0.14 0.26 0.57** 0.60** 0.84** 0.54** 0.54** 0.53** 0.65** 1.00  
D/E_6 0.85** 0.37** 0.30** 0.60** 0.61** 0.89** 0.60** 0.55** 0.51** 0.71** 0.71** 1.00 
















Table 5-B.1: Factor loading for the three-factor ALS-18  (n = 113) 
 
Items Standardized  Standard 
error 
Anxiety/Depression   
1.At times I feel just as realized as everyone else and then within minutes I 
become so nervous that I feel light-headed and dizzy 
0.54 (0.062) 
3. One minute I can be feeling OK and then the next minute I’m tense, 
jittery, and nervous 
0.81 (0.053) 
5. Many times I feel very nervous and tense and then suddenly feel very 
sad and down 
0.75 (0.052) 
6. Sometimes I go from feeling extremely anxious about something to 
feeling very down about it 
0.54 (0.064) 
7. I shift back and forth from feeling perfectly calm to feeling uptight and 
nervous 
0.79 (0.0511) 
Depression/Elation   
2. There are times when I have very little energy and then soon afterwards I 
have the same energy level as most people 
0.64 (0.066) 
10. Sometimes I can think clearly and concentrate well one minute and 
then the next minute I have a great deal of difficulty concentrating and 
thinking clearly 
0.66 (0.069) 
12. I switch back and forth between being extremely energetic and having 
so little energy that it’s a huge effort just to get where I’m going 
0.78 (0.077) 
13. There are times when I feel absolutely wonderful about myself but soon 
afterwards I often feel that I am just about the same as everyone else 
0.68 (0.064) 
15. I shift back and forth between being very unproductive and being just 
as productive as everyone else 
0.71 (0.045) 
16. Sometimes I feel extremely energetic one minute and then the next 
minute I might have so little energy that I can barely do a thing 
0.83 (0.058) 
17. There are times when I have more energy than usual and more than 
most people and then soon afterwards I have about the same energy level 
as everyone else 
0.72 (0.070) 
18. At times I feel that I’m doing everything at a slow pace but then soon 
afterwards I feel that I’m no more slowed down than anyone else 
0.66 (0.046) 
Anger   
4. I frequently switch from being able to control my temper very well to 
not being able to control it very well at all 
0.86 (0.046) 
8. There are times when I feel perfectly calm one minute and then the next 
minute the least little thing makes me furious 
0.86 (0.043) 
9. Frequently, I will be feeling OK but then I suddenly get so mad that I 
could hit something 
0.87 (0.044) 
11. There are times when I am so mad that I can barely stop yelling and 
other times shortly afterwards when I wouldn’t think of yelling at all 
0.81 (0.048) 
14. There are times when I’m so mad that my heart starts pounding and/or I 







Table 5-B.2: Factor loading for the six-factor ALS-18 (n = 113) 
 
Items Standardized Standard 
error 
Anxiety   
1.At times I feel just as realized as everyone else and then within minutes I 
become so nervous that I feel light-headed and dizzy 
0.59 (0.063) 
3. One minute I can be feeling OK and then the next minute I’m tense, 
jittery, and nervous 
0.88 (0.057) 
7. I shift back and forth from feeling perfectly calm to feeling uptight and 
nervous 
0.82 (0.055) 
Anxiety/Depression   
5. Many times I feel very nervous and tense and then suddenly feel very sad 
and down 
0.97 (0.104) 
6. Sometimes I go from feeling extremely anxious about something to 
feeling very down about it 
0.65 (0.075) 
Depression   
2. There are times when I have very little energy and then soon afterwards I 
have the same energy level as most people 
0.63 (0.067) 
10. Sometimes I can think clearly and concentrate well one minute and then 
the next minute I have a great deal of difficulty concentrating and thinking 
clearly 
0.70 (0.075) 
15. I shift back and forth between being very unproductive and being just as 
productive as everyone else 
0.76 (0.056) 
18. At times I feel that I’m doing everything at a slow pace but then soon 
afterwards I feel that I’m no more slowed down than anyone else 
0.72 (0.048) 
Elation   
13. There are times when I feel absolutely wonderful about myself but soon 
afterwards I often feel that I am just about the same as everyone else 
0.74 (0.087) 
17. There are times when I have more energy than usual and more than 
most people and then soon afterwards I have about the same energy level as 
everyone else 
0.76 (0.079) 
Depression/Elation   
12. I switch back and forth between being extremely energetic and having 
so little energy that it’s a huge effort just to get where I’m going 
0.81 (0.084) 
16. Sometimes I feel extremely energetic one minute and then the next 
minute I might have so little energy that I can barely do a thing 
0.86 (0.064) 
Anger   
4. I frequently switch from being able to control my temper very well to not 
being able to control it very well at all 
0.86 (0.044) 
8. There are times when I feel perfectly calm one minute and then the next 
minute the least little thing makes me furious 
0.86 (0.045) 
9. Frequently, I will be feeling OK but then I suddenly get so mad that I 
could hit something 
0.87 (0.043) 
11. There are times when I am so mad that I can barely stop yelling and 
other times shortly afterwards when I wouldn’t think of yelling at all 
0.81 (0.048) 
14. There are times when I’m so mad that my heart starts pounding and/or I 









5.11 Appendix 5-C: Tables of item correlation for ALS-18 factors 








Anxiety/Depression    
1.At times I feel just as realized as everyone 
else and then within minutes I become so 
nervous that I feel light-headed and dizzy 
0.67** 0.31** 0.13* 
3. One minute I can be feeling OK and then the 
next minute I’m tense, jittery, and nervous 
0.85** 0.46** 0.32** 
5. Many times I feel very nervous and tense and 
then suddenly feel very sad and down 
0.80** 0.56** 0.48** 
6. Sometimes I go from feeling extremely 
anxious about something to feeling very down 
about it 
0.65** 0.42** 0.37** 
7. I shift back and forth from feeling perfectly 
calm to feeling uptight and nervous 
0.81** 0.50** 0.45** 
Depression/Elation    
2. There are times when I have very little 
energy and then soon afterwards I have the 
same energy level as most people 
0.35** 0.71** 0.33** 
10. Sometimes I can think clearly and 
concentrate well one minute and then the next 
minute I have a great deal of difficulty 
concentrating and thinking clearly 
0.39** 0.72** 0.53** 
12. I switch back and forth between being 
extremely energetic and having so little energy 
that it’s a huge effort just to get where I’m 
going 
0.57** 0.79** 0.49** 
13. There are times when I feel absolutely 
wonderful about myself but soon afterwards I 
often feel that I am just about the same as 
everyone else 
0.53** 0.73** 0.40** 
15. I shift back and forth between being very 
unproductive and being just as productive as 
everyone else 
0.41** 0.74** 0.53** 
16. Sometimes I feel extremely energetic one 
minute and then the next minute I might have so 
little energy that I can barely do a thing 
0.54** 0.83** 0.52** 
17. There are times when I have more energy 
than usual and more than most people and then 
soon afterwards I have about the same energy 
level as everyone else 
0.48** 0.75** 0.50** 
18. At times I feel that I’m doing everything at 
a slow pace but then soon afterwards I feel that 
I’m no more slowed down than anyone else 
0.27** 0.74** 0.39** 
















Anger    
4. I frequently switch from being able to control 
my temper very well to not being able to 
control it very well at all 
0.38** 0.51** 0.88** 
8. There are times when I feel perfectly calm 
one minute and then the next minute the least 
little thing makes me furious 
0.41** 0.51** 0.88** 
9. Frequently, I will be feeling OK but then I 
suddenly get so mad that I could hit something 
0.44** 0.55** 0.90** 
11. There are times when I am so mad that I can 
barely stop yelling and other times shortly 
afterwards when I wouldn’t think of yelling at 
all 
0.31* 0.38** 0.86** 
14. There are times when I’m so mad that my 
heart starts pounding and/or I start shaking and 
then shortly afterwards I feel quite relaxed 
0.45** 0.60** 0.78** 
























Anxiety       
1.At times I feel just as realized as everyone else and 
then within minutes I become so nervous that I feel 
light-headed and dizzy 
0.79** 0.28** 0.17 0.33** 0.40** 0.13 
3. One minute I can be feeling OK and then the next 
minute I’m tense, jittery, and nervous 
0.88** 0.52** 0.36** 0.43** 0.46** 0.32** 
7. I shift back and forth from feeling perfectly calm to 
feeling uptight and nervous 
0.86** 0.47** 0.39** 0.47** 0.50** 0.45** 
Anxiety/Depression       
5. Many times I feel very nervous and tense and then 
suddenly feel very sad and down 
0.56** 0.91** 0.49** 0.50** 0.52** 0.49** 
6. Sometimes I go from feeling extremely anxious about 
something to feeling very down about it 
0.34** 0.90** 0.32** 0.42** 0.39** 0.37** 
Depression       
2. There are times when I have very little energy and 
then soon afterwards I have the same energy level as 
most people 
0.34** 0.25v 0.73** 0.54** 0.55** 0.33** 
10. Sometimes I can think clearly and concentrate well 
one minute and then the next minute I have a great deal 
of difficulty concentrating and thinking clearly 
0.31** 0.39v 0.79** 0.45** 0.56** 0.53** 
15. I shift back and forth between being very 
unproductive and being just as productive as everyone 
else 
0.30** 0.45** 0.80** 0.47** 0.60** 0.54** 
18. At times I feel that I’m doing everything at a slow 
pace but then soon afterwards I feel that I’m no more 
slowed down than anyone else 
0.19** 0.30** 0.82** 0.51** 0.51** 0.39** 























Elation       
13. There are times when I feel absolutely wonderful 
about myself but soon afterwards I often feel that I am 
just about the same as everyone else 
0.43** 0.50** 0.54** 0.89** 0.61** 0.40** 
17. There are times when I have more energy than usual 
and more than most people and then soon afterwards I 
have about the same energy level as everyone else 
0.42** 0.40** 0.59** 0.87** 0.61** 0.50** 
Depression/Elation       
12. I switch back and forth between being extremely 
energetic and having so little energy that it’s a huge 
effort just to get where I’m going 
0.51** 0.81** 0.61** 0.64** 0.92** 0.49** 
16. Sometimes I feel extremely energetic one minute 
and then the next minute I might have so little energy 
that I can barely do a thing 
0.48** 0.86** 0.69** 0.64** 0.92** 0.51** 
Anger       
4. I frequently switch from being able to control my 
temper very well to not being able to control it very well 
at all 
0.30** 0.38** 0.54** 0.34** 0.43** 0.88** 
8. There are times when I feel perfectly calm one minute 
and then the next minute the least little thing makes me 
furious 
0.31** 0.42** 0.51** 0.38** 0.44** 0.88** 
9. Frequently, I will be feeling OK but then I suddenly 
get so mad that I could hit something 
0.29** 0.51** 0.50** 0.43** 0.51** 0.90** 
11. There are times when I am so mad that I can barely 
stop yelling and other times shortly afterwards when I 
wouldn’t think of yelling at all 
0.27** 0.27** 0.43** 0.40** 0.47** 0.86** 
14. There are times when I’m so mad that my heart 
starts pounding and/or I start shaking and then shortly 
afterwards I feel quite relaxed 
0.35** 0.45** 0.49** 0.64** 0.52** 0.78** 




























































Mood instability has received increased clinical and research attention. Significant 
correlations of MI with a variety of psychopathologies are known to occur in general and clinical 
samples, including depression and anxiety (Bowen, R., Baetz, Hawkes, & Bowen, 2006; 
Marwaha, Balbuena, Winsper, & Bowen, 2015). In addition, the transition toward motherhood 
has been recognized as a time of greater vulnerability for women to develop mood related 
symptoms including depression, anxiety, and MI (Bowen, A, Bowen, Balbuena, & Muhajarine, 
2012; Kessler et al., 2003; Steiner, Dunn, & Born, 2003). Perinatal mood disorders, particularly 
perinatal depression and anxiety, have been investigated extensively (Leigh & Milgrom, 2008; 
Pope, S. & Pope, 2000). Despite the recognition of a high prevalence of MI in perinatal women, 
little is currently known about MI during pregnancy and the postpartum period. Further, the risk 
factors that may increase a woman’s vulnerability to experience perinatal MI have not been 
confirmed. The potential effects of antenatal MI on neonatal outcomes have also received little 
research attention or recognition, and no-known studies have examined the relationship. 
Furthermore, little is known about whether existing instruments of MI are valid in measuring MI 
in perinatal women. 
Thus, there is a compelling rationale for perinatal MI research. However, the intense 
focus of research on perinatal depression and anxiety has meant that other distressing 
psychological symptoms tend to be overlooked, including symptoms of MI. Given the 
importance of early detection and intervention, this comparative lack of recognition of the 
affective states may lead to some expectant and new mothers who are experiencing MI to be 
overlooked, and potentially left unsupported and untreated. 
Several of the major risk factors for perinatal depression and anxiety are psychosocial 







suggested that the same factors may also be important risk factors for MI in the general 
population (Marwaha, Parsons, Flanagan, & Broome, 2013). In terms of the longitudinal 
relationship between MI and depression, Marwaha et al. (2015) found that MI predicts 
depression inception after 18 months in a population study, while Thompson, Berenbaum, and 
Bredemeier (2011) found a significant association between MI and major depressive disorder 
after controlling a major depressive episode at baseline in a student sample. Thus, it is vital that 
cross-sectional and prospective longitudinal research examines the potential role of MI and these 
factors in perinatal MI, which should include the examination of risk factors for MI, the 
association between antenatal MI and PPD, and effects of antenatal MI on neonatal outcomes. In 
addition, there is a lack of research on the validation of instruments for measuring MI in 
perinatal women. Therefore, in order to gain a comprehensive understanding of perinatal MI, a 
broad range of possible predictors, including mental health, interpersonal, social, and non- 
psychological factors, need to be considered. Additionally, effects on neonatal outcomes exerted 
by MI during pregnancy should be investigated, and finally, determining the psychometric 
properties of instruments for measuring MI in perinatal women is necessary.    
6.1 Overview of dissertation objectives 
The above rationale provided the impetus for the following four manuscripts presented in 
this dissertation. The main objectives of this study were therefore to: 
1. Review the currently existing research of MI in the perinatal women 
systematically; 
2. Examine a broad range of factors that have previously been identified as risk 
factors for perinatal depression and anxiety, and to assess their potential role in perinatal MI; 







controlling antenatal depression, psychosocial and non-psychosocial factors; 
4. Examine the trajectory of MI through the perinatal period potential (from early 
pregnancy, to late pregnancy and to postpartum); 
5. Investigate the effects of antenatal MI, depression, and anxiety on neonatal 
outcomes including 1-minute Apgar, 5-minute Apgar, BW, BW for gestational age, and PTB; 
6. Explore construct validity of the ALS-18 in pregnant and postpartum women with 
mood symptoms. 
6.2 A systematic review: perinatal mood instability 
Perinatal MI has been observed in women during their reproductive years (Bowen, A et 
al., 2012; Bowen, R, Bowen, Baetz, Wagner, & Pierson, 2011; Mitchell, 2017). Existing MI 
research on general and clinical populations indicate that MI is strongly associated with a variety 
of mental disorders (Bowen, R. et al., 2006; Marwaha et al., 2015; Thompson et al., 2011). 
However, limited research has focused on MI in the perinatal population. 
A systematic review of existing literature published between January 1985 and July 2017 
was conducted in this study. A total of 1,927 abstracts were returned from the search and with 
1,063 remained for abstract screening after duplicate removal. Only seven studies were deemed 
relevant and selected for final analysis. Only two of those articles investigated perinatal MI, one 
study examined the relationship between maternal emotional dysregulation and mother-infant 
interaction, and the rest of the articles primarily explored PPD, PPB, or experience of being 
pregnant, while perinatal MI was a component of the studies.  
A significant gap of research in perinatal MI was recognized in the review. As the first 
known systematic review of MI in pregnant and postpartum women, the findings indicated that 







predictor for late psychopathology up to 14 months postpartum, and maternal emotion 
dysregulation impedes child development. Studies also suggest that mood regulation training and 
coping skill education would improve mothers’ ability to regulate mood and emotion. 
6.3 Understanding perinatal mood instability 
In order to better understand perinatal MI, the current study focused on the risk factors 
that were associated with perinatal MI cross-sectionally, the longitudinal relationship between 
antenatal MI and PPD, and the trajectory of MI through perinatal period. To the best of our 
knowledge, this is the first study to investigate perinatal MI in relation to its risk factors, PPD, 
and trajectory. 
6.3.1 Risk factors for perinatal mood instability 
Risk factors for perinatal depression and anxiety have studied extensively. Studies found 
an array of different categories of risk factors including mental health, demographic, 
psychosocial, behaviour, and obstetric variables (Robertson, E, Celasun, & Stewart, 2003; 
Robertson, E., Grace, Wallington, & Stewart, 2004). In regards to risk factors for MI, a cross-
sectional study of the population-based survey found that depression, stress, low SES, young 
age, and being women were associated with MI (Marwaha et al., 2015; Marwaha et al., 2013). 
However, risk factors for perinatal MI have not be examined according to our systematic review 
findings described above. 
In the current study, we investigated the association between perinatal MI and its risk 
factors including depression, psychosocial, behaviour, obstetric, and demographic variables. 
Among these risk factors, three risk factors emerged from the multivariate linear regression 
analysis: depression, history of depression, and stress at T1, T2, and T3, and labour/birth 







T3 when compared with women without depressive symptoms. Women who reported having a 
history of depression showed a significantly higher level of MI scores cross-sectionally at T1, 
T2, and T3, while the finding still held when women who were currently depressed were 
excluded from analysis at T1 and T3, which may indicate that history of depression as a risk 
factor for MI is not driven by current depression. Experiencing stress in all stages of pregnancy 
and postpartum significantly and consistently increased the level of MI. If women did not have 
labour/birth complications, their risk for an elevated level of MI was significantly lowered at 
postpartum. 
6.3.2 The association between antenatal mood instability and postpartum depression 
Ample studies of perinatal mood disorders have investigated the longitudinal relationship 
between antenatal risk factors and PPD, and found that mental health, psychosocial, behaviour, 
demographic, and obstetric risk factors, such as antenatal depression, elevated stress, and lack of 
social support during pregnancy are associated with PPD (Heron et al., 2004; O'Hara & McCabe, 
2013). However, the relationship between antenatal MI and PPD had not been examined despite 
the fact that pregnant women experience a higher level of MI.  
Prospectively, we explored the relationship between antenatal MI and PPD. We found 
that MI at 17 weeks of pregnancy was significantly associated with depression at four weeks of 
postpartum while controlling for depression, and other psychosocial and non-psychosocial 
variables at 17 weeks of pregnancy, suggesting that MI during early pregnancy is an independent 
risk factor for subsequent PPD. An elevated level of MI at 31 weeks of pregnancy was not 
recognized as a risk factor for PPD. In addition, women with depression symptoms during 
pregnancy were found to be significantly associated with depressive symptoms after giving birth, 







developing PPD. These findings are in agreement with other previous studies (Chojenta, Loxton, 
& Lucke, 2012; O'Hara & McCabe, 2013; Pope & Pope, 2000; Robertson, E. et al., 2004; 
Steiner, 1998, 2002).  
6.3.3 The trajectory of perinatal mood instability 
Similarly, the trajectory of perinatal mood disorders has been documented; a majority of 
studies found that depressive and anxiety symptoms have a declining trend from pregnancy to 
postpartum (Evans, J, Heron, Francomb, Oke, & Golding, 2001; Heron et al., 2004; Pope, S. & 
Pope, 2000; Smith & Howard, 2008). No studies of the trajectory of perinatal MI were found in 
the current existing literature from our systematic review.   
The current study examined the trajectory of perinatal MI, and found an overall declining 
trend from early pregnancy (T1), late pregnancy (T2), and postpartum (T3). Specifically, 
perinatal women experience the highest level of MI at T1, a slightly lower level at T2, and a 
13.71% decrease from T2 to T3. The declining of MI level from T2 to T3 was statistically 
significant, which suggests that pregnant women are more likely to experience elevated MI 
symptoms than postpartum women. We also evaluated the trajectory of MI in women with 
depression, more stress, or history of depression, and found that the trajectory of MI did not 
change significantly, suggesting that women with depression, higher levels of stress or history of 
depression had experienced a significantly higher level of MI through the entire perinatal period 
in comparison to women who were not depressed, less stressed, or no history of depression. 
Furthermore, the trajectory of depression in depressed women showed no significant change with 
a slightly increasing trend from T1 to T3. However, MI level in depressed women had declined 
from T1 to T3, suggesting that MI has its distinct trajectory among depressed women during the 







6.4 Effects of antenatal mood instability, depression, and anxiety on neonatal outcomes 
Study findings of the relationship between antenatal depression and neonatal outcomes, 
and between antenatal anxiety and neonatal outcomes have been inconsistent. For example, 
studies conducted in developing countries (e.g., Bangladesh, India) have shown a positive  
relationship between antenatal depression and neonatal outcomes (Nasreen, Kabir, Forsell, & 
Edhborg, 2010; Patel & Prince, 2006), whereas studies conducted in developed countries (e.g., 
Sweden, England, and the current study in Canada) indicated no significant relationship between 
antenatal depression and neonatal outcomes (Andersson, Sundström-Poromaa, Wulff, Åström, & 
Bixo, 2004; Evans, J., Heron, Patel, & Wiles, 2007). Some studies have found a positive 
relationship between antenatal anxiety and neonatal outcomes (Dayan et al., 2006; Goedhart et 
al., 2010; Li, Liu, & Odouli, 2008), while other studies have reported no significant associations 
(Andersson et al., 2004; Berle et al., 2005; Flynn, McBride, Cely, Wang, & DeCesare, 2015; 
Larsson, Sydsjö, & Josefsson, 2004). Again, we could not find information on the association 
between antenatal MI and neonatal outcomes according to our systematic review findings. 
The current study investigated effects of antenatal MI, depression, and anxiety on 
neonatal outcomes. We found that antenatal MI and depression did not show significant effects 
on neonatal outcomes (1-minute Apgar score, 5-minute Apgar score, BW, BW for gestational 
age, and PTB). However, antenatal anxiety, and several other measures were associated with an 
increased risk of LBW, and low 1 and 5-minute Apgar score, and /or SGA. 
In this study cohort, elevated anxiety symptoms at T2 was found to be significantly 
associated with LBW, and low 1-minute and 5-minute Apgar score, and experiencing a higher 
level of stress at T2 was identified to have an increased risk for having a baby with SGA, which 







Non-smoking during pregnancy was recognized as a protective factor for SGA, which is in line 
with other studies (Chiolero, Bovet, & Paccaud, 2005; Raatikainen, Huurinainen, & Heinonen, 
2007; Suzuki et al., 2008). Finally, being primiparous was significantly associated with LBW 
and SGA in the current study, which is also consistent with previous studies (Shah, 2010).  
6.5 Factor structure and psychometric properties of ALS-18 in pregnant and postpartum 
women 
Affective lability has been measured by different instruments, mostly among general and 
clinical samples. In a systematic review, Marwaha et al. (2014) identified a total of 24 distinct 
measures that were utilized in a variety of mental disorders, and found that the ALS-54 (Harvey, 
Greenberg, & Serper, 1989) has good internal consistency and is the most frequently used 
instrument in the area of affect lability studies. The ALS-54 focused on a six-factor model of 
affect lability: depression, anxiety, elation, and anger as well as the proneness to oscillate 
between depression and elation, and between depression and anxiety. The ALS-18 (Oliver & 
Simons, 2004) is a short version of the ALS-54, and is also a widely used measure of labile 
affect as it consumes less time, and its psychometric properties have been studied in non-clinical 
and clinical populations. The ALS-18 item version is rested on a three-factor model of affective 
lability (anxiety/depression, depression/elation, and anger), and each factor includes at least two 
items from each of the original six subscale version in the ALS-54. However, the constructs of 
ALS-18 have not previously been validated in pregnant and postpartum women despite the fact 
that affective lability is a prominent feature in perinatal women. 
In the current study, we examined whether ALS-18 could serve as an effective measure 
of affective lability in pregnant and postpartum women with mood symptoms. To examine the 







measurement model and to determine how well the measurement model fits to its data. We found 
the three-factor model demonstrated a close to acceptable fit, while the six-factor model, where 
ALS-18 items were assigned to their original ALS scale, indicated a better fit over the three-
factor model, which replicated findings from the original ALS-18 study by Oliver and Simons 
(2004). Overall, we found that ALS-18 can be used as an instrument for measuring affective 
lability in perinatal women.  
6.6 Contributions of this research and suggestions for future work 
The findings in Chapter 2 represent the first study to systematically review the currently 
available literature on the state of perinatal MI, its relation to perinatal depression, and its 
association with child outcomes. The chapter contributes by indicating a significant gap in 
perinatal MI research. This is the first study, to date, to identify that very limited studies exist in 
the area of perinatal MI, particularly, there is a lack of recent studies (only three articles were 
published within ten years). Although we extended the literature search from 1985 to 2017, only 
seven articles met the inclusion criteria over a span of more than 30 years. Furthermore, only 
three articles were perinatal MI related, and the rest represented perinatal MI as a component of 
PPD or a symptom of being pregnant. The remarkable gap in perinatal MI research significantly 
impedes our understanding of perinatal MI. We lack a comprehensive grasp of the subject, for 
example, the etiology of perinatal MI, genetic influences, the mechanisms through which risk 
factors would affect perinatal MI, the relationship between perinatal MI and other mood 
disorders during the same period, and occurring outside of pregnancy and postpartum, and 
effects on neonatal, child, and mother outcomes.     
Chapter 3 and 4 examined MI in pregnant and postpartum women cross-sectionally and 







prospective longitudinal study that assessed perinatal MI using VAS at early and late pregnancy 
and postpartum, which provided valuable information for research on MI in pregnancy and 
postpartum women, thus increase our understanding of perinatal MI. The strengths of the study 
include a relatively large community sample, the longitudinal nature of the data, and the repeated 
assessments of participants. The data collection was conducted by the same training research 
assistants that maintained consistence in assessments (Pannucci & Wilkins, 2010). In addition, 
assessing MI in quantitative research tends to quantify the level of individuals’ experiences of 
MI, which would not indicate how individuals feel about MI, what individuals’ thoughts about 
frequent and extreme mood fluctuations are, how they cope emotionally, and what impact MI has 
on individuals’ lives. In order to present and interpret perinatal women’s own experiences of MI 
in a narrative manner, future studies could focus on women’s perspective, and lived experience 
of perinatal MI by utilizing qualitative research methods.   
Chapter 3 represents the first known study to investigate risk factors on the course of MI 
in pregnant and postpartum women, the association of antenatal MI with PPD, and the trajectory 
of MI from early pregnancy, to late pregnancy and to postpartum. The findings revealed the risk 
factors for MI cross-sectionally, and the relevance of individual risk factors on the course of MI 
during pregnancy and postpartum was investigated using linear mixed models (LMM) with 
intercept as a random effect. The study examined the longitudinal relationship between antenatal 
MI and PPD, and we also examined the trajectory of perinatal MI by utilizing LMM to identify 
group differences (e.g., depressed vs. non-depressed). In addition, we compared the level of 
perinatal MI and depression between women who took antidepressant medications and women 
who did not take antidepressants, but we suggested interpreting the results with caution due to 







counseling or medication compliances were not taken into consideration. Future studies could 
investigate the effectiveness of antidepressants on perinatal MI in a larger sample, and other 
covariates should be considered. Furthermore, the positive relationship between depression and 
MI has been demonstrated in general and clinical populations, and the current study replicated 
the finding in perinatal women both cross-sectionally and longitudinally. To understand the 
relationship, studies illustrate that depression and MI share some common correlations, such as 
neuroticism, trait negative affect, and stress (Beatson & Rao, 2013; Bowen, R, Mahmood, 
Milani, & Baetz, 2011; Denollet & De Vries, 2006; Miller, D., Vachon, & Lynam, 2009; Miller, 
J. & Pilkonis, 2006; Quilty, Sellbom, Tackett, & Bagby, 2009). The current study found that 
elevated stress was associated with both MI and depression in perinatal women. Neuroticism and 
negative affect have been found to be correlated with depression in perinatal women (Robertson, 
E. et al., 2004; Stewart, Robertson, Dennis, Grace, & Wallington, 2003), and future studies could 
investigate the association of perinatal MI with neuroticism and negative affect.  
Chapter 4 examined effects of antenatal MI, depression, and anxiety on neonatal 
outcomes, which is the first known research focused on determining the association between 
antenatal MI and neonatal outcomes. The findings of the study showed that there was no 
correlation of antenatal MI with neonatal outcomes, which contributes to research in regards to 
understanding the effects of antenatal MI on neonatal outcomes. The results of effects of 
antenatal depression and anxiety on neonatal outcomes in the current study replicated other 
previous studies (Andersson et al., 2004; Evans, J. et al., 2007; Glover, O’Connor, & O’Donnell, 
2010; Khashan et al., 2014). Furthermore, unlike a majority of studies that examined the 
relationship only at one time point during pregnancy, our study used two time points (T1 and T2) 







antenatal MI, depressive, and anxiety on neonatal outcomes across the antenatal period: a period 
with increased risk of mood related symptoms and disorders. In the current study, BW for 
gestational age is categorized into SGA (< 10th percentile), AGA (within 10th and 90th 
percentile), and LGA (>90th percentile) in accordance to published recommendations. Original 
score categories above 10th percentile were collapsed to obtain a manageable number of 
categories to perform logistic regression. Future studies could investigate effects of MI on LGA 
with a larger sample.  
Chapter 5 represents the first known study to examine factor structure and psychometric 
properties of ALS-18 in pregnant and postpartum women. Identifying the number of dimensions 
that underlie a particular mental disorder is essential in understanding its etiology and outcomes 
(Cosgrove et al., 2011). The previous research tested ALS-18 in nonclinical samples of 
undergraduate students (Look, Flory, Harvey, & Siever, 2010), and its psychometric properties 
have been studied in clinical populations (Aas et al., 2015; Look et al., 2010; Weibel et al., 
2017). In regards to instruments in measuring perinatal MI, a majority of measures in assessing 
perinatal MI have been used either one single question about mood fluctuation (Wilkinson, 1999) 
or VAS (Bowen, A et al., 2012; Hapgood, Elkind, & Wright, 1988), of which its psychometric 
properties were not examined. As the first study to date, we found that ALS-18 can be an 
effective instrument of measuring affective lability in perinatal women with various mood 
symptoms. Our sample size is relatively small; future studies with a larger sample are required to 
examine the psychometric properties of ALS-18 in pregnant and postpartum women, and 
conduct a cross-validation test to evaluate model outside of the sample to increase the 







A comparison of study findings between the existing quantitative studies (based on our 
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6.7 Limitations of the research 
The study findings should be interpreted with caution given several study limitations. 
First, the majority of the sample was Caucasian and well-educated. According to the 2016 
Census of Canada (Statistic Canadian, 2018), 25.8% of females between 25 and 34 years old, 
and 24.4% of females between 35 and 44 years old in Saskatchewan have a high school diploma 
or higher education (there was no information on women 18-25 years old, and only had 15 years 
old and over) compared with 70.1% of the current sample. In addition, Aboriginal people 
accounted for 15.6% of the total population of Saskatchewan compared with 7.2% in the FIP 
sample and 11.5% in the MMHP sample (Statistic Canadian, 2018). This limits the 
generalizability of the results to women who have lower education attainment, and who are 
aboriginal. Being an Aboriginal woman is associated with a higher risk for perinatal mood 
related disorders (Bowen, A. & Muhajarine, 2006; Bowen, A, Stewart, Baetz, & Muhajarine, 
2009). The aboriginal population has been correlated with lower SES, and one of the gaps in the 
research literature is risk factors for perinatal mood disorders that are specific to women from 
low SES backgrounds (Reading & Wien, 2009; Robertson, E. et al., 2004). In addition, a 
growing body of research suggests that immigrant women have higher rates of depression 
prenatally and postnatally (Mechakra-Tahiri et al. 2007; Miszkurka, Goulet, & Zunzunegui, 
2010; Stewart et al. 2008; Zelkowitz et al. 2008). Research on Canadian immigrant women 
shows that immigrant women constitute a high-risk group for depression (Stewart et al., 2008), 
and pregnant immigrant women may be at particularly high risk (Zelkowitz et al., 2004). Thus, 
future research should focus on investigating the factors that increase vulnerability to experience 
MI and other mood related disorders specifically in perinatal aboriginal and immigrant women, 







Second, the measures used in the current study relied on participants’ subjective report 
and retrospective recall. Retrospective recall can be influenced by cognitive processes used to 
reconstruct past events (Schwartz & Rapkin, 2004). Individuals are more likely to recall or report 
the experiences that seem more personally relevant, and are more likely to recall memory that is 
congruent rather than incongruent with their current feelings (Fredrickson, 2000). Particularly, 
physical, cognitive, and emotional changes among perinatal women have been documented that 
might have affected the objectiveness when women answered the questionnaires (Franzini & 
Fernandez-Esquer, 2004). For example, some women often experience severe nausea and 
vomiting during the early stages of pregnancy that may influence their self-report on 
psychological states in general (Swallow, Lindow, Masson, & Hay, 2004). Third, self-reported 
risk behaviours such as smoking, alcohol consumption, and drug use are often under-reported, 
particularly during the perinatal period because of social desirability bias (Alvik, Haldorsen, & 
Lindemann, 2005; Van de Mortel, 2008). Fourth, we used baseline information including 
demographic predictors, which may have changed over the perinatal period. However, one 
advantage of this approach can lead to identifying risk factors early during pregnancy that 
provides the opportunity for early intervention for at risk women.  
Finally, the study results cannot be used to make causal inferences about the relationships 
between study variables, since mental health status, especially depression, has been found to alter 
people’s perceptions of emotion, and perceptions of stress, and availability and utilization of 
social support (Michels, Kruske, & Thompson, 2013; Reay et al., 2012).  
6.8 Implications 
Pregnancy and the postpartum provide a unique opportunity to screen and assess women 







period. The findings of manuscripts one to four have important implications for the mood related 
symptoms screening because the current focus on depression and anxiety measured by the EPDS 
will not likely to detect many of the women who experience perinatal MI (Miller, R. L., Pallant, 
& Negri, 2006; Rallis, Skouteris, McCabe, & Milgrom, 2014; Wardrop & Popadiuk, 2013). 
Given the high prevalence of MI in perinatal women, there is a need to accurately screen and 
detect MI in expectant and new mothers. In addition, the findings indicate that the ALS-18 can 
be an effective tool for measuring perinatal MI. 
However, little research has examined perinatal MI as a distinct affective state, as the 
manuscript one indicated. Increasing our understanding of MI during the perinatal period may 
have important implications for both public and clinical practice since the presence of perinatal 
MI may impact on the strategies and resources utilized by health related agencies and health 
professionals. Due to the fact of normalizing perinatal MI, increasing awareness among the 
public, particularly perinatal women, through health promotion is essential. For health 
professionals, early detection and intervention of women who experience MI during the perinatal 
period are key. In addition, the high prevalence of perinatal MI, and the relationship between 
perinatal MI and depression may itself potentially result in PPD if it is not resolved (Marwaha et 
al., 2015; Thompson et al., 2011). Thus, although the treatment of perinatal depression is 
generally considered to take precedence (Miller et al., 2006), the psychological wellbeing of new 
mothers is likely to be optimized by tailoring the treatments to their comorbid perinatal MI 
symptoms, if present, as they might be expected to interact with each other to worsen the 
symptoms (Marwaha, Parsons, & Broome, 2013). 
The study findings in manuscript two identified that MI during early pregnancy was a 







our study results. Thus, the findings point to the importance of developing specialized 
interventions, to be delivered by mental health professionals, and counselors, who target MI 
symptoms before the birth. For example, working with expectant women to educate them on MI 
including possible impact on women’s mental health, relationship with their partner, and 
interaction with their infant after giving birth, to learn coping skills to manage MI including how 
to recognize MI and regulate MI, to facilitate women to increase ability and confidence in 
managing MI including role-playing, or if necessary, to implement pharmacologic intervention. 
One challenge for primary health care providers in identifying perinatal MI, and 
facilitating further referrals, is the tendency for them to predominantly consult with mothers 
alone during perinatal period. Possibilities for increasing awareness of MI among the partner and 
family are very important, as there is evidence that social support plays an essential role in 
managing perinatal mood disorders (Corrigan, Kwasky, & Groh, 2015; Reid & Taylor, 2015). 
Health professionals should work with expectant and new mothers, their partners, and other 
support that goes beyond the marital relationship, including women’s mothers and close friends 
in regards to health promotion, therapy sessions, and treatments. 
Furthermore, the link between prenatal MI and labour/birth complications has important 
healthcare implications. The study results indicated that the women who had labour/birth 
complications were at a greater risk of experiencing MI four weeks after delivery. Thus, it is 
prudent to provide additional education, and psychological support to women who undergo 
labour/birth complications to reduce the level of MI, or decrease the possibility of MI from 
occurring during postpartum period. 
As the ability to engage in screening and the provision of possible assessment tools in 







option is for health care professionals to consider using the ALS-18 as an initial screening tool. 
The ALS-18 has the advantage of being a short and easily administered scale, and as 
demonstrated in the current study, it can be an effective instrument for measuring perinatal MI. If 
a woman is found to score highly on the ALS-18, a referral can be made. Additionally, hospitals, 
primary care settings, and programs that were specifically designed for perinatal related care, for 
example, the MotherFirst in Saskatchewan, have social work service or referral service available 
to women undergoing antenatal or early postnatal care, and referrals can be made by midwifery, 
nurses, or obstetric staff, or women can be encouraged to self-refer. Due to the potential for 
untreated mental health concerns to have deleterious effects on new mothers, their infants, and 
the wider community, developing clear screening and referral pathways is important for the 
overall well-being of mothers, babies, and their families, and also for future research and clinical 
practice. 
6.9 Conclusions 
The current study filled some of the gaps that were identified in our systematic review 
of perinatal MI, and adds to the ongoing understanding of perinatal mood symptoms, 
specifically MI. We were able to identify the risk factors for perinatal MI at early and late 
pregnancy, and postpartum: depression, history of depression, stress, and labour/birth 
complications, and antenatal MI at early pregnancy was found to be a significant risk factor 
for postpartum depression. Although the trajectory of perinatal MI for the whole sample 
follows a similar evolution of perinatal depression over the perinatal period, it had a distinct 
trajectory for women who experienced depressive symptoms. In addition, the findings of the 
association between antenatal MI and neonatal outcomes were negative in the current study. 







and 5-minute Apgar scores, alleviating stress and smoking cessation during pregnancy were 
recognized as protective factors for having a baby with SGA, and being first time mother was 
significantly associated with LBW and SGA. Furthermore, the psychometric properties of 
ALS-18 were validated in perinatal women, and the results showed that the ALS-18 can be an 
effective instrument in measuring MI in perinatal women with mood symptoms. Our findings 
support the need for health promotion that increases awareness of perinatal MI, for early 
detection and early intervention of perinatal MI by adding MI screening into routine perinatal 
care, and for targeting perinatal women with certain characteristics, most notably depression, 
anxiety, history of depression, high stress level, and labour/birth complications. Prioritizing 
these needs may help to recognize women at greater risk of developing mood related 
symptoms during pregnancy and postpartum, thus appropriate interventions and supports can 
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6.11 Appendix 6-A: Table of comparison between existing quantitative studies and the current studies 
 
Table 6-A.1: Comparison between existing quantitative studies (5) and the current studies 
 
Existing quantitative studies 
 
 
Contributions of the 







Measures Time points Major findings 




















 16 weeks Scores on all seven 
dimensions of the 
PDSS were elevated. 
Dimension of 
emotional lability had 
the highest mean score 
among the 7 
dimensions. 
1.Longitudinal study-at three time 
points during the perinatal period 
2.Larger sample size – followed 
women from early pregnancy to 
postpartum  
3.Investigated the relationship 
between perinatal MI and its risk 
factors, between antenatal MI and 
PPD, and the trajectory of perinatal 
MI  
4.Used VAS (5-item 
questionnaires) primarily to assess 
perinatal MI (In the existing study, 
emotional lability is only one 
component of PDSS)  
5.Used EPDS to assess depressive 
symptoms. EPDS has been 
validated in perinatal women 
worldwide, and the most used 
instrument for measuring perinatal 
depression  











Table 6-A.1: Comparison between existing quantitative studies (5) and the current studies continues 
 
Existing quantitative studies 
 
 
Contributions of the 







Measures Time points Major findings 
    Antenatal  Postpartum 
 
  
        
Bowen 















30 weeks  
4 weeks Perinatal women 
showed higher mean 
levels of irritable, 
anxious, and high MI 
than the non-perinatal 
women. The findings 
still held when 
pregnant women with 
depressive symptom 
were excluded from 
the study.  
1.Larger sample size 
2.Investigated the relationship 
between perinatal MI and its 
risk factors, and identified 
risk factors: depression, 
history of depression, more 
stress, and labour/birth 
complications 
3.Examined association 
between antenatal MI and 
PPD, and found antenatal MI 
at early pregnancy as an 
independent risk factor for 
PPD 
4.Explored the trajectory of 












Table 6-A.1: Comparison between existing quantitative studies (5) and the current studies continues   
 
Existing quantitative studies 
 
 
Contributions of the 







Measures Time points Major findings 
    Antenatal  Postpartum 
 
 


















 0-2, 6, 13, 
26, and 60 
weeks 
Emotional lability was 
the important affective 
component of the early 
postpartum. Lability of 
mood in the early 
postpartum was related 
to psychiatric 
symptoms up to 14 
months postpartum and 
was the strongest 
predictor of later 
psychopathology. 
1.Larger sample size – 
followed women from early 
pregnancy to postpartum  
2. Investigated the 
relationship between 
perinatal MI and its risk 
factors, and the trajectory of 
perinatal MI 
3.Examined relationship 
between MI and PPD 
outside of the early 
postpartum period, and 
found MI at early pregnancy 
to be a significant risk factor 
for PPD 
4.Used EPDS to assess 
depressive symptoms  
 












Table 6-A.1:  Comparison between existing quantitative studies (5) and the current studies continues   
   
Existing quantitative studies 
 
 
Contributions of the 







Measures Time points Major findings 
    Antenatal  Postpartum 
 
 
        

















 24 weeks Higher maternal 
emotion dysregulation 
was significantly 
associated with higher 
facial affect synchrony; 
the relationship 
between the effect of 
maternal 
psychopathology and 
facial affect synchrony 




three time points during 
perinatal period 
2.Larger sample size of 
perinatal women 
3. Investigated the effects 
of antenatal MI, 
depression, and anxiety on 
neonatal outcomes, and 
found no association 
between perinatal MI and 
neonatal outcomes 












Table 6-A.1:  Comparison between existing quantitative studies (5) and the current studies continues   
 
Existing quantitative studies  










Measures Time points Major findings 























The immediate postpartum was 
the peak period of positive affect 
for both primiparous and 
multiparous mothers and their 
male partners and was also the 
peak period of negative affect and 
mood lability for primiparous 
women. There was relatively little 
change in mood from the second 
to the third trimester, and in the 
early postpartum. However, 
primiparous women showed 
increased mood lability while 
multiparous women did not 
experience the increase.  




perinatal MI and its risk 
factors, between antenatal 
MI and PPD, and the 
trajectory of perinatal MI 
3.Used VAS (5-item 
questionnaires) to assess 
perinatal MI (The existing 
study did not specify what 
mood related questions were 
used to assess MI)    
 
       Additional contributions:  
1.Systematically reviewed 
existing literature of perinatal 
MI, its relation to perinatal 
depression, and its effects on 
children 
2.Investigated psychometric 
properties of ALS-18 in 
perinatal women with mood 



















































































































6.13 Appendix 6-C: Questionnaire for the MMHP study 
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